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Background: The fish-parasitizing nematode Anisakis pegrefjii induces 
gastrointestinal disease and allergy when ingested by humans, and can cause 
occupational allergy in seafood processing workers. The present study examines 
immune and allergic responses to A. pegrefjii' in wildtype and gene deficient mice, 
with special focus on interleukin(IL)-4, IL-l3, and the IL-4 receptor alpha (IL-4Ra). 
Methods: Experimental murine models of Anisakis infection, Anisakis-induced 
anaphylaxis and Anisakis-induced dermatitis were established in order to gain insight 
into the immune responses generated against Anisakis and unravel mechanisms of 
allergic disease. Mice deficient in IL-4, IL-l3, IL4IIL-l3 and the IL-4Ra were 
utilized to elucidate the distinct functions of these molecules. In addition, T-cell 
specific IL-4Ra deficient (LckcreIL-4Ra-/IoX) and macrophage specific IL-4Ra 
deficient (Lys~reIL_4Ra·/IoX) IL-4Ra deficient mice were used to unravel the cell 
specific requirements for IL-4Rq expression in anaphylaxis and dermatitis. 
Results: Anisakis infection elicited rapid infiltration of immune cells into the 
intraperitoneal cavity in all strains, with IL-13 -/- and IL-4Ra -/- showing the 
strongest responses. Anisakis infection induced a strong Th2/type 2 response in 
wildtype mice, characteristic of gastrointestinal helminth infections. When challenged 
orally with Anisakis extract, previously infected mice produced a response typical of 
food allergy, with itching, diarrhoea and airway mucus hypersecretion. In contrast, 
allergic responses were reduced and abrogated in IL-4 -/- and IL-4Ra -/- mice, 
respectively. Oral dosing of mice with Anisakis extract resulted in production of the 
Th2-associated antibodies IgG 1 and 19E, but did not elicit strong Th2 responses in the 
manner of live larvae, and virtually no allergic response was seen after challenge. 
In a model using intraperitoneal sensitization and the adjuvant alum, Anisakis proteins 
were able to cause anaphylaxis comparable to that caused by OV A. OVA-induced 
anaphylaxis was found to be dependent upon the FcyRIIIIII and associated with mast 
cell degranulation. Specific deletion of IL-4Ra on CD4+ T cells abrogated 
anaphylaxis substantially, despite the presence of IgE and Th2 cytokines in these 
1 
mice. IFN-y was found to be crucial for this protection, as its depletion reversed the 
resistance of this strain. 
Epicutaneous sensitization with Anisakis larval antigens induced local inflammation, 
epidermal hyperplasia, Th2 cytokines, and production of anti-Anisakis IgE and IgG I. 
Intravenous challenge of sensitized mice resulted in anaphylactic shock. Skin 
inflammation was IL-4 independent but IL-13 dependent, while systemic anaphylaxis 
reactions were p'redominantly IL-4 mediated. Macrophage/neutrophil specific 
expression of the IL-4Ra was not required for anaphylaxis but exacerbated skin 
inflammation. CD4+ T-cell specific specific IL-4Ra deficient mice experienced 
partial inhibition of systemic anaphylaxis, despite showing skin inflammation 
comparable to that of wildtype mice. 
Conclusions: Anisakis infection strongly predisposes to allergic responses against 
ingested Anisakis proteins and is more effective than oral sensitization with Anisakis 
proteins alone. However, Anisakis proteins alone are able to cause allergic reactions, 
contrary to the suggestion that live infection is required for reactions. IL-4, IL-13 and 
the IL-4Ra play important and distinct roles in Anisakis allergy that vary according to 
the route of sensitization. Studies with cell-specific IL-4Ra knockout mice provided 
deeper insight into the mechanisms of anaphylaxis and atopic eczema. The data 




The aim of this study is to investigate the immune responses induced by Anisakis 
infection and to elucidate mechanisms of Anisakis allergy. The study focuses on the 
role of the cytokines IL-4 and IL-13, and their shared receptor subunit, the IL-4 
receptor alpha (IL-4Ra.). 
Specifically, we aim to investigate: 
cellular and humoral immune responses induced by Anisakis 
the ability of Anisakis proteins to sensitize through ingestion and epicutaneous 
exposure 
the ability of Anisakis proteins to cause ingestion-related allergy and anaphylaxis 
the role ofIL-4, IL-13 and the IL-4Ra. in immune responses to Anisakis 
the role of IL-4Ra. expression on CD4+ T cells, macrophages and neutrophils in 
anaphylaxis 
the role of IL-4, IL-13, the IL-4Ra. and IL-4Ra. expression on CD4+ T cells, 
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t· ittu~ 1.1. Global d ilit ribu tion of soi\-lraQsmiUflI behnintb infec:lions and 
~ehi!lll»omi:u i~. Soil tnmsminro helminths 5Uch as roundworms. hook ... orms and 
... lIip"onn$. as "ell as the IIdmintlls causing bilhan:ia (Schi.<IO.Wltlo spp) an: mo~ 






Inf~'Ctiou~ and para~iue diseases a~ Ihe primary eausc:s of death .... orld",idc. despile Ihe 
fact Ihut most orlhesc: diseases arc preventable ~ Treatable t. One category of pIllllSUC$ -
, 
the helml nths (palllsilic WOIlTIS) - contributes greaTly 10 the disease burden. especially in 
the deve loping world (sa Fig. 1.\). Important helminths include Schistosoma, thc causc 
of sc:hislO$Omiasis (1HIharlll). and !he soil-tl1lnsmined helminths (STH). including 
round .... orms. hook .... OIlTII and "hipwonns, ~ommonly kno"TI as intcstinal wonn,. 
Around 2 billion people are inf~led by these helminths. and about 300 minion people arc 
severely ill h«ausc of them lJ, SchlstosolTlCs UfililC water snails as a vector, and so 
schistosomiasis is located around freshwatCl' sou~cs such al lakes and dams in tropical or 
subtropical r'fgion,. STH are more widely di stribllled and arc linked to I lack of access 10 
sanitation: consequC1Illy they arc mo~ common in areas of poverty 1. ' , '. 
Symptoms of STH mfecliollS include nausea, tiredness, 10" of appetite and abdominal 
pain. Most infettions are not life-threatening but can cause significant morbidity Ihrough 
sequestering of vitamin A and iron, and by causing 1015 of appetite l,ll-t. This can result 
in g:rov.th retardalion and impainnent of cognitive development 1.', In addition, imestinal 
worms can supp~ss immune responsc:s and so may innuC1l~ the response 10 othcr 
diSQses and 10 "actine! 9. 10. Heavy infections can cau5C intestinal obstruction that 
requi~5 surgery II. Occasionally worms migrate 10 olher organs such as the bite ducts. 
which abo requires surgical intervention 12. 
Th" most common intestinal helminths arc the nematodes ,brari;r lumbrir;Oitie;r, N~alQr 
a~rl~"u;r, Trichuris /rkhurla. AnydWrQma dUQdenaJi;r and S ~err;Qrol/s -. 6, II. 
However. occasionally humans may be infected by helminths far ,,·hich another animal is 
the nalllral host. Such infections are tenr.ed iWOnOtlC. In 1960 a previously undescribed 
7.oDnotic infection WM reported by Van Thiel : intestinal infeCliol'1 WIth the rol¥l",,"'onn 
Anjwfos slmplu in a patient "ho had eaten raw herring" (Fig. 1.2). This case occurred 
in the Netherlands. bUl made a huge impacl 011 Japan~ parasitologists. woo ~cognizo:<l 
that the Japancse habit or eating raw fish meant lhal similar Clises wcre highly likely in 
• 
Iheir own country U Subs.equenlly. In 196-' a special Japanest research group was 
t>Stahlishtd 10 in\nligate the disease. IIhich was 10 btcome known as 8Ilisakiasis. Since 
then. toousands of C<I!;C5 have bttn teporttd from Japan and hundrtds from European 
countries whert Ihe conswnRlion of Jish is high, weh as Spain Bnd haly 1;"11. Stalter.ed 
caK5 ha~e also b«n reported from locations world-wide. induding other European 
counlrics. Sorth and Soulh America. England and New Zealand I,. .. , [I is likely Ilmt rhe 
rising popularily of sushi and sashimi around Ihe world will Increase Ih~ incidence of 
anjsa~lasis further :'. Ouuide of Japan. Spain and l\:l[y, anisakiasis is highly Iike[} 10 be 
mi5diBgoosed due 10 alack of awareness amongst physicians II.1/i. 
l .l The biology of An/sakis Ip"cies 
Artlsakl$ spp. belong to the subfamily Anisakinae, filmily Anisakidae. superfamily 
Ascaroidea. suborder Astaridina, order Ascarida, subclass Secementrea., Class Nematoda 
1'. Ph>logenCl1c studies indicate thai the human pal'l1sile 10 ",hieh il is most closely 
related is Asc(l~il (Fig 1.3) .1. N. As a genus, ArtiSllkif is found ""orld·wide, bul AnlstJijl 
species are differentially distribuled grographically and utilize different host species Jll.ll . 
Rec()gnized spceies include Ihe three sibling species of the Allisulcil sfmplu complex (A. 
limpltx sensu Ilr/clo, A Ilmpia C and A. pcgrejfi,). 35 well as Ihe morpoologically 
differenl A fJ"Pif"u. A :iphidurum. A. srhupakori. A. ph)'MfcrIS and A brewspirulatu )1· 
>Ii. These arc species that havc been conJinncd allhe genetic Ie> el using isozyme analysiS 
or PCN,·based approaches. Se\eral olher sp«ies ha\'c mn di.'iCo~m:d but are 1101 yet 
properly characterized. such u A ins/gllis. A.uI~ndri and A. dU$SlImierii::1. 
The 01M< genera In the subfamily Anbalml.le, collccti~ly kno\o\TI as the anisakids. arc 
PUUdo/UfOno..a, CO/UfOC'lX',"1im and IfYSltf"Ofh)iucium. All ofthesc: nematodes appear to 
ha\C similar life-c)cles (Fig. 1.4), although thei' host specie1l vary " 17. ]' . The 
primllJy/deJinili\'e ooSI5 of aRisak ,ds arc sn mammals such as whales, dolph,"!. seals 
and sea [ions. as well as aqualic birds lind turtles. Allisakis $ilP utili~e cClaccans such as 
OO[phll\5 and whaln as primsry hoSIS. E"s all! passed In!o Ihe sea .,ja thc facees of the 
eClat cans. The JirSI rTtO\I[t (LI - L:) takes place Inside the egg. releasing frce·swimming 
" 
o.ap!<"r I 
'-Igure 1.2. AnlJllkis I"grrJ]ii. a) A large (diameter I).Scm) petri dish cool.llinlng 
Anl.l'Uku pegreffii third·SUlj;c IIII'\<!>C (I.,). b) Clo!;C· up of the 1111'\ ac ..... h ich .1" ay$ mo\ e 
to cluster tog~th~r. e) Anisabs pe!<:reffi coils up ..... hen dormant. d) An ,fniS<lkiJ pi'greffii 
I.). '"awake". 
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f lJurt 1.3, " ph}logtndk IrH of nem. ' ode sp«ies. Ph)iosenellt analysIS .... '3S 
performed on 5!l\illJ subunit ribosonull ON .... S¢qlltrlCl:5 (ron .. "id~ ~gc or 1KfTl3tOlks 
The millis indlalc that A"lSUku spp ~ dORly gcncl1Cl1l1y related 10 A#QrU _ ~nd 
TozOt:ufTlnm/s. From BlaMa-(I99!)II, . 
L; larvae lhal are ingesled by liny crustxeans such as krill (e.g. Euphasio. Tysanocssa). 
lhe filSl inlermediate hOS'ts 16, n. 17. The cNstace:ms in tum are eaten by second 
mlmnediate hosb, which are list!. tar~r CNSlaCc:ms or cephalopods. Inside Ihese hostS. 
the: la ..... ae moul! into. third-stage larvae artd become encapsulated on Ihe sl! rfoct!l of 
orgllflS or muscles. Larga fish may become infec ted by ealing Jmaller fish. lend ing 10 an 
aceumulal ion of larvae lhat increases with the age of the fish . All kinds of L)-infecled 
seafood can cause anisakias.is when ingested by humans. Humans are Ilf1 "accidental 
hosl
M in ... hieh 1M lao'Be cannol complete IMir life-cycle; other accidenlal hoSIS include 
bears. otlers and cats lI ..... In Ihe nalural cyde. Ihe th ird-stage larvae in fish arc ingesled 
by cetaceans and moult Into founh-s!3ge larvae and then adullS. They cluster inside the 
stomachs of Ihe cetacean$. ... hcre the female adult worms are fenilized and lay eggs, 
oomplcting the cycle. OccasioroJ1y. anls:tkids moult into fourth-slage larvae in humans. 
but do 1101 progres.s into adults. P5C'Udou:lTallO~'U spp. arc more likely to moul! into founh-
stage lanac Ihan Amsokis spp. In a rare case, an adult male ... orm of Pscudoternnova 
\0,'15 found in a patienl 'I This is regarded as lin exceptioo ':. 
1.3 Oisu se (1lused by Anisilkis spKies 
Live Anisabs LJ are capable ofinitcting humans 10 cause a disease known as anisakiasis. 
This disease. which will be discussed in more detail in Chapter Two, normally pro:scnts lIS 
mild 10 severe abdomina l pain. nausea. verniting andlor diarrl>oca. and is in some Cl\5CS 
9Ccomp:1l1ied by allergic reactions such as unicaru. (hives). angioedema. bronchospasm 
WId even severe anaphylaxis <}.Os. The diseaSC' therefore lies at an inleresting junction 
between parasitic initction and allergic response. Manr facets of tile immune response 10 
helminths and sJlergcns arc similar. bul lhe 1"0 diSCll$CS do nOl usuall y coa~e. In facL 
the current tboughl is IMI helminth infedion mar $Upprc" symploms of allergy. 
Apart from allergic symptoms ~uning during acUte mfection 'With AnioUlkis, there an' 
also several case repo['ls of allergy 10 Aniso.tls proteins occurring in lhe occup~rional or 
domestic scuing. with symptoms such as asthma, minit;" conjunctl\'itis and dcrmalitis'" 
10. There lire also some cases "here consumption of cooked or canned fish 1IJlpc:!1$ to 
" 
In!tOd""lion Chapln I 
hale led to Anisokis.speelfic allergic ~ac:lions 51, Skin prick teS! ing wllh dct'p.frot~n II(Id 
lIeat·tn.cd or boiled extnlcts has dcmonstnuoo the resistlll1cc of AnLrokis allergens to 
cooking, IlIld many Anbakis allergens are also resiSla.u to dcllrsdation by the digestive 
cnz)me pepsin " . 1:, This suggest! th8;l reactions might occur aftcr cXp05ure to An/sakis 
antige!u alone (v, live larvlle) 16. Howocr, mMy authors C()Ils'lder react ions to Anisokis 3 
p$Cudo-aJlerg> that occurs due to innammatOr)' responses gencraled during !}cUII' 
Infection (\lid requires a live parasite Jl, Studying the immune and allergic responses 10 
An/wkiJ may help resolve this issue. 
I , ~ I'rc"en tion or a n i~.kiasis 
111e best mCan5 of avoiding infection with Anisokis or rdated nematodcs is to cnsu re chllt 
all fish to be con!umed rnw or p;If1ially cooked is deep-frozen (·20"C) for 31 leilSl 24 
iwurs SI, and th:ll cooked fish readu:! 3 tcmperature of at !east 6O"e througllout for 10 
minutes or O\rr I. , Thr number of Cll$CS of ani.sakiasis in thc Netherlands lias dropped to 
almost ZCTO since thes .. measures ",~re included in Ihr kgislation " . Other (oumrics have 
laken similar mell$llres, Current European Community regulations require visual 
examination of fish with rem(l\lal of heavily parasitized specimens from the market, and 
extraction of ,'isible lan'De in 1e5$ heavily parasitized specimens, as "I'll as freezing of 
fish to be COIlMlmed TaW or undeKooked to -21fC for 2J hours throughout the entire 
prodl.[(t " . Food and Drugs AdminiSlra(ion (FDA) regulalior15 in the United SlIItes 
require thld all fish and shellfish that will 00( be cooked or processed It (emperaturl'$ 
abo'·e 6Ife arc bhtst·ITozcn (0 -3S"C or below for IS hours or frozen lIt -23"C 1)1' below 
for 7 days ~, According w the South Ali'ican Bureau of Standards. intcrnationat food 
saft1y laws are applied In Soul.h Africa JI. Whitc such measur .. s may make commn-cially 
a"ailable frozen fish safe. fresh fish can be bougltt or caught by consumers. and such 
stringenl procw..res ma) nOl be followed in the domcstIC rnvironment. Fresh fish that 
was prewmed !O be "'cli-cooked is often the source of infection in reported cases" 
furthermore, IT«zinl of fish alters lite Oa,'our of sushi and ochrr fish delicacies, 50 the 
practice may be intentionally .'·oided 01 This means Illat AnisakJs infoctions arc likdy to 
continue (0 occur in the future despite Jeaislation. 
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figun' 1,-1 . Thc lifec"clf of A"it~Qkjs and olher II. nin kitis. A/fi"Qki~' ~ggs ~nter [he wilier 
in the fan:es of CL1&eans. Inside the eggs. the lan'ae develop inlo Ll stage larvae before 
hatching. L! are ingested b)' tiny crustaceans such as krill. In turn. Ihe krill are eaten by 
fish. cephalopods and large crustaceans. the second in leTmcdiall' hosts in whiCh Ih.-Iarvae 
develop imo LJ sluge. Finally. 1.1 larvae are ingested by Ihe primary host. II cdaccan, 
Thc~ moult inlo aduJL~. and Ix'gin to reproduce. LJ can be accidentally ingeslt:d by 
humans or olher land mammals. but are not adapted \0 these hosts anti cannol <'ompk!e 
thei r life eyck. PiC lure from lhe- website- of the Centre for Diseast' Contro l (C DC) ]7. 
1.5 The i "'''' un~ ce~r"'u~ t o intesT;n,,! nem"Todes 
1.5. I I lIn" l ~ and adallli,·e imlll u ne responses 
Immune responses to palhogens 8re characlcrized by innale immune responses, which an: 
Ihe forst line of defence and are rapidly llCli vale<!, and adapti'·c immune responses. "hich 
develop more slowly and provide a tailore{! response directed against spe.;ifoc antigens I!. 
The innate immune system is composed ofNK cells, dendritic cclis (DCs), mscrophagC'S, 
neUlrophils. eosinophil>. mast cells. baS(!phils, platelets and the complement system ~.~. 
Upon a primary exposure \0 a helminth various degrees of inflammatory responses arc 
Iriggered, characterized by the recruiunem of Inflammatory efTeC\or cells such as 
ncutrophils and eosinophil! and changes in blood ~cssel pcnneability and blood flow 6Il 
61. These changes can be Initiated by tm: acnvation of the ahem alive complement 
pathway and thc non-specific degranulation of maSI celis. Basal le\ cis of eosi nophi Is arc 
always preStnl and thc presence of m:lminths can cause them to rapidl~ infiltrate to the 
site ofinfcction 61.61 . 
Non-specifk inflammalion is minimal in most nalural host-parasite systems. bUI is oflen 
enhanced in unnatural or non-pennissi\c hosts >0. Amsl1ku spe<:ies and A",o'II))"IO",l1 
cl1l1illllm. a canine hookworm, are e.umplcs of unnatural parasites of humans that can 
elicil si gniiicant eosinophilic emeritis during a primary infe<:tion <\01. 6J. ThIS non·spe.;ific 
inflammatory rcsponse ma~ be th~ principal mechanism of limiting primary infections in 
unnatural host.parasite systems <.00. Natural parasites have evolved evasive me<:hanisms 
and immunosupprcssive molccules. and enhanced effcctor responses mediated by the 
adaplivc immune systcm an: require{! for their expulsion -. 
The adaptive immune system is composed of lymphocytes. of which the two major 
classes are T cells and B cells 69. B tells are responsible for producing antibody, while T 
cells can destroy dIseased cclls (cytotoxic T cells). prevent excessive immune reactions 
(n:gulalOry T cells) and ordtestratc immune responses ~. tfle secretion of an ami}" of 
immunoregulatory mole<:u1es called ~)'Inkines (helper T cells) Antigen-presenting cells 
(APes) such as dcndritk cells and macrophagcs continua ll y proeess and present 




tt'C()gnizC$ • fon:ign antigen ,t is .cti\'ated 10 proliferatc and diffcrcntiatc . Prior 10 the 
rrlease of lymp/KK)ltS inlo the (irculalion, rrgulalOry mechanisms tnSurt that 
lymphocytes "hich re<:ogniu "self' .nligens Irr eliminated 71 . n. 
In rreent )'ellt5 a numlxr of pan em-recognition r~tors (PRR,) have txen identir~ on 
APes. specific to componenls Uull may Ix found in certain classes of pal hagen such as 
NCINial DNA and components ofb3Clt:rial and fungal ~II walls 7).". When I PRR binds 
10 ,ueh a component. pathwlIYs an: [riggerrd in the APC [hal cause changes in gene 
exprrssion, innuencing the funCl ion Ind behaviOlJr of the APC 70, 7<1. This includes 
changes in [he cxprrssion of chemokine recqJ!o,"" c)'lokines and costimulalory 
molecules. The immediate C)lokine environmen[ during antigen prrsentation and the 
differrntial expres,ion ofcO$timulatory molecules on APCs innuence the differenlialion 
of naive T ce ll s into ptlrticulv T cell subsets 77. 71. Therefore diffe rent classes of 
pothogens can specilicall)' elicit certain substts of T ~Iper celts and consequently induce 
the efftctor rrsponru associated "ith thaI subset. As helminth infections an: consistently 
,S5O(IDlrd "ith adaptive TI1.2 type responses. it is possible that some feature(s) common 
10.11 nematodes is recognized by tile host7't. 
1.5.2. T he role of C I).I· T helper cells in resista o~ 10 ;nl..sllna l nema to!les 
Iluman epidemiological studies and e ~ perimc:ntal mouse models boih suppon [he idea 
thaI tq)Caled infeelion by helminths can lead to acquirrd pl"01ecti\'c immunllY in the host 
~l . C()4' T helper (Th) cells play an impononl role in mediating the adapli~ Immune 
rrsponse by tl1.e secreliOll ofa wide variety of cylokines, atld arr known to be essenlial ror 
resistance to nematodes 61 . A na~ T cell elIn differenti ate into one of several T «11 
subsets. defined by their C)10kinc>cxpression profi les 77. n, t) Currenl modds descrilx 
four mBJor substlS: Thl , Th2, Th 17 and T regula tOl)'(rrg) C<.'lls It. t) (Fig. 1.5), Th I «1[5 
arc aSso<:iatcd With the DClivalion of C)10wxic responses and rCSiSlIlIlC-e 10 intl1lttllular 
parasites, "hile Th2 cells arc assoo::iated wilh allergies and resistance 10 helminths 61.11 
Th I 7 (clls arc proinnammalory and associated ",th au toimmune diseases and tC5istan« 
10 extrpcc[lul81 pathogens, and Trrg cells are anti-inflammatory and are asSO(:iBted I'<ith 
lmmunosupprenion fl. fl, IL-12 promotes differentiation IOwards Thl cells, .... ftile 1L-4 
" 
promotes tht' devdopmmt ofTh2 type cells 11,1.<, ", Th2 and Th! response'S arc mutually 
antagonistic and TCUM e~tdtl\(e luggesU that there may be D similar relationship 
betw«n Treg (IIIlti.innammatDr» ) and ThI1 (pro.inflammatory) ~ells n, ll, Il, 
Tr:IIIsforming growth factOl'(TGF)..p in tht' ab~ce of IL-6 promotes the de~elopmem of 
Trq,; cells. while the combination ofTGF-~, IL·6 and IL-23 promotes Th I 7 cells 12.11 
In mouse models. TesislIJIlce to helminths is alSoclatcd with the aCli~ation of Th2 cell5 
and the produ(tion orthe Th2 tyP( ()'Iokin .. ! IL-4, IL·S, IL-9, IL·IO and IL·13. while the 
acti"31ion of 'Illl cells and Ihe pre,;ence of IFN-), 3re anociatcd with prolonged or 
chronic infection ., .• ' , 1IO.I6-li, Similarly, in humans helminths induct' Th2 type re5por=5, 
which arc associated with reduced worm burdens 11. 00 In addition. helminth infcoction.s 
are often associated y.ith Treg cells, regulatory B cells and the production of IL.I O tl. 
The aS50ciaied immunosuppression may protect pat:lSites against innamlTUltory host 
defences and also benefit humans to an exto:nt by limiling hatrnful innammillion 11. ... tl· 
". While IL-IO is ofto:n IISsocillled y.ith Th2 responses in helminth infect ions .1.", there 
is some C'Vidrncc that IL-IO associated Th2 mponsn are modified. y.ith production of 
IgG rather than IIIE, compromiSC'd specific T cell pn:Ilifmation, decreased levels of IL· S 
and l:OSinophils. and inhibition of mast cell dcgranul3tion and c)-tokine production 0), n. 
" 
1.5.3, Effector mccbaaisms in im munity 10 inteslinal nematodtS 
Mueh of our knowledge about immunity \0 intestinal nematodes IS gleaned from 
I.abor.uory models of intestinal nematode infcttlon 61, (n mice, helminlh infections a~ 
a.o;sociated wilh eosinophilia, maSloc)10,is, goblct hyperplasia, high total (polyclonal) IgE 
production, helminth-specific IgE and IgG! production and the accumulation of 
alttmmively activated macrophages 60, 1'I,fI, 1110, 101. Similar features are evident in humans 
Md livestock lel, 10J. Experimental models indicate that the effector mt'chanisms requin:d 






























Figure 1.5. T helper cell ~ ub~clS. Nar\'e T celh can differentiate into distinc t T cell 
subsets lIS a result of d ifferent erwironmcl'llal coodilions during antigen pre5Crllmion. IL-
12 favours differentiation into Thl cells. which arc imponam in defence against 
intracellular pathogens. while 1L-4 indoces dilTcrenliat ion into Th2 cells. associated ",ith 
helminth immunity and all ergy. Tnc combined prcscnCl." ofTGF-1l and IL-6 induces the 
pro-inflammatory Thl7 sub>;ct. while TGF-f} in the absence of IL·6 promotes the 
development of Tregs. imponan\ mcdimors of immune suppression. IL-23 promotes 
Th17 differentiation. B:JSC<I on a figuI"C by TalO and O'Shea c. 
" 
"'orm forms of the plIrllsite fICI. ... n. HN For exllmple. eosinophils lIppear to plllY II I'QI~ in 
the damllginp, or kIlling of Inr\Xti~e L3 klrvae. bUI nOl in the expuls ion of m~turc worms, 
C'<ccpt perhaps in unnatUral or non·pcrmissiHl hosts 60. Eosinophils r~lelisc potent 
mediatol'$ such as eosinophil pero~idase and major baSIC proteIn tOOl can damage and kill 
helminth larvae lal IL-S released by TIl2 cells !IIimulales eosinophil prod~lion .rd 
differemi:uion and increases the killing capacity of eosinophils 10t>1~ Sp«ilic antibody 
Iithoughlto enhance eosinophi l-mediated killing of larvae 60_ 
In COIllraSl, mast cells 11110 goblet «115 often playa role in !he e~pulsion of intest inal 
dwelling adult worms 60.", MaS\OC)t05iS is controlled by TIl2 c)1okines. includingIL_3. 
IL-4, IL-9. IL-IO and the gro", h factor Slcm cell factor (SCF)/oI, ",. MaS! cells release 
multiple mcd,ators, including pl'Qteases., c}'lOklnc!, histamine and leukotri~les, and 
disrupt gut epithelial barrier funclion 110, 111, In pnnicula r, it has been shown Ihal moose 
mast cel l protease_I (;" IMCI'_I) ,"creases inteslinal fX'rmeabilily, presumably by 
degrading, componl."nt of the li~hl jun.;tion bct .... 'CCf\ gut cpi!h~l ial cells, leadIng 10 an 
increase In intralum IIUI 11uid th.:d may help flush OUI parasites' II BOlh 1 L-4 and IL -1) alll 
Il!ou¥htto tlCl" eITI."ctor moiC(;ules in in.:n:asing imestinaJ perm~bilil) and contraClihl}' 
to. I .... 111.11). Experimental dau ha$ sho .... n that IL-ll plays an Important and 5OmClimC:'l 
critical role in upulsion, although the precise mechanisms ha,'c yeliO be fully elucidated 
" It Il:Is been sho"" Ihat goblt:1 cell hyperplasia is dependen t on IL- IJ Il<-ll<', Goblet 
cells secrete mucins Ihat hoeJp Irnp and expel inlestinnl n..",~todes from the gUt OJ 
Enhancement of epithelial cell turnover by [L- I) also appears to play ~ rok W hc:lnJWlh 
I."xpulsion 1"_ 
A fairly n~w area of r~se3reh e"plores the role of altemal i~ely activaled macrophages as 
effector cells in hoelminlh mfections 100.. III, II' In contrast to classically activated 
rnacrophages, "hlch are a.;tj'3tcd by IFN-r and lNF 10 produce microbicidal NO. 
a!lematl"ely a.;ti~ated mxrophages are ad;vated b) IL-4 and ,IL-13 (and to a lesscr 
degm" by 11 -10) to express the enzyme :lrginase-l 100. 1::11 (Fig. 1.6) Arginase-I and NO 
SyDth:lse (NOS-2) compete for thl" sall1<' substrate. L-argmine III NOS-:! con"errs t-
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Figu", 1.6. Alll'rna l~'r man uphagl' a~li"'l ion . Th~ en7yme5 nilrk oxide synthase 
(NOS-2) and arginasr · 1 (Arg-I) oompete fur the substrnte L-arginine. In "classically 
acti'ated- macrophagcs.. Thl type c)loIo:incs acti\!lIe nitric o.~ide s)"Jllhase (NOS-2), 
"hith clll3l~7.u the production of antimicrobial nitric uxide (NO). In "al t~mal i" e l y 
acl;"aled·· macrophagcs.. Th2 c}lokines activale arginase· 1 (Arg-!), which cala l)"l.cs the 
production of uru and L-omithine. L-omithine acts as a substrate for the generat ion of 
pulyamincs and prul ines. metabolites in ce ll proli fffil tion and collagrn produclion. 
re~pe:cti,·el~. Adapted from Wynn TA (2003) l~. 
" 
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Fig~rc: 1.7 • • : rr..,dur m«hanism5 in helminth upulsion. The Tb2 t}lOki~s il-4. lL· 
3. IL.9 and II....U enhance the gencnllion and :lelwalion o r efTcclOr cells such as 
eosinophils. IT\3Sl cells and goblet ~ells. Eosinophits rc'lease toxic prodocl$ in~oh'ed in 
killin!: the lanai 5UI~5 or helminths. "hiic masl cells and goblet cells assist in the 
expulsion or inlcstinal-li~ing "onns by increasinil inttslinal permeabililY and secreting 
mucus. mpecti\·eI). ThO - naiVe T cell. TII2 - T helper 2 cell. 0 -0 cell. E - eosinophil. 




a metabolite required for the production ofprolinc and polyamine!. Proline is required for 
collagen deposillon. "hile polyamine, play an essential rol~ in cell proliferation IlO. 
These met:ll!olilet are implicated in fibrotic diseases but their effects in helminth 
infection ar£ still being ell:plored 100. III. IlO. I~o"-evcr. it has becn shown thai argin8$£.1 
act" ity mediale!i host prolccti~e responses to the intestinal nematOlk Hefigasomoidu 
po/ygyro.f Ill. Other met~bolic producl5 produced as a result of alternative macrophage 
aclivation and/or ~rginase-I induction may also ploy H role in immunity to helminths 1::-<. 
In summary. Th2 cylnk,ne! orcheslr3lc B number ofinte5tinal ehanges that render the gut 
lumen environment intolerable for the estabhshment or surv, .. 1 of ~matodes I: (Fig. 
1.7). As some helminths h~ve larval stages that migrate through tlte lungs. similar 
effector responses are ini tiated in the ai rwaY$ ", rnte~tingly, the Silme effector 
mecbanisms involved in resistance to helminths are oAw in"aI"ed in the pathology of 
allergy ". II is speculated that Th2 responses evol\~ 10 manage helminth infections, but 
in the absence of helminth.induced regulatory mechanisms can result in allerg" 
responses 10 harmles, proteins '". 
1.6 The al1e~ic immune response 
AllerS}' is also termed type I hyperKnsitivity (immediate type: hypcfllensitivity) and is 
0Ile: of four classes of hypersensi tivity reactions that involve tissue damage due to 
immWlOlogical mechanisms IU. It is mediated by specific IgE ~ntibodies produced after 
exposure \0 hannless proteins present in the surroundings. Certain proteins (allergens) are 
more likely to elicit an Igl:: response, and certain people (atopic,) have a genetic tendency 
10 produce specific IgE 10 these proteins and subsequently develop altergic reactions !:.. 
Allergy I;<I.n be divided into a sensitization and an effwor stage m. When an allergen 
comes into contact with the immu~ S)'Slem, it is proces~d by APCs and presented to 
II:ITve T cells (Fig. 1.8). In an Il..-4-<1ominatcd c)'tokinc e""ironment, naTVe T cells 
diITerentiate into Th2 cells which produce lL-4, IL·5, IL·9 and fL·13, c)1Okines "hidl 
pl~)' a ~entl1ll role in allergic disease .. III t~. Allergic disease is .ssoti:ued with 
activation of Th2 cells, IgE production, eminophilill. mag celt degranulltion. va3(ular 
InlrOdll<llOll _.0 
and In[eS[ll1al po:rmubilily, goblet ttll h}'pcflIluia, mucus h}'~r.;ecn:liort and fibrosis [; 1 
Gtnctic I'ariants in IL·4, 1t.-13 and Ihe IL-4 TecqltOT are associated I'llth atopy and 
ISthJTU[ 1IO. lll, 
1l-4 Dnd IloI3 induu IgE iSOlype switching in ooman a celis, while 11.-4 inductS IgE 
,,,itching in mice Ill. 1Jl. Ill. An individual ",;th spec ific 19E agamst an all~gen IS ~id [0 
be sensitized [0 thai allersen. Specific IgE binds to [he FctRI on t~ surface of mast ctlls 
and basophils "', A ~d exposure to the $IIT1e aller&en crou-Imb this bound IgE. 
causing the mast cells or basophil, [0 d~nu!al e. teleasing poIen[ inllammatory or 
vasoactive media[or.; such as hiSlamine. leuko[rienes. C)10kilKs, $mKOnin, PAF, and 
, 'anous proleases ,n.IJ6. This is known as !hi" crrtdor sUlge The mediators telca.srd from 
mast cells are primarily rtSponsible for the acute S)"m ploms ofillergy, which can include 
Itch ing. unicaria, angioedema, rhinitis, cl)I1junaili[is, asthma. dCTmllilis, ga5[rointtSiinal 
disturbanCe!!. Ind anaphylactic shock 116. 1l7. [n additil)l1 . released mediatofli stimulate 
in flammatory cell proli feratil)l1, recruitmmt and accumulation 111-1:". 
ASthma is perhaps Ihe most "'etl studIed of the allergic di5el.Sts, 8I1d mouse models 
illustrate how Th2 effector mechanisms rontribute 10 its alkrgic pathology (Fla. 1.9) The 
symptoms of aeute asthma are caused by excessi"e m~u, production in the lungl, acule 
inflammation and bfOncho-constrKtion due 10 the reteaK of mediators by maSI ctlls I", 
1!7. 117. Tho:$(: mechanisms narrow the lirways and limit aIrflow, uusil1g breattling 
problems Ill. Chronic asthma is uused by clYonic inflammation and tissue damai\e thaI 
leads 10 li ... w.)' "'mOOding Ihrough collagen deposition, smOOlh muscle h~"roptl)· and 
eplttlelial I%ll shedding 117. 100. "These changes can Mverely decrease lung function. 
It is thoughl that 11..-1) is !he central mediator of allergic asthma'" ,'f.. 111. " ' . Mke 
"'hid! o~e"",ptess ll-13 show elevated specifIC IgE, maSt cell degranulation and 
histamine rcle~. and also silo", allergen-induced pathology in the lungs including goblet 
cell tlyperplasi'8I1d mucus hypersctre1iOll. fibrosis, eosinoptlilia and raised levels ofTh2 
910ltlne!l 1<l.The release of [oxi, products by cosinophils and other inflammatory cells 
play an important role in ongoing inflammation j,O. CO,,- T ~ells playa crucial role in 
""'", , 
remodeling of the airway wall. possibly by producin& IL-D. "hiell induces fibrosis I., 
.oc, '<I. The~ is e\'idcncc thai allemati\ cl) activated macrophages play In imponanl role 
in r.brosis and tissue remo<leling by producing proline. a precursor of collagen lXI, 
Similar cffecl(N" mechaniSms may playa role in odler allergic diseases such . s rhinitis, 
«zeroa and food .lkrgics. and this is a subject of ongoing ~search. 
I.; IIdminths and a IlH!;y: The h}gicne hypothesis 
The dramatic increase in the prevalence of allergy over the last few decades has occurred 
predominantly in the develo~d world, sugge,ting lhal environmental faclOrs ITUI)' bC' 
re~ponsible ' ''. In 1989. Strachan proposed the ~h)giene h)'pothcsis" baseoJ on 
epidemiological dala !hUt .ss()(:;aled innc ased sanitation anJ reduced childhood 
infections wilh an increased risk of allergy '<I, This hypothesis propoies thaI early 
infeclion~ or eltI'QSure to microbial products such as tndolOltin reduce tht risk of alltraY 
by skewing immune responses IOwardS Thl and '''''IIy from lh1 responses t4li. 
However. more ~entl~ it has been si1o"n thaI the P~'II!tn~ of allergy is low in 
populations .... ith high pTt1<-.lencet of Th2-inducing helminth infections OJ. In addition. 
Thl-mediated autoimmune dtseaJd such as Crohn's disease. innammalor) bowel 
syndrome. multiple $Clerosill and t)PC I diabetts ~ on t~ rise: in the same s.anitiZC<.i, 
urbanized populations that are eJlptrienclRg an increased pn-valence of allergy ,.7, t<l, 
This has led 10 a \lIriation of tht hygiene I\)pothes is in ..... hich infections by helminths 
tand possibly other microbes) are lIlought to induce suppressive regulatory responses lIlat 
modulatc b<Kh. exe~ive Th2 and Thl responscs ,/<, t.· , tJO These suppressive responses 
at<;: thought to involve the Man ti·inflammatory network", consisting o fT regu lator}' cells 
and the c}1okine mediatol'!l lL·IO and TGF·P"" ' $. 
ITAT .. ' .. ~ 1 
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Figu~ 1.11. 8 ask IIl«hlnisms of 11Ierl:Y. Antigen prcsct1linR cells process and prescm 
incomill!: allergens 10 nahe T cel ls. In the prc:>encc: of IL .... mll\:\: T ,,:lIs dirreml1im 
inlo Th2 c('115 I'hich prod~ • \\ ilk range of pro.aJJergic C) lolcines. These irocludc IL-4, 
IL-S, Il·9 and IL·ll. \llIich enhance the generation WId lICli-alion of dfeclor cells such 
Il5 mllSl cells. msioophils WId goblet cells.. I L4 and IL· JJ stimulate B-o::ell production uf 
IgE. \\hich binds 10 FecRI m:C'ptON on m.nt cells lind hasophils. Upon a SCI;OOO exposure 
10 the aJlergCT1. bound lal:; molecuks I~ cron-Jinked, causing the degranulation of mast 
cells and basophil! and Ute: relt'llSo: of inflammatory mo:dialQl"S such as hisuomiBe. 
le:u l.oulcncS, c)1olincs and pro!iUlil1lllldins.. Funhmnore. IL-4 and IL-Il stimulate: the: 
gro"lh and chcmotads of fibroblasts and Ihe s>lIthcsis of c:xU'lI«'lIular malrix proteins. 
"hile 11.-5. IL-9 and TGF·~ sl imulaie .subepithelial fibrosis. Together Ihis can lead \0 
tissue remodelling. APC - antigen preseming cell. Th ~ T helper cdl. Th2 ~ T helper cell 
IYpo: 2. () .. B cell. E .. Olsioophil Mc18 .. mast <;e1l'ba!\Qphil. Fb • fibroblast. M .. 
mutus. FiGure adapted from Romagnani S (2000)'.!O. 
" 
Allerg ic Asthma Model 
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AirwIY obit ruc: t lon 
FiRU~ 1.9. TII2 .,ffmar mec:banisms in allt"l"lK: IStllm •• The same: Th2 e:ffector 
mecllanisms that assi$! in helminth de:frnce a~ detrimc:ntal during allergic astllma. MUC"us 
II) pcrsecrctioo by goblet cells and inflammatory mediatOf release: b) Ill8SI "ells rontri~nc 
to lI;rwlI)' ooMruClion. Eosinopllils rekllSf; tOAk and inOammatOl") mediators that cause 
tiSl;u<! damag" in the: lung. leading to airwa) remodel ing. APC - amigcn presenting (ell. 
ThO - BaTVe T helper cell. Th2 ~ T ~Iper 2 "c:ll B ~ B cell. E ~ rosinoph iL G - gobl~ 
'" (ell. M - mast rell. From Brombac:hcr F (2000) . 
" 
InlrQducnon 
Various cross-seclional epidemiological 5tudu~s hal e shown an inHTsc correlation 
between helminth inrec:tiOll and allergic sens;tiullon m_ISJ, and other SludlC!i have 
demonSirDted an increa~ '" atoP) (measured as positi,c skin prick tCSt rcsults 10 Ono:' or 
more ucrOllIlt'rgens) rollowing IMi-heiminthic tmllmml~ Ul. 150. lSI. HO\\e'cr. there are 
also many slUdies thpt hal e 5h0\\'lI no correiatlOfl or e,en a posit;'e correlalion bC1wC1:n 
helminth In feclion and DlOpy Of allergic disease "*''':. and no effect of anlihclminlhic 
trealmenl on alOp) I". It has also Ix.-en sugg~o:d that an inlene auociBtion bet"ccn 
alopy and helminth infections could be due to n:"etSC ULI$3tU)!'I that is, a!'l atopic state is 
prmectl\e all,lnsl helmlnlh Infection and people with chr~mic helminlh i!'lfcelion arc mO!'C 
likely 10 be !'lOll-atopic fl. I .. 
Dcsplle these inconsistcr.cies. ;t ;s elrar that lIc1minths can Induce strong immune 
suppressivc responst'S ' ... fI t6J. I", and many e~pcrimmtal murine models hJ'c 
dCm(l!'lSlraled proteclivc effects ofhelmi!'lth~ against allergy. 5h0\\'n to be medialed by T 
regulBlory cells andiO( 11..-10 !l.tl. "'·111 To c~plajn the dispari ties het"ce!'l the various 
field Sludies. it has been suggested that the intensity III1d durBliOll of infeclion, age II 
;nfcehon and species of helminlh may influenec the effects or the helminlh on the 
immune J}'StCfn In. lJJ ChroniC infection andior a high plrasi te burden Is thought 10 
induce rcgulBtOl")' immune responses. resuhini\ in a SUPJ'l'l.'$Sion of allergic disease. while 
lo,,-Ic"el andior lransient IIlfeclions may txacerbale allefi\ic discase by stimulatmg Th2 
respoo§C:'! In 
A recalt TC'Iiic...' and meu-3nal)'s i!; of JJ helminth_alkrgy studies rrom 1962 onwards 
(includIng n - 25753 patlcnts) found tbat o'eral!. helmInth in rution was not protect ive 
against ilSthmalYlhul.c:; hOYle~er, hook" ornl was significaml) associated wilh prolutio!'l 
agaInst asthma Ihat correlaled 10 the inleosit) of infCClio!'l 16C. In contlllst. AJcQrlJ 
IlimbriroidcJ WIS signifICant ly associated "lth an incrrased ri~k of asthma, This 
illustrates !hat differe!'ll spcciC'! of helminth may have d ifferent effects on asthma and 
OIher allergic disc~s. in a!'l inle!'lsity-dcpmdent manner . In experimental mou~ studlC'!. 
the suppn:ssi\<' effects of different helminth species on allergies do !'IOI share a common 
rneclIanism, Ylith lL-IO bring the protective mediator in some cases and nOI in others fI, 
" 
,,' " ' Much as there arc d;lT~r~nc~$ '" the rncch:U1i~ms of "orm e~pulsion bel"",:,,n 
srcci~~ "". SO 00 1h"r~ 3Pf'<"3l" to Ix differenccs in the n"gulalory m"chnJ1l5ms slImublcd 
b~ d,ffno:nl helmmth sp'-c'es Thc outcome of an) parasite·artergy Im,'raelion lIppt:3r$ to 
,kp~nd upon tlk' ba!a~lc", bct"c;:n parasn ... Induction of supprcSJ;Vt.' n"gulato7 (lL·IO) 
«"ponses and detrimental rtL4) alkrglC responses PI 
)"'bny epidemiological Studl~l d~signed to explore tbe assaciaHon bet"<.'(.'n atop) IIIld 
hdmimh infccl10ns do nOl contro l for confounders, such lIS the prevaknc<.' of OIIleT 
infc'ctious diseascs in helminth·infectcd populallons 11. Thl·polariling mfcClionS such as 
tub.:reulosis and faccal-oral infections have ~Iso bc.:n MSQCintcd "ith II r~-dm:cd incidl'ncc 
ot atopy/nllcrg) in humons and mic~ '".111. Experimental dmn show thal microbes lind 
t~ir produc15 ,an also ir,ducc regulatory/s uppressive ~Sf'IInSl's 11'9 II is 1I](:rcforc 
possible that InK'ctions with helminlhs, b.,cl~na lmel viruscs comblll~ to sllmulote the 
r~gulator) r~sponscs n~ccss.1ry for Ihe prevention of allergIC dlscase 1S/.1. 1'''. ". 
r~p(mml'lt.ll data wil l help lInrovel th,' mcchanisms of thiS regulation, and may even 
rewal IIllmuoomooulmory molecules from hdminlhs and othcr infecliou$ agents thai 
could lie uscd in thcr"dpy agaillst ~llcrglCS alld f!u\Oimmunc diseases ," 11 has already 
bttn !hown thaI deliberate T Sills infection is Sllfe and d "fcctivc in alleviating 
inl1ammll1ory bowd disease 110. and trials arc plannL-d involving Ihe admlnistralion of 
hool.worm to patIents .... ith asthma or olher allcrgic$ 1.1 
I .S \ common re«plor ror II. · -i ",,,11I.· 1J: the II.· -i rfICcplor al pha 
\ I1Inll~ of c.\j')('rimcll1al models 3nd cl'idemioloJliGlI studies have cst:lblishcd tho: 
ImponBnce of 11.." and 11.·1 3 In helminth Inf«rion and In allcrgy The gencs for IL4 and 
IL.13 arc closely hnked on bolh human and mD1I$C (hrotnQsomc~ In IL-4 and 11.·13 
hav ... 10" ammo acid homology (.bo\!l 31W.) but wry similar l~ni3ry stru(:tures 112. II), 
and sh..re a r«cptOt" subunIt, Ihe JL·4 r("Ccptor alpha (IL--l RQ) 12J The IL .... Ra can pair 
",th the common l chaIn subuml. II componenl of many cylokine reccplors. or "ilh IL· 
13Rul or 11.·13Ra2 (Fi¥_ I 10)"". Th..· c:ombmation oflL--lRQ and the tommon y thain 
is ~nu"n as the' IL·J receptor I)PC I, and is utilized by 11..-4 onl). The IL-I RQ subunit 
palf~d ,,"h the Il·IJRo. l forms a complcx known as IL-J receplor type 2 or IL·I) 
" 
",,<~ph)f. through "h,ch boIh 11.-1 and II-I) can signal. The IL-URal on ns own binds 
1l.·U \lHII .. nl~ \Ieak affin ll y Ho",~er, \\h~n IL-I3Ral combines \Iith IL4Ra. the 
«:SlJltm~ rumple, has a hIgh aflin it y for IL.- l3. E.xperimenlal datu suggests Ihal both IL· 
"and IL: I) induced sIgnal transduction occurs through the IL4R,a. Ilowever rrcent datn 
sugge5ls thJt 11..-1 J may abo signallhrough the IL-13Ru,2 III 
\I ron bmdmg of 11.4 to the IL4i{u. or bind,ng of IL·13 10 lhe IL4Ru./IL.I)Ral 
c,wnple\. a conform~"onal ch~nge occurs in Ih. It-lRa Ihal brings together receptor-
associated hml~ kinasu OA Ks). JAK-de~ndent tyrosine phosphorylalon of Ihe 1l.4Ru, 
(!Ccurs. and Ihe II _41\a subsequenlly phosphorylates the Il'3.nscrlpllon roetor known as 
sign.1l tl';ln!iducer and aclivalion of trnnscriplion (STAT) 6. enabling 't 10 II'lInsJOC31c 10 
Ihe nucleus \\ here h actl\'3tC~ the Ir:lnscriptlon of man) Th2-associalN genes I .. , 1._ 
()llwr sill'mllmg int<.'fm~diales such :t.S insulin rrcep10r substrate (IRS}-I12 can abo be 
ph<,sphof) lalcd by Ihe IL-4Ra I .. Duc 10 Ihis eommOllsignalling pathway, IL-4 and IL· 
13 s!'Jre many biologic.al funclions, tncludlng induclion of B-ccll isol)~ sWllching 10 
JgL. aClivatlon of ahern3ltVe mllCrorhages and inh ibttlon of innamm9lor} macrophage 
1""001«1S. uprrgulal;on of major hlSlocompallhiltty complex (MHC) elass II and 
r"',-""olion of '11. 2 1 YP'" "'<I""n ... ~ Ill, lIJ IJ7 
Both JlA ami 11-13 arc predom'naml~ prodllC~ by :tCli\alcd CO''' 1112 cell$, m.tSt cells 
IllId oowpf\ils, although IhH<' a~ nO! lIlI'ir onl)' cellular sources m. Although t!lere is 
o\'erbp belweert IL-4 and II -13 funclioolnr;. lhe 1"0 Qlokincs abo have distincl 
func!ioos. This is dut on p;'trt 10 Ih" differenlial npression of lhe ~ariOU$ rt'C~Of 
componenls on difTerrnl celll~pes_ For example, T oells do nm up!'C'ssIL·1JRal. Dn.J 
can Ihcrcforc n01 respond 10 1t-IJ, As II result. IL-4 can dIrectly IndU(:C Th2 cdl 
difT<."I'C'nlialion, bul I L·13 canOOI, although II can In.lin'CIly promO!.£' Th~ Iype rrspooseS 
'" , ~,,1lI' DifT("renccs in IL..4 8nd Il-1J functioning may also occur due 10 lhe 
cOO1rk~il) of receptor usage, ",hreh can result In differences .n downslream signalling 
I· Fef tXDmplt, IL-4 signals I hrou~h both lhe IL-4R I~JK' I and the Il-lR IYpe 2. while 
the II, -13 (:tn buld I" both 1L.-IJRa I and J L.-l3Ra2 110. 191 Furtlll'nno"" soluble forms. of 
'" 
t"t",d~i"" o.pter t 
the IL-4Ra and the IL-13Ra. also occur and are thought to regulale IL-4 nnd IL-13 
responses tll. l'Jl:. 
Due to their association w,th allergy, IL-4, IL-13 and their receptors are potC'lltial 
thempeUlie targets. Scvmll climcaltrials using ncutralizing antibodies have alread)' taken 
place while Dlllers are in progress 111, m. Whi le anti- IL_4 monoclonal antibodies ..... ere not 
effe<:lI~e at pre.'enling asthma, soluble IL_4Ro. antagonists did show dnkal benefits m 
I", Recent experimental data indicates Ihot 11.-13 pID>"s a distinct and central role in 
effector mechanisms in allergic asthma 111,111. 141, Ijl, Apart from bemg a eenl11l1 mediator 
of goblet cell hyperplasia and mucus h),persceretion in the lunK. it al!lO appears to play an 
import ant role in fibrosis associated "ith air"'a), remodeling 117.191. 1'16. Phase I trials 
u$ing anti- l1.--lJ against asthma as well as the development of anti-IL-13 m:eptor 
antibody are in progress 191, 19'. However, some mou:IC $Iudies indicate thai blocking of 
11._4 and lL-13 in combination may be more effC'Cth'e m. 1", There are indications Ihal 
11.--1 3 may hB,'e effects in the absence of the IL-4Ro. "', In lIddition, IL-4Ka -1_ mice 
develop 19E and allergic responses afler prolonged $CIlsiti;r;atlon lOll, lIIl, As studi<:5 
IIldiealc thai differen t allergic diseases and routes of SI:Tlsiti1.alion involve ~'llriable roles 
for IL-4 .nd IL-I3, thel"l'lpeUlic approaches shoold be accompanied by a full 
un(\er$W1ding orllle mechanisms In,·ol\'ed. 
1,9 Anim. r modtl5 of allergy 
AlIerw is a complc.~ and multifactorial disease that requires interaction between a 
number of different cell-Types and mediators_ As such it is difficult 10 unnwcl 
mechanisms of allergy ill Vitro. For example, while IL-4Ra was sIIown to playa 
profound 1011.' on the activity of smooth muscle cells j " "ifro, the jll "jVQ 10$$ of 1!.-<lRa 
on smOOlh museles cells did not influence aiT\\'ll) hyperreacti\'it)' or alT\\'ay innammalion 
m. This makes it difficult to assess the significance of ill "ilro resuhs In relation to 
human disease Sinlilarl> , data acquired III models uMrig animals such as mIce unnol be 
extrapolated dirttlly to humans because of spe<:ies-spe..:ific dlffCJence$. Howe\'er, with 
Ihis cueal in mind, animal models provide a doser simulation of the human sy$lem titan 
ill vitro studies, 
" 
IntrodU<IIon ChlplCf I 
Figure 1.1 0. 11..4 lIm1 1L. 1J shllrt _ romlllt:>. retel)lor , y5ltm. IL-.t binds IQ the lL· 
..I Ra chain, \lhkh can combine "ith the common gamma (y) chain re,eptor. 11.·13Ru I or 
I L·13 Ra2. I L·13 binds to the 1l..t3 Rul wid 1l .... 13Ru2, both of\lhich CWi complex \I;lh 
the IL4Ru chain. Sisnal transduction for both C)'lokinl'$ Qccun through the IL4Ru. The 
role of 1L- 13 Ra2 is incompletely u!llkl'Slood. Soluble form$ of the IL-4 Ru (sILARa) 
and IL·U Ral (sIL·I3 Rul) also c);ist and m~1 modulate IL-4IIL·13 responscs. Figure 
adapted from 8romba.:hcr (8rombachl'l' 2000/' , 
" 
Chap1<r I 
To date. numerous experimental models of allergic disease have been eslablished in mice. 
including models of asthma. dermalilis, food allergy, anaphyla.~is and minoconjunctivitis. 
Many scientific groups have progressed from using ,,'ild-type mice to using transgenic or 
knock-out mice which over-cxpre5s or lack specific genes, in order to detennine the 
function and imp<'.lrtance of specific proteins with the ultimate aim of designing new 
thernpies !OJ. In this project. previously generated mice deficient in IL-4 lI>O. IL-13 "',IL-
41IL-1 J 110 or the IL-4 receptor alpha (lL-4Ra) l~ have been us.ed in order to elucidate 
ITM:chanisms of Anisakis-associated disease. In certain models. cell-specific requirements 
for lL-4Ra have bem invesligaled using rec<:ntly generalC'd macrophage/neutrophil or T-
cell sp!:cific IL-4Ra deficient mice. 
1.1 0 Cell specific knockOUl mice 
In recent years a genetic technique has been developed that allows cell-specific gene 
deletion. This technique employs the DNA sequences and enz}me5 that bacteriophage PI 
uses to excise itself from a host cdl genome 2ID. lOfi, .... 'hen bacteriophage PI DNA is 
integrated inlo a hosL cell genome.;1 is nankC'd by recombination signal 5eqL1ences known 
as /QlOP sites. These sites are reeogniud by the enzyme Cre recombi~~. whkh excises 
intervening DNA by cull ing it a1 the sites and joining the twO ends together 10 fonn a 
circle. By inlroducing loxP sites on either side of a gene Of exon in the mouse genome, 
this mechanism can be used to excise specifLc genes or exons. and the process can be 
manipulated for cell specifie deletion. Mice containing 10xP sites flanking a specific gene 
or exons are malC'd wilh transgenic mice that express Cre reeombinase under the control 
of a tissue-specific promoter. Therefore. the active ere rerombinase in the appropriate 
lissue will excise the DNA between the insencd 10xP sitts. effectively inactivating the 
targeted gene. Cells which do not express the proLll()1er rontrolling Cre rceombinase will 
nOI have excision of the r<:levant gene, resulting in a tissue specific knockout mouse. 
1.10. 1 T-cf ll s pccific I L-~Ra _1_ (Lck ... IL-4Ra .. ··") mice 
Mice with a spedfie deletion of IL-4Ra on T-cells have been gencratC'd uSing the 
principles outlined above 21)1 (Fig. 1.1 I). First. an IL-4Ra-/- mouse WI was crossC'd with a 
tmnsgenic mouse expressing ere reoombinase under control of the T-cell specific 
" 
~, 
promOt~r. 1)'mphfX)1c speeilic I)'rusine ki/lMl," (uk"'}!01 in OT"dtr to produ~ a lo:k""'l· 
.IRa mouse. Subsequently. the Lck"'"!l.-4Ru'" mouse was c:ro!$d with. mol.LSl: bearin& 
two loxw Il..:lRa alleles (Iox/lox) in onkr 10 produce Lc"<*'L-lRa""'" offspnng. II.· 
.IRa hemll)'gosit)' (""") inc:lrases tho: probability of CIr·mediated deLrtion of the lo~ed 
alit-Ie, Ldf""JL-4Ra'- mi~ weT\' back-crossed 10 BAlBlc "ildtypes (or 9 g..nellltlOns 10 
gencrlltc Lck""IL_4Ra- mice with a BALBI, background :m. 
Ld.:MI[l-4R(l""" mice were identified by PCR g~OI)'ping, and FACS anal)'si, and real-
time PeR were then used 10 confinn the ~iticity and effiCIency of!L-tRa .t- deletion 
on T -alb m . The ttsu!!! SOO"'l.'d thallL-4Ro. was efficieril ly deleted on CD3'CD4* cells 
but incompletely depleted on CD3'CDS' cells and NK T -<:ells. and remained preson\ on 
B ceils. y6TCR*COr T-cells. dendri tic cells and macrophages. The Lck'''IL-4Ra-
mice arc lhertfore effectively CD4' T -ull 1t,.IRn ./. mice. Isolated CD4' T -<:ells from 
these mice do not proliferate in respo nse to [1..-4 but maintain proliferative respon5e5to 
IL·2. In addition, Th2 differe ntiation i5 imp.tired in naIve CD4' T·ce ll s from Lck'"'[L-
4Rn"'" mice, while Th I differentiation is not. However, NO production by macrophages 
is inhibited by IL·4 and [L·IJ in these mice, and anligen·induced IgE is pre~nt at on ly 
Iligl111 y reduced levels as compared to wild·type mice. This demonstrates the impairment 
in Lck""IL.4Rn·- mice of IL·4Rn mediated funCiions in CD4+ T·cell, bill rIOt in oilier 
cells such as macrophagu and BoCclls. 
1.10.2 Macrophagrl ncut rophil s~cific IL..jRn ./· ( L)'5M"'IL-IRn~') mice 
Moerophag~neulrophi! speciftc IL-4Rn ./. micc hal'e ~n recently generated ll' (Fig. 
1.12). Transgenic mice With a lysozyme M promoter driving Cre recombinase were 
mated ",ilh [l-lRn.f· mice 10 produce lysM<""l..jRo; ./ . offspring. These offspring ",ere 
maled with mice bearing Il4Ru nankcd b) loxp sites (IL.4Ru loo",,) . reru!lIng in 
offspllnll With LysM driven crr·mediated deletion oflL.4Rq. L~·sMCreIL-lRIl·-. PCR 
senotypinll was used 10 Idnuify Lys~tCreIL-lRu'- mice. DIsruption of IL-IRn 
e~pm.sion and funcl ion occurred in mlltrnphagC!l and nculrophils onl~. with functional 
lests demonstr&tinll norm.1 IL4/1L-1J responsi,'cr,eu In T-GeI1s. B·cells and dendritic 
"-, , 
cells. Lys~ICrdL-4Ra-- mkc arc tliadon: df«livdy macrophage/neutrophil sp«ilif 
IL-4Ra. knocwutS. Accordingly. LysMCrrlL-4Ra""'" mice Yoere found 10 have impairnl 
II.-VILI) induc('d ahemal;,', acli'-81ion ofmacrop/laS" 119. 
Il4Ra .... ~ X Lck"* 
I 
Lck<re IL4Ra .... IL4Ralo .... ' 
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Background: Anisakis pegrejJii, a nematode that infests fish, is able to cause 
gastrointestinal disease and allergies in man. The present study examines immune and 
allergic responses against A. pegrejJii in wildtype and gene deficient mice. 
Methods: Wildtype, IL-4 -1-, IL-13 -1- and IL-4 receptor alpha (IL-4Ra) -1- mice were 
injected intraperitoneally with live A. pegrejJii larvae, and cellular responses were 
detennined by analyzing infiltration of immune cells into the peritoneal cavity and 
peripheral blood eosinophilia. Cytokine and antibody responses were measured by 
ELISA and compared with responses generated by oral sensitization with Anisakis extract 
alone. Sensitized mice were challenged orally with Anisakis extract and examined for 
allergic reactions, histopathology and mast cell proteases. 
Results: After Anisakis infection there was infiltration of immune cells into the 
intraperitoneal cavity in all strains, with IL-13 -1- and IL-4Ra -1- showing the greatest 
infiltration along with splenomegaly. Anisakis infection induced a strong Th2/type 2 
response in wildtype mice, typical of many gastrointestinal helminth infections. 
Importantly, when challenged orally with Anisakis extract, previously infected mice 
produced a response typical of food allergy, with itching, diarrhea and airway mucus 
hypersecretion. In contrast, allergic responses were reduced and abrogated in IL-4 -1- and 
IL-4Ra -1- mice, respectively. Oral dosing of mice with A. pegrejJii alone and no 
adjuvants resulted in production of type 2 antibodies IgO 1 and IgE, but did not elicit 
strong Th2 responses, and little to no allergic response was seen after challenge. 
Conclusions: These data show that Anisakis infection predisposes to allergic responses 
against ingested Anisakis proteins, and that both IL-4 and IL-13 are important in Anisakis 
allergy. Different immune responses to Anisakis in the various strains may represent the 
diverse responses to Anisakis infection in humans. 
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Table 2.1: Dishes at risk of harbouring infectious anisakid larvae 
Country 
origin 
Japan Sushi or sashimi 
South America Ceviche (raw fish marinated in lemon juice) 
Spain boquerones en vinagre (anchovies in vinegar sauce) 
Italy aUci marinate (pickled anchovies) 
The Netherlands Green herring (salted or smoked) 
Germany rollmops (pickled herring) 
Scandinavia gravlax (dry, cured salmon) 
Hawaii lomi-lomi (raw salmon) 
South Africa Smoked snoek or undercooked cater (snoek roe) 
U.K. Smoked salmon 
Italy, U.K., U.S.A. Seared tuna 
Russia Raw caviar/fish roe 
Malaysia Fish tripe (undercooked) 
Worldwide Undercooked fresh fish, e.g. hake, cod 




Anisakiasis refers to the disease caused by ingestion of members of the anisakidae 
family, which includes Anisakis spp, Pseudoterranova spp., Contracaecum spp and 
Hystero'thylacium spp.l. The source of infectious larvae causing anisakiasis is commonly 
a dish consisting of raw, pickled or smoked fish, examples of which are to be found in 
many countries (see Table 2.1). Accordingly, the incidence of anisakiasis is highest in 
countries where these dishes are frequently consumed. For example, in Japan, over 2000 
cases of anisakiasis are reported every year 2. However, many infections have also 
occurred after consumption of freshly caught fish such as hake or cod that appears to be 
well-cooked but has not been sufficiently heated through (e.g. grilled, microwaved or 
shallow-fried fish) 3. 
Ideally, fish should be eviscerated immediately after being caught so that the large 
number of dormant larvae in the gut and mesenteries of the fish do not crawl into the 
flesh upon warming up 4, In order to kill the smaller amount of larvae that may be 
. . 
present in the musculature, fish should be deep-frozen (-20°C for 24-48hrs hours) or 
cooked so that all parts of the fish reach at least 60°C for 10-20 minutes 5.', However, 
freezing or heating can alter the flavour of sushi or other raw fish delicacies ,,8, In Spain, 
an alternative method of pickling fish has been proposed in which the fish is exposed to 
high concentrations of acetic acid in order to kill any contaminating parasites, and the 
acid is subsequently diluted down for consumption 9. Other seafoods such as squid and 
molluscs have also been implicated in Anisakis infections, and care should be taken to 
properly prepare these as well 10. 
In Japan and Europe, the majority (over 90%) ofanisakiasis cases are caused by Anisakis 
species, followed by Pseudoterranova decipiens (approximately 4-5%) and then other 
unspeci~ed species, possibly Contracaecum or Hysterothylaci~m I, " 11. However, these 
figures vary from place to place due to differing geographical distribution of species, with 
Pseudoterranova causing anything from 0-22% of anisakiasis in various regions of 
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Japan 12, and often reported as the cause of infections in the Americas 13-1S. Little 
epidemiological information is available from Africa Reported cases include two 
children from Egypt with urticaria due to Anisakis sensitization 16 and a South African 
man with food-related allergic reactions due to Anisakis 17. In addition, a study of 
occupational allergies amongst seafood-processing workers in the Western Cape of South 
Africa found a prevalence of 8% sensitization to Anisakis 18, and additional cases of 
occupational Anisakis allergy are occasionally reported to our unit. Anisakiasis or 
discovery of anisakine larvae in patients has not been reported from South Africa, 
although presumably cases of live infection do occur, especially with the recent trend 
towards visiting sushi'restaurants, and the high levels of Anisakis infestation in the fish 
snoek (Thyrsites atun), a local favourite that is commonly sold fresh (i.e., unfrozen). 
Infection with Pseudoterranova spp, Contracaecum spp. or Hysterothylacium spp. is 
often mild and transient, causing nausea, cramps, pharyngeal irritation, and occasionally 
allergic symptoms 14,15. Larvae are usually coughed or vomited up 36 hours to 2 weeks 
after ingestion. Occasionally, especially in the case of Pseudoterranova spp, they can 
penetrate the gastric tract to cause acute disease, but on the whole are less invasive than 
nematodes of the species Anis~kis 12, 13, Anisakiasis caused by infection with AnisaJds 
spp. exists in gastric, intestinal and more rarely, extragastrointestinal forms, and may be 
acute or chronic. Infection with one or two worms is usual, but multiple infection is 
occasionally reported, and as many as 56 larvae have been found in one patient 2, 19. 
Symptoms of acute anisakiasis normally begin several hours to several days after 
ingestion of the live larvae. 
2.2.2 Gastric anisakiasis 
Typically, gastric infestations present within the fust 12 hours after fish ingestion. In 
Japan, gastric anisakiasis is by far the most common form, whereas in Europe intestinal 
anisakiasis is said to be more frequent 8, 11. The reason for this discrepancy is not known, 
though it has been suggested ~t differences in food preparation may play a role 11. ,It 
seems more likely that differences in diagnosis or reporting are to blame 5. In Japan there 
was once the misconception that intestinal anisakiasis was more common in the north and 
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gastric anisakiasis in the south, but it is now known that there is no difference in their 
distribution, and that the discrepancies were due to differences in utilization of 
gastrointestinal endoscopy 7. In Europe, where there is less awareness of anisakiasis than 
in Japan, it is more likely to be misdiagnosed. Gastric anisakiasis can be confused with 
food poisoning, indigestion, gastric ulcer or appendicitis, and can spontaneously resolve 
if the larvae are vomited up during the acute stage. 
Symptoms of gastric anisakiasis can include acute abdominal pain (mild to severe), 
nausea, vomiting, diarrhoea, abdominal distention, chest pain, urticaria and anorexia, 
though in some patients the initial infection is asymptomatic and is only discovered 
subsequently when the disease becomes chronic or larvae are discovered accidentally 
during surgery 20, 21. After ingestion, Anisakis larvae secrete proteases that enable them 
to penetrate the mucosal Wall, eliciting an inflammatory response 22. Endoscopy during 
acute gastric anisakiasis reveals reddening of the gastric mucosa, oedema, haemorrhage 
and ulcerations or erosive lesions at the site of larval penetration, while radiology shows 
thickening of gastric folds, and may reveal the larva itself 23, 24. Gastroscopic removal of 
the larva(e) with forceps brings rapid relief 25. If pain is tolerable, treatment with 
antihel~inthics, anti-inflammatories and analgesics may be s~fficient 26-29. However, if 
the larvae are not removed, treated or naturally expelled, they may penetrate into the 
submucosa and elicit eosinophilic infiltration and granuloma formation, causing 
symptoms of chronic gastric anisakiasis, including bloating, loss of appetite, dyspepsia 
and occasionally gastric bleeding. Symptoms may continue long after the larva has 
perished, due to a continuing inflammatory response to larval remains. 
Chronic gastric anisakiasis may be confused with eosinophilic gastritis, Crohn's disease 
or gastric ulcer 5,30,31. Abscesses or submucosal tumour-like lumps can form, and several 
reports illustrate cases where gastric cancer was diagnosed, following which biopsy 
revealed remains of Anisakis larvae in pseudo tumours 32, 33. It has even been postulated 
that Anfsakis infection is a risk factor for gastric cancer, dlJe to its association with 
polyadenoma tumours and the in-vitro mutagenic and tumour-promoting, anti-apoptopic 
activity of certain fractions of Anisakis extract 34,35. Japan simultaneously lays claim to 
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the highest incidence of gastric cancer and gastric anisakiasis in both men and women. In 
Chile, where raw fish is also frequently consumed as ceviche, gastric cancer is also very 
frequent 35. 
2.2.3 Intestinal anisakiasis 
Acute intestinal anisakiasis manifests as severe pain in the lower right quadrant of the 
abdomen, accompanied by nausea, diarrhoea, vomiting and fever, usually beginning 8-48 
hours after ingestion of live larvae 36,37. It can be confused with acute appendicitis, ileitis 
or food poisoning 27, 38. Radiological findings show oedema, eosinophlic infiltration, 
thickening of the bowel wall and a resultant narrowing/obstruction of the intestinal tract 
21,37, 3941. Leukocytosis with neutrophilia is common and occasionally eosinophilia may 
occur 42,43. In cases where pain is intolerable, surgical resection is required to remove the 
wonn. Otherwise, a combination of anti-parasitic and anti-inflammatory drugs may 
suffice, as in gastric anisakiasis. However as in the case of gastric anisakiasis, if acute 
intestinal anisakiasis is not treated, chronic intestinal anisakiasis may result, with 
deposition of connective tissue and accumulation of eosinophils around larval remains in 
the submucosa 1,30. Persistent cramps in the lower abdomen, intennittent constipation and 
diarrhoea, weight loss and sometimes bloody stools can result from the inflammation 
and/or intestinal obstruction 21, 27,36,44. These symptoms can persist for years until the 
granulomas and larval remains are removed by surgery. Often, such symptoms are 
mistaken for Crohn's disease, ulcerative colitis, diverticulitis, appendicitis, non-specific 
eosinophilic enteritis or irritable bowel syndrome 27. 
2.2.4 Extragastrointestinal (ectopic) anisakiasis 
More rarely, after penetrating the mucosa the Ansiakis larva may migrate to 
extragastrointestinallocations. Larvae have been found in such places as the oral cavity, 
spleen, lungs, oesophagus, pancreas, ovaries, peritoneum, liver and lymph nodes 7,35,4548. 
They may elicit inflammatory reactions that lead to their discovery, or encapsulate and 
remain there until being gradually degraded 49. Occasionally they are found accidentally . . 
during surgery. A Japanese study found an incidence rate of 0.4% (52 of 14162 cases) for 
ectopic anisakiasis. 
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2.2.5 Gastroallergic anisakiasis 
In a subset of patients, Anisakis infection is accompanied by allergic symptoms such as 
urticaria, angioedema, bronchospasm and anaphylaxis 43, 50, 51, The ensuing combination 
of gastrointestinal and allergic symptoms has been termed "gastroallergic anisakiasis" 43. 
Sera from patients with gastroallergic anisakiasis typically already show Anisakis-
specific IgE at the time of the reaction, as opposed to sera from patients with gastric 
anisakiasis, in which specific antibodies may only appear 10-30 days after infection 35, 52, 
It has therefore been speculated that gastroallergic anisakiasis is a memory response to a 
prior, possibly asymptomatic infection in conjunction with a primary response to 
previously unrecognized antigens S3, Hypersensitivity symptoms may precede, follow, or 
coincide with gastrointestinal symptoms, and tend to dominate the clinical picture. Often 
the severe epigastric pain and mucosal oedema common to gastric anisakiasis are not 
present. 
Symptoms can begin anywhere between a few hours to more than a day after ingestion of 
the parasite, and patients may therefore not relate the ingestion of the fish to the 
symptoms. The disease appears to be short-lived, with symptoms of some patients 
disappearing before arrival at the emergency room. Most recover within one day after 
treatment with epinephrine, corticosteroids and antihistamines, and removal of the larvae 
if present. Daschner et al 2002 53 suggest that the allergic reaction against the parasite 
helps to expel it more quickly, explaining the generally shorter course of the disease as 
compared to gastric or intestinal anisakiasis. However, because a high proportion of the 
reactions are anaphylactic and therefore life-threatening, some patients do require longer 
periods of hospitalization, 
Studies in countries with a high consumption of fish indicate that a large proportion of 
anaphylaxis cases are due to Anisakis, In Spain, when considered a hidden food allergen, 
Anisakis is responsible for the largest number of anaphylactic reactions to food 51,54, An 
analysis of 665 cases of anaphylaxis at a Spanish hospital found that Anisakis was . . 
responsible for more cases of anaphylaxis than all foods combined, and was the third 
most common cause of anaphylaxis, following drugs and Hymenoptera stings 55 
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Ingestion of Anisakis is also an important cause of chronic urticaria in these countries 54, 
56-58. Because larvae are not always found in patients diagnosed with gastroallergic 
anisakiasis or urticaria, it is uncertain whether a live worm is required in order to elicit 
the allergic symptoms or whether allergic reactions can occur to dead parasites or their 
proteins. Dascnher et al 59 consider pure allergic reactions to Anisakis without 
gastrointestinal symptoms to be'rare. Several oral challenge studies found that patients 
tolerated the ingestion of capsules containing killed Anisakis larvae and were symptom 
free on a diet allowing deep~frozen fish 60-62. However, several other studies note that 
some patients have Anisakis-related reactions to well-cooked fish, including canned tuna, 
and a small number of patients on a deep-frozen fish diet continued to experience allergic 
reactions 54, 56, 63-65. Furthermore, several proteins found in Anisakis are both heat stable 
and resistant to pepsin digestion 64, 66-69. A case has also been reported where a patient 
had severe anaphylactic reactions to a skin prick test with Anisakis extract on two 
occasions 70. Whether or not live larvae are required for allergic reactions is therefore still 
controversial 5. 
2.2.6 Diagnosis of anisakiasis 
In the past anisakiasis has oft~n been misdiagnosed as appendicitis, ileitis, Crohn's 
disease, eosinophilic gastroenteritis, gastric ulcer, food poisoning, fish allergy, idiopathic 
anaphylaxis, idiopathic urticaria and even gastric or intestinal cancer 27,63. However, in 
countries such as Japan, Spain and Italy where cases occur relatively frequently due to 
consumption of raw fish, diagnosis is now improving. In other parts of the world, it is 
likely that many cases of anisakiasis are still being missed. 
Abdominal pain, nausea, vomiting and/or diarrhoea within 48 hours of consuming fresh 
seafood should indicate the possibility of Anisakis infection 43, 63. As many cases of 
anisakiasis have occurred after consumption of presumably well-cooked hake or cod, 
ingestion of raw seafood should not be the only factor meriting further investigation. 
Discovery of larvae is a defini~ive diagnosis, but usually only in gastric and coloni~ 
anisakiasis can they be directly seen by endoscopy 35,71 and in chronic cases they have 
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usually already passed through the mucosal wall 5 Resected intestine can be 
histopathologically examined for larval remains 5, 
Radiography can reveal larvae appearing as thin filling-like defects 23. Pathology of the 
gut and intestine observed by radiology or ultrasonography contributes to the diagnosis 
buf is non-specific 23, 24, 30, as is leukocytosis 37, and eosinophiLia is only seen in a subset 
of patients 35, 37, 42, 43, 72. One study found that eosinophil cationic protein appears to be 
raised in the first 72 hours following infection and may therefore be a useful marker 
when combined with a history and symptoms 42. 
Positive skin prick tests to Anisakis, Anisakis-specific IgE and raised total IgE are good 
diagnostic markers during gastroallergic anisakiasis or. chronic gastrointestinal anisakiasis 
27,43,73,74, but in primary infections serological conversion may take some time 53, Due to 
cross-reactivity of Anisakis somatic antigens with other hehninths and invertebrates 75; 76, 
antibodies against excretory-secretory (ES) proteins may be better diagnostic markers 66, 
and a rise in specific and total IgE one month after the infection is considered a good 
indication of true infection 43. Antibodies against Ani s 1, an excretory protein of 
Anisakis, seem particularly specific to infection with live Anisakis n, 78, An ELISA has 
been developed that utilizes this antigen 79, but it is not widely available, 19B 
immunoblotting analysis may also be used for diagnosis 49,64,80, When a hypersensitivity 
reaction dominates, as in gastroallergic anisakiasis, fish/seafood allergy should be ruled 
out by means of specific IgE determination or skin prick tests 5. 
2.2.7 Immunology of anisakiasis 
The extent of tissue destruction and inflammation resulting from infection with Anisakis 
is out of proportion to the small size of the parasite (1-3cm long), indicating that host-
parasite interactions are responsible for the pathology of anisakiasis 11, It is therefore 
important to understand immunological aspects of anisakiasis in order to fully 
comprehend the disease, Data on the immunological mechanisms behind Anisakis-. . 
associated pathology in humans are incomplete. Infection is primarily associated with 
intense eosinophilic infiltrates around the larvae, with some patients additionally showing 
67 
leukocytosis with increased neutrophils and others demonstrating peripheral blood 
eosinophilia. Studies in guinea pigs and rabbits demonstrated that Anisakis extract is 
strongly chemotactic for eosinophils but not neutrophils 81, 82, It is thought that tissue 
damage and not the wonn itself evokes the neutrophils 72. Anisakis extract injected 
intradennally into guinea pigs caused a large accumulation of eosinophils. starting within 
1 hour and reaching a peak 8hrs 'after the injection, In patients. serum levels of eosinophil 
cationic protein (ECP) are raised in the first 72 hours after gastrointestinal infection 42, 
Eosinophil Major Basic Protein (MBP). known to damage parasites. has been detected in 
eosinophils of the inflammatory infiltrate of biopsies from patients with anisakiasis 83, 
Inducible nitric oxide synthase (iNOS). another molecule that aids in parasite killing. was 
also expressed in the tissue and thought to be produced by the eosinophils. In vitro. 
Anisakis extract down-regulates NO production by macrophages 84, 
The release of ECP. MBP and nitric oxide as well other products such as peroxidases and 
eosinophil-derived neurotoxin are probably responsible for wonn death. but also cause 
local tissue damage 72. The larvae usually die within a few days I, 72 and degenerate in 
about 8 weeks 85. during which time they are surrounded by necrosis. oedema and 
massive eosinophilia mixed with neutrophils. macrophages and lymphocytes 7, 35, A 
granuloma fonns around the larval debris. with deposition of fibrotic tissue and fonnation 
of foreign body giant cell lymphocytes. In some patients this gradually disappears 
(leading to the tenn "vanishing tumours" 7, 86), while in others clearance can take longer 
and the continuing inflammation results in symptoms of chronic anisakiasis. 
An examination by reverse-transcriptase PCR of intestinal resections from anisakiasis 
patients containing infiltrates of eosinophils and lymphocytes demonstrated expression of 
Th2 cytokines (IL-4. IL-5) and T cell receptor (TCR) in 100% of the tissues, but no IFN-
y or IL-2, indicating a Th2 type profile and suggesting that Th2 cells mediate the 
immunological effector mechanisms in anisakiasis 83, IL-4 stimulates IgE production, 
while IL-5 is responsible for. inducing eosinophil proliferation, differentiation and 
activation 87. These data therefore fit with the features of the disease. 
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2.2.8 Animal models of anisakiasis 
Several authors have used animal models of anisakiasis in an attempt to further elucidate 
the immunological mechanisms of disease 88-9S. The consensus is that intraperitoneal 
infection is the best route of inoculation, because in orally-infected mice more than 50% 
of the larvae can be lost via the anus, leading to problems with dose standardisation 89. 
When larvae that are not lost in this way reach the gastrointestinal lumen, they quickly 
burrow through the mucosa to enter the abdominal cavity, resulting in what amounts to 
intraperitoneal infection in any event. Jones et al have shown that the pathology of 
intraperitoneal infection closely mimics human infection 88, Furthennore, intraperitoneal 
injection is less traumatic for the mice than oral administration, due to the relatively large 
size of the larvae compared to the mice. Intraperitoneal infections were therefore used in 
the current study. 
Jones et al (1990) surgically implanted Anisakis larvae into the abdominal cavity of 
CBAlJ mice and looked at pathology at 1, 2 and 3 weeks post-infection 88. After one 
week, neutrophils had accumulated around the larvae. By two weeks, most larvae were 
still viable and surrounded by granulocytes, occasional multinucleate giant cells, and 
mature 'granulomata consisting of eosinophils, fibroblasts and' collagen. At three weeks 
post infection the larvae had been invaded by inflammatory cells and were dead. 
Surrounding granulomata consisted primarily of connective tissue with scattered 
eosinophils, with multinucleate giant cells adjacent to the larvae and eosinophils adjacent 
to larval debris. Systemically mice had varying degrees of neutrophilia, which began to 
return to nonnal values by week 3. Peripheral blood eosinophils were slightly decreased 
at weeks 1 and 2, but also returned to nonnal by week 3, suggesting homing of the 
eosinophils to the site of the larvae during acute infection. 
In a similar model using intraperitoneal injections with Anisakis larvae, Iglesias et al. 
measured antibody production during the first 8 weeks post infection in BALB/c x CBAlJ 
mice 89: The majority of injected larvae were shown to rem~n viable up to 2 weeks, 
producing excretory-secretory CES) products that stimulated an immune response. The 
larvae later died and were broken up, releasing internal components that induced a 
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secondary response. IgM and IgG I were the predominant antibodies produced, with only 
slight increases in IgG2a, IgG2b, IgG3 and 19A. IgM antibodies against somatic antigens 
(SA) reached a peak at two weeks post infection, while IgG I showed a first peak between 
3 and 4 weeks post-infection and continued to climb up to 8 weeks post-infection. The 
authors suggest that the second peak was due to the release of new antigens during the 
break-down of the worm. Antib"dy responses against ES proteins peaked slightly sooner, 
with IgM at a maximum by week 1 and IgGI peaking at week 3. Total IgG levels peaked 
for ES products at week 2 and SA at week 6, after which they declined and remained at a 
fairly constant level during the 21 weeks post-infection at which they were measured. 
Perteguer and Cuellar (200 I) measured increases in IL-4 between days 6 and 12 and 
again at 3 weeks post oral infection, indicating the likely cause of the skewing towards 
type 2 antibody production 91. Studies in rats showed production of specific 19B that 
reached higher levels after a second infection, with a peak at 3 weeks after re-infection, 
indicating that an allergic state could be caused by multiple infections with Anisakis 
larvae 94, 
Different strains of mice have different responses to Anisakis, demonstrating the 
importance of the genetic background of the host in the immune response to Anisakis 9S. 
Human patients show a wide range of disease caused by Anisakis, ranging from 
asymptomatic to inflammatory to allergic. In this study, we aimed to determine the roles 
of the important Th2 type cytokines IL-4 and IL-l3, as well as their receptor, IL-4Ra., on 
the immune response to Anisakis infection and subsequent allergic responses, In order to 
do this we utilised gene-deficient mice with "knock-outs" in the genes for IL-4 96 or IL-
4Rg. 97 on a BALB/c background, and exposed them to intraperitoneal Anisakis infection. 
When available, IL-I3 deficient mice 98 were also included in the experiments. Antibody 





BALB/c mice (8-lO-wk-old) and IL-4 -/- 96, IL-13 -/- 98 and IL-4Ra -/- mice 97 on a 
BALB/c background were housed under SPF barrier conditions using individual 
ventilated cages (IVC). All experiments complied with the. South African Code of 
Practice, and were approved by the University of Cape Town's Animal Ethics 
Committee. 
Anisakis larvae 
Anisakis pegrejJii larvae (L3) were collected from the intestines and mesenteries of 
parasitized fish (Thyrsites atun) with forceps, and extensively washed in 4% acetic acid 
and phosphate-buffered saline (pBS)(see Appendix A). Larvae were frozen for extract or 
stored live at 4°C in Iscove's Modified Dulbecco's medium (IMDM) containing 
100Jlg/ml penicillin and 100Jlg/ml streptomycin (all Gibco, Paisley, Scotland). Before 
use in live infections, larvae were re-washed in sterile PBS. 
Anisakis extract 
Anisakis larvae were frozen and homogenized in PBS, then sonicated with a Microson™ 
ultrasonic cell disrupter (Misonix)(Long Island, U.S.A.). The extract was centrifuged and 
filter-sterilized through a O.20JlID filter (Sartorius, Goettingen, Germany). Protein 
concentration was measured by BCA test (Pierce, Rockford, Illinois, U.S.A.). 
Concentrated extracts were produced by centrifugation through 15ml ultrafiltration units 
with a lOkD cut-off. (Millipore; Amicon, Cork, Ireland). 
Anisakis infection 
Mice were anaesthetized with 200JlI of ketamine (Anaket-V; Centaur Labs, 
Johannesburg, South Africa)/xylazine (Rompun; Bayer, Isando, South Africa) anaesthetic 
(see Appendix A), and then injected intraperitoneally with !\yo larvae in 1ml PBS (see 
Appendix A) at week 0 using a 12 gauge needle (Identipet, Pretoria, South Africa). In 
some experiments, mice were re-infected at week 8 with another two larvae. 
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Anisakis infection with oral challenge 
Mice were anaesthetized with 200J,Jl of ketamine (Anaket-V; Centaur Labs, 
Johannesburg, South Africa)/xylazine (Rompun; Bayer, Isando, South Africa) anaesthetic 
(see Appendix A), then injected intraperitoneally with two larvae at week 0, re-infected at 
week 8, and challenged orally with Smg Anisakis protein extract at week 11 using oral 
dosing cannulae (VetTech, Cheshire, U.K.). Allergic reactions were evaluated using a 
modification of a previously described scoring system 99. 0, no symptoms; 1, scratching 
and rubbing around the nose and head, hypersensitivity to touch, irritability; 2, diarrhoea, 
puffiness around the eyes and mouth, pilar erecti, reduced activity; 3, cyanosis around 
mouth and tail, lying flat but upright; 4, lying on side, loss of grip, loss of consciousness; 
S, death. 
Oral sensitization protocol 
Mice were dosed weekly with 100J,Jl PBS or Img of Anisakis extract in 100J,Ll PBS using 
oral dosing cannulae (VetTech, Cheshire, U.K.), for a total period of S weeks. On the 6th 
week mice were challenged orally with Smg of Anisakis extract and observed for signs of 
allergic reactions (see above). 
Peritoneal lavage 
Mice were killed and intraperitoneal lavage was performed using Sm1 of 10% FCSIPBS 
(Delta, Kemptom Park, South Africa). Cells were separated onto 3-
aminopropyltriethoxysilane(APES)-coated slides by cytospin, allowed to dry overnight 
and stained using a Shandon Kwik-DiffTM staining kit (Clincal Science Diagnostics, East 
Grinstead, U.K.). Differential counts were performed under a light microscope. 
Percentages were converted into cell numbers by multiplication with total cell counts. 
Isolation of splenocytes 
Spleens were aseptically remov~d from mice with forceps, and splenocytes were isolate~ 
by pressing through a metal sieve in lOml IMDM(Gibco, Paisley, Scotland). The cells 
were centrifuged at 1200rpm for S minutes, and the pellet was resuspended in 3-Sm1 of 
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ice-cold red cell lysis buffer (Appendix A). After 2-S minutes on ice, the cells were 
centrifuged at 1200rpm for S minutes. Pelleted cells were resuspended in 10ml ofIMDM 
supplemented with 10% FCS (Delta, Kempton Park, South Africa), 2mM L-glutamine 
(Gibco, Paisley, Scotland), 100J.1g1ml penicillin (Gibco, Paisley, Scotland) and "100J.1g1ml 
streptomycin(Gibco, Paisley, Scotland) The splenocytes were then filtered through a 
70f.1I11 cell strainer (BD Falcon, Bedford, Massachusetts, U.S.A.) to remove debris, and 
diluted 1: 1 0 to 1 :30 with Trypan Blue (Sigma, Steinheim, Germany) and PBS for 
counting. 
Splenocyte restimulation 
Splenocytes were diluted to 4 x 106 cells/ml with supplemeted IMDM (Appendix A), and 
cultured in 48-well plates (Costar, Corning, New York, U.S.A.), with 2S0J.11 of cells 
added to one of the following: 2S0J.11 medium, wells pre-coated with anti-CD3 (clone 
14S-2C11; lOJ.1g1ml) overnight at 4°C to which 2S0J.1l of medium had been added, 2SJ.1g 
conA in 2S0J.1l medium, 2S0J.11 of 200J.1g1ml Anisakis extract in medium, 2S0J.1l of 
200J.1g1ml Grade V ovalbumin (Sigma, Steinheim, Germany) in medium. The cells were 
.incubat~d at 37°C with S% C02, and supernatants were collected after 48 hours and 
stored at -80°C. 
Cytokine ELISAs 
Sandwich ELISAs were performed to determine cytokine levels in cell supernatants. 
Nunc Maxisorp microtitre plates (Nunc, Reskilde, Denmark) were coated with purified 
anti-IL-4 (clone llBll, 2J.1g1ml), anti-IFN-y (clone An18KL6, IJ.1g1ml) or anti-IL-S 
(l J.lg1ml), anti-IL-9 (2J.1g1ml), anti-IL-13 (l J.lg1ml), anti-IL-l 0 (l J.1g1ml)or anti-TGF-~ 
(O.S J.1g1ml)(all BD Pharmingen) diluted in PBS, and incubated overnight at 4°C. Plates 
were blocked with ELISA block buffer (Appendix A) for 1 hour at 37°C, then washed 3x 
with ELISA wash buffer (Appendix A). Serially diluted standards (purified recombinant 
IL-4, IL-S, IL-9, IL-13, IFN-y, IL-IO or TGF-~ (all BD Biosciences Pharmingen, San 
Diego, U.S.A.) or cell supernatant, all diluted in ELISA dilution buffer (Appendix A) 
were added to the plates, and incubated overnight at 4°C. Samples to be used in the 
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detection ofTGF-~ were pre-treated with acid to unfold the protein for antibody binding. 
(Appendix B). The plates were washed 4x, and biotinylated goat-anti-mouse IL-4 
(0.5J.lg/ml), IL-5 (0.5 J.lg/ml), IL-9 (I J.lg/ml), IL-13 (0.5J.lg/ml), IFN-y (0.5J.lg/ml,), IL-IO 
(0.5J.lg/ml) or TGF-~ (0.5J.lg/ml) antibodies (all BD Biosciences Pharmingen, San Diego, 
U.S.A.), diluted in ELISA dilution buffer, were added for 3 hours at 37°C. Plates were 
washed 4x and 1 J.lg/ml alkaline 'phosphatase(AP)-labelled streptavidin (Pharmingen) was 
added for 1 hour at 3~C. Finally, plates were washed 4x and 4-nitrophenyl phosphate 
disodium salt hexahydrate (PNP) (Sigma, Steinheim, Germany) substrate (see Appendix 
A) was added. Absorbance was measured at 405nm with 492nm as a reference 
wavelength using a VERSAmax tuneable microplate reader (Molecular Devices, 
Sunnyvale, California, U.S.A.). Cytokine levels in supernatants were determined by 
reading from the standard curve. 
Bloo~ collection and eosinophil counts 
Blood samples taken before challenge were collected in serum separator tubes (BD 
Microtainer™ SS7. BD, Franklin Lakes, U.S.A.) by tail vein bleeding under an infra-red 
heating lamp. Alternatively. blood was taken from killed mice after cervical dislocation. . . 
For eosinophil quantification, blood was diluted 1 in 10 in Discombe's fluid (Appendix 
A) and eosinophils were counted in a haemocytometer (Neubauer, Germany). For serum 
collection, blood samples were centrifuged for 15 minutes at 3000 rpm before being 
placed at -80°C for storage. 
Antigen-specific antibody ELISAs 
Nunc Maxisorp ELISA plates (Nunc, Reskilde Denmark) were coated overnight at 4°C 
with Anisakis extract in PBS at 5J.lg/ml (for IgGI, IgG2a, IgG2b) or Img/ml (for IgE), 
then blocked in ELISA block buffer (Appendix A) for 1 hour at 37°C. Plates were 
washed 3x with ELISA wash buffer (Appendix A), and serum samples serially diluted in 
ELISA dilution buffer (Appendix A) were added. Plates were incubated overnight at 4°C, 
then washed 4x. AP-Iabelled goat-anti-mouse IgG 1, IgG2a, IgG2b or IgE, 0.5J.lg/ml, 
(Southern Biotechnology, Birmingham, Alabama, U.S.A.) was added for 2 hours at 37°C. 
Plates were washed 4x and PNP (Sigma, Steinheim, Germany) substrate (see Appendix 
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A) was added. Absorbance was measured at 405nm with 492nm asa reference 
wavelength, using a VERSAmax tuneable microplate reader (Moleular Devices, 
Sunnyvale, California, U.S.A.) 
Total IgE ELISAs 
Cytokine sandwich ELISA was performed using purified anti-IgE (clone 84.1 C) as a coat 
(lJ.1g/ml) and AP-Iabelled goat anti-mouse IgE (Southern Biotechnology, Birmingham, 
Alabama, U.S.A.) as a secondary antibody, according to the protocol outlined above 
("Antigen-specific antibody ELISAs"). Purified recombinant mouse 19E (BD 
Pharmingen, San Diego, U.S.A) was used as a standard, starting at a concentration of 
10J.1g/ml. 
MMCP~l and histamine ELISAs 
MMCP-l levels in serum were measured by ELISA according to the manufacturer's 
protocol (Moredun Scientific Ltd, Midlothian, U.K). Histamine levels were quantified 
using a histamine ELISA kit (IBL Immuno-Biological Laboratories, Hamburg, 
Germany). 
Bronchiolar lavage 
Mice were injected intraperitoneally with 300J.11-1ml of lethal anaesthetic (Appendix A) 
as necessary. Dead mice were pinned to the dissecting board and sprayed with 70% 
ethanol. The trachea was exposed and the lungs were lavaged twice with Iml of 10% 
FCS (Delta, Kempton Park, South Africa)/PBS using Iml 18G cannulae (Introcan, 
BlBraun, Melsungen, Germany). The broncheolar lavage fluid was centrifuged at 
2000rpm for 5 minutes and cells were resuspended in 500J.1l - Iml of PBS. Viable cells 
were counted using Trypan blue (1: 1 dilution)(Sigma, Steinheim, Germany). Cells were 
fixed to APES-coated slides using a cytospin, and the slides were allowed to air dry 
overnight. Slides were stained using a Shandon Kwik-DiffTM staining kit (Clinical 
Scienc~ Diagnostics, East Grinstead, U.K.) and differential counts were performed using 
a light microscope. 
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Lung tissue analysis 
Lungs were removed from killed mice, weighed, homogenized in 100mM Tris-Triton 
buffer (Appendix A), sonicated for 20 pulses at an output of 9 watts, and centrifuged for 
20 minutes at 12000rpm. Supernatants were removed for eosinophil peroxidase (EPO) 
measurement. Alternatively, tissue was homogenized in PBS for antibody and MMCP-I 
ELISAs. For histology, tissue. samples were preserved in 4% phosphate-buffered 
formalin, cut in 5-7f.1m paraffin sections, and stained with haemotoxylin and eosin for 
cellular infiltration and Periodic acid-Schiff reagent for mucus. 
EPO assays 
Serial dilutions (l in 2) of HRP standard (Sigma, Steinheim, Germany) were performed 
in a microtitre plate (Nunc, Reskilde, Denmark), using Tris-Triton buffer (Appendix A), 
with a starting concentration of 0.54 units. In parallel, lung tissue samples were serially 
diluted (1 in 10) in Tris-Triton buffer. The plates were incubated at 37°C for 10 minutes. 
Equal volumes of TMB substrate (KPL, Maryland, U.S.A.) were added and the plates 
were incubated at room temperature for approximately 2 minutes until the desired colour 
change was achieved. The reaction was stopped using equal volumes of 2M H2S04, and 
the absorbance was measured at 450nm with a 540nm reference wavelength using a 
VERSAmax tuneable microtitre plate reader (Molecular Devices, Sunnyvale, California, 
U.S.A.). 
Statistical analysis: Values are given as mean ± SEM or SD. Significant differences 
were determined using the unpaired two-tailed Student's I-test using computer software 
(GraphpadPrism TM), For allergic score graphs, the Mann-Whitney test was used for two 
experimental groups, and the Kruskal-Wallis test with Dunn's post test for three or more 
groups. Values P< 0.05 were considered significant. 
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204 RESULTS 
2. ~ . 1 Cellula r 1m mllne rnpll nu' against A,,/sIll/if 
!nll1lpentoncal injection of A "isakis !an'3C was associated wilh an inflLlX of immune cells 
into the peritonc:a! cavil)' in all 5truins (Fig. 2.4.1). "J'hc:re W3S ~ sleady rise in infiltr:lting 
~111i after mfection. with an increased ntunbtr of ~Ils al wed:'1 and a further incre3SC b)' 
week 2. Lar;ae found in infected mice durina the firsllwo 10 three ""~ks after infection 
were usually still moving. while lllIvlle fOllnd after thi$ stage were dead. It Wllll difficult 10 
find lar;3C. bUI when Ihey were discovered they were in moSI cases anached l(l the 
mesenteries or abdominal fM oflhe miee There was no obviOlls effect of mouse stl1l;n on 
larvlll survivaL However. the dltliculty in finding larvae in Ihese expcnmcm.s predu.cks 
any definite conclusion about the effects of ILA. Il-13 and the Il-4Ra on deSlruction o f 
larvae. 
Il-4Ra -/- mice had hipr numbers of infilll'3linl! cells in the inlraperltoneal ClIvily than 
other strains. followed by IL-13 -1- and lhen IL-4 -I. mice (Fig. 2.4.1). Wildtype BALBlc 
mice had the least innllmm3tion. although the number of infiltrating cells did increase 
relative 10 sham-mfected mice The same panc:m of inflammalion was found in spleens. 
"'i th increasc:d numbers of splenoC)1es colll1led in spleen! wt'n at week 2 in !L-13 -l-
and IL-4RIl -1- mice. Splt'llOmegal)' "1IS t'speciaJly evilknt In lL-4RIl -1- mice and was 
consistently observt'd over severn! e"pcrimcnts. 
Differential cell counts showed a dramalic iocreasc in the number of nelltrophils in the 
Intrapcritoneal cavity on the day following infeclion (Fig. 2.4.2) in wUdLypt. n.-13 -l-
and IL-4Ro -I. mice As It-4 -f- mice already had hight'T background levels of 
neutrOphil5- the increase was nOI noticeable in this strain. Eosinophils also began to 
3ppCat 1II OOy l. bill "ere ITlOI'e evidenl from week I onward!. when their numbers had 
mcreased. 
" 
Total intraperitoneal cells Total spleen cells 
D"l' 7 D"1 \. 
Tim_ po01 lo f,,~ , io .. Tim_ 1'<''' inr~< Ii"" 
_ WT DIL-4KO ~IL-13 KO OIL-4Ra KO 
Figure 2.4.1 toeal and s)"~ lcmi( increa5el in immune ceUs fullowing AJli5llkis 
inf'-'"l'L iOn. Cells from inlmpcritoncallavages and spk .. n~ were pOoled Cn - 4) and coumed 
following infcclion wilh 2 Amsakls lorvae. Results are representative of ;II least tWO 
experimems. 
" 
By week I. Increased numbers of monocyteslmacrophages and lymphocytes w~te 
evident. Leveb of all these cells remained increa~ at we~k 2 bUI had begun 10 drop 
back 10 normallc,'els at week 4. Mast cells werc only present in very Jaw numbers in the 
differential cell count:;;. but appeMed to increa5e over time. 
2.4.2 llcripheral hlood ~os i nopbilia ~ frcr A ni$"ki.· ;n(Nlion . 
Absolute numbers of eosinophils in the peripheral blood varied between experiml'l1ts and 
betwcxn male and fl'll1alc mice. However, there was p trend over several experiments 
towards an increase in periphet:l! blood eosinophils ill wildtype. 11..-4 -/- and IL-4Ra -1-
mice after infection. which reached significance in some of the expl.'rim~ts (Fig. 2.4.3). 
A peak $eemed to occur at approximately three to four weeks po.t in f""tion. around the 
time of death of the larvae. IL·13 . / . mice had only low numbers o f eosinophils in tk 
pt:ripheral blood. 
2. ·t 3 Cy lokine prnd uelion U)· pc rilOn~n l cr ll.~ in A ,li!,,,kis infee linn 
J'critoneal lavage cells taken from sham-infected mice or ill day I post infection did nOl 
produce significant amounts of cytokine5 when restimulated with Anisakis or anti·CD3 
(Fig. 2 .4.4). By week I post infection. sp lenocytes werc producing c>10kincs. with 
wildtype mice producing predominant ly Th2 cytokines and the knockouts showing mixed 
Thlrrh2 type responses. Similar responses occulTed at week 2 post infection. although 
lFN--y production had decreased. At week 4 post infection restimulation of peritoneal 
lavage cells with AnlsoH, extract led to production of 1\..-4, IL-S and IL-13 in wildtype 
mice (Fig. 2.4.5). In I\,,-4 -/- mice, production of 1\..- 13 was significantly lower and there 
was a trend towards lower 11 ... -5 levels . Cells from IL-4Ra -f- mice produced only low 
levels of cytokllIes. 
2AA C O'" cells p Ia), " pr imary ro le in peri loneallL-I a nd fl .. ·1 3 production 
CD4· cells werc removed from peri toneal lavage cells using magnetic beads in order to 
inve:;tigate the role of CD4' cells in cytokine production in the. peritoneal cavity. Efficacy 
of CD'; ' cell depletion was confirmed by FACS analysis (data not shown). Undeple\ed 
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Figure 2 .. U . Oiffercnlial ~ell counu of pcrilonc>ll lav:age cell~ following AIIUllicu 
inreclion. l' cri\oncal cells from individual wildlYpc. l L-~ -1-. lL· !) -f- and 1I.-4Rll -1-
miee (n ~ 4) were fixed onto slides by cytospin. and difTcremiaJ coums were performed. 
Dam prcsemed as mean +1- SE1I.l Statistical significance was assessed versus sham-
infcc\('d mice. ' . P<O.05: " . P<O.Ol: •••• P<O.OOI. N ~ not detcdcd. 
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Figurr 2..1.3 . AnisuA-js i nrf~ li{}n ruultrd in II trend '"wards iuncbed lltriphcnl 
blood f(isinophHs. In thr« stpatal.: experiments (a-c) p¢ripht'OII blood eosinophi l' ..... ere 
diluted in Discombc's fluid and counted following inf~lion with 2 Anisoki.r 1arv~e (n • 
4-5). Data p~scnled as Iman +1. SEM. Statistical sigmficance was assesstd against 
sh:un-infected mice. '01'<0.05; '·,1'<0.01. 
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Figur~ 2AA. I'~rit o n~al b'·age nil f,1okine produftion aflfr inf«tion. Pooled 
peritoneal lavage cells (n g 4) were: restimulated ""Ih anli-CDJ nr Anistlkis e:<lnlCt.. ood 
cytokine5 in the supernate ..... ere measured b,· ELISA. 
" 
Anisaki.,,·stimulaled peritoneallavaoe ceUs 
It", ..j 11..-5 11.,13 lFN-r 
_ Wikl1ypc CJIL-4·/· DIL-4Ra ./. 
Figure 2.4.5. C rlQkine production br pt'ritoneal « lis lit .. « k -l pOSI infcf lion. Pooled 
peritonl'aJ lavage cells (n ~ 4-5) isol3led at wc-ck 4 post infec: lion with 2 Allisakis lar ... ae 
wen: n:~!hnuh1ted with 100000g!ml of A"i.mkis extract Re$ldl5 are n:pres<::ntJIi\" of two 
cxpcnmcrl13. OatD pn:seJUt-d as mean +/. SEM. Statistical significance was assessed 
between w ildtype and Imockoll! strains. N, not dCII.'Ctablc; " P<O.05; ... P<O.O I 
!l 
restinllllated with anti-COJ d~OrtSlratfd higher production of ItA. IL- IJ and 11.-10 
than sham-infected mice (Fig_ 2.4.6). In OOfltMlSt. CD4' cell &pleted p<:ril~al lavage 
cells had 3brogated production of theSt cylokines. A decrel\5le in IL-n produced by 
.. ",sakis-stimulated peritoneal 13vagc cells ... ns also observed folloWIng CD·f cell 
depletion. This indic31es lh3t Th2 cells p~1Il in lhc peritoneal cavity following A niMlkl$ 
infection are primarily responsible for production of llA and IL- Il. liowc\'cr. CD·f cell 
depletion did not abrogate It-IO production in Anl£Okir-stimulated JlC'rito~al lavage 
cell$. IGIO may therefore be partially produced by non-CD4' cells in response to 
AnisaJds. Funhennore. CD·f cell depIction abrog:lled IFN·" production in peritonenl 
kwage cells from sham-mfeeted. but not Anisakis-infected mice. It is likely that other 
mlilir:ll:ing immune een, in Ani$l1k/S-lIlfccted mice are respoMible for the rem.:uninll IFN-
'f prodUCIIOn. In addluon. C~' cell dePletion abrogated u.-S production after anl;'CO) 
Slimulation in sham-infected mice, ~ut did not abrogate Anisllkls·induced IL·j 
prodUCtion. indiC3t;nl!, that An/flIkis n:tr.lCt may directly stimulate non-CD4 cells to 
produce IL·S. 
2.4.5 SplcRoC)'te f) tokine prod uet ion in A .. 15tJkL. i nr~ cl ion 
Splcnocytcs from wildt)'pe, IL-4 -1-, 11..-13 -, . and IL-4Ra. ./- rnlce were restimulaled 
whh anti-CD) ~t various time· points post infection and c)'tokinc resronses were 
eVJluated up till two weeks. Significant differences in p:lIlcms of cytokine production 
were observed among strain<; (Fig. 2.4.7-2.4.12). 10 wildt)'pe mice, rroduction of IL-4. 
1L-9 and It·IO rC3ched:l peak bctwecoOlle day and two week! post infcction (Fig. 2 4.7 
Wld 2.4 8). This WIIS followed by a drop in production by week 2. Following tills, ItA 
and 1J..-9 production regan to rise !lg3in, pcrhaps as a result of I'Clease of proteins from 
killed larvae. Wid was significantly iocl'Cl5ed "lien evaluated lit ... eek" (Fig. 2.4.9 Wld 
2 4.11). [n COOlr.lSt. IL-IO producllon Rmained :It basc:hne lnels. This could indicate 
thut IL-IO production is Slimulated b) h"e larvae but 001 by the release of protelllS by 
dead 13rvae. II,-!J and 1l ... S production btgan to IIlCrtllSe after wed, I ~d 2 n:~Ii'·cI)·. 
perhaps lIS II conseqocncc of the earlier pe3k in IL-4 production. and were Significantly 
higher "hen measured luter at week" (rig. 2.4 7 • 2.4.9 and 2.4.1 1). IFN-y produc1ion 
was reduced up to two wecks post inf~'(tion bUI by "eek 4 had returned to normal • 
.. 
pcrh.lp5 With ~Iution o f Ihe infection. AI week 4. wildtypc mice showed a cylOkine 
profile Illal .... 115 significantly skewed tOWlIrdS a Th2 response (Fig . 2 .4.9). 
Sham·lnfaCled. antl-C03 Sham..mfecteil, Aruakis extract 
I .~ 
fl.-l II.-S tl.-IO II.- U IFN"I' 
Anr3akrs infected, ilDtl-C03 
11.-1 II~S 11.-11 tl.-Il II .... ., 
_ Tow oeD! dcpbcd 
Figure 204.6. C IU' (til lI rp luion rtduC'H ()lOkinr prllllu( lion from pc'rilllnra l 
lange t't'1t~ . Peritoneal 1:I\':lgc ceUs taken al week 4 post infection (n • 4, pooled) were 
dc:pleled ofC04' cells using magemic beads lind n:stimulate<! with anti·CD) or AniJaki$ 
cxtmct in par1IlIel with untreated cdls (lOwl peritoncalla\'age ce lls). C)1okine produc::tion 
.... as measured by ELISA Data presented as mean +f· SEM. 
" 
Like splellOi;ytes from ..... ildtype mice, IL-I 3 -1- spleooc)'t.:s sho ..... ed increases in IL-4 and 
11.-9 production betwttn day I and week 2_ and thae was lin increase in IL- IO 
prod\ll:tion pt week I compared to day I and ..... eek 2 (Fig. 2.4.7). In addition. IFN-r 
production by splenocytcs dropped following infection (Fig. 24 .8). However. IL-5 
production showed ~ gradu:!1 decrease following infection. 
In contrast, splenocyte' from IL--I .,. mice did not show illCrt'ascd production of an)' of 
the Thl cytokines. apart from 1\ small and c:.rly increase in 11. ·9 (d:ly I). IFN-y 
production wa~ decreased after Infection. as ""liS IL·I (l production. A sinlliar paltcm of 
cytokine production was found in 11.·-IRa·' · mice. wilh a small initial peak in production 
of IL-9. unchanged 11.-5. and decreased 1t.-13 and IFN·y. An initial decrease in IL-IO 
production was followed by a slighl bul signi ficant nse in rroduction at week 2. [n 
addit ion. IL·4 [evels steadily increased after infection. Whcn responses were evmualed al 
week 4. c)'tokine production had relurned to normal in both knockout strainS, apart from 
sllght[y raised [1.·9 and ~Jightly decreased IL· 13 produc tion In IL-4 -I. and IL-4Ra-l· 
mice. re!ipCCllvdy (Fig. 2.4 II) and 2.412). 
2.-1.6 An tibod)' re$pon~~ in a [lrimMry A" isakis infeclion 
lsotypt !ipCCific responses wen IIIveSIl&ateJ in wlldtypc. [L·-I -,- and [L·4Ra .,. mlcc 
(Fig. 24.13) Wildtypc BALBlc mlcc produced predominantly type 2 anllbodies In 
response to Atlisakis larvae. with spedfic IgGI and tOta] and spe<:ific rgE. Anisakis-
specific IgM levels started to nse ~ithin 1 ""fCk. peaking III"(H.md wttk. 2 and then 
d~lining sli&Jltly unlll week. 5, "hen :mother rise was apparent . The second pt:lL toutd 
have becn a response to p,OIein! released from killed IIm'ae. IgO [ production 
commenud aroond sometime between week I and 2 and contmucd to rise . As with IgM. 
there was a sudden increase in IgOI !llres at "eek S. reflecllng a po$5ible response 10 
proteins rt:[eased from destroyed Anisakis larvae. IgG 1 titn's n'nJaIrll'J at fftltly eonstant 
levels unlil re,infection. LC\'els or Ig02a. IgOlb and IgO) wert cxtremely low. however 
there were small pew al week 3 and 5. [n contrast. IL-4 -1- mice had f31sed levels of all 
lsotypes c.~cept 19E. Again IgM was the first iSOlYpe present, raised al week. I and 
rerr\:lining fairly COnst;'UI1 with a slight peak at week. 3, and a Sttond peak:lI week 6 
.. 
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"' igUff l .4.7. IGntliu of Thl erlokint p roduction from reslim ulaled splcnoeylts. 
Spkooc) tcs from sham-infccted (represented on axis m day O)(n ~ 4) and Anisahr-
in fected mice (n - 4) at l. 7 and 14 days post infection wert isolated and rtstimulmed 
wnh MII·CD). Cytokillt: produelion was measured by ELISA. Dam pl"l:senloo as mean 
+1_ SFM Sllllislical signi fi canc .. \'el"llus slwn-infe<:\o!d mice is shown . •. P<0.05; •• 
1><0.01. •• 0 . P<O.OO I 
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Fi!;urt 2 .... 8. Ki ncl ;Cll or IFN..,. Mnd 11.,. 10 produ~tio n fron. r tslimu lattllsplenocyt6. 
Splenocyte5 rrom mam-infetted (~presented on uis 111 day O)(n - 4) nnd Ani,oki,-
Infected mict (n 4) at 1,7 and 14 days post infettion Wtl'e i,013ted and l'eslimuloled 
"'lth anti·Cm. Cytokine production was measum:! by ELISA_ Slmti!;licol slgnifit:lUlCe 









Figu re 2.4.'1. CyEllkine prluJu~liun in wildtypc mice at I ... ·tk -'. Splcoocytes from 
mdividual mice infl"<:te<i with Anisabs or sham-infected (:Ontrols (n .. 5) WCn:" isohuoo as 
\Il"<:k 4 lind restimuilited with anti·CD3 or ConA. Cytokine production was measurrd by 
ELISA . There was !lot enough 5upernatllJ1l to lest for H.-9 in oonA n:"stimu!ased cells. 
Data prcSl'J1(ed os mean +1- SEhl. Statistical significance Icr5US sh.lm-infecu:d mice is 
shown.' .1'<0.05; " . P<O.OI: ••• • 1'<0.001 . 
• 
_ Wik!lypt C3 IL·4-/. OIL-4Ru. -I-
FiKure 2.4.10. C)'lukine produclinn b)' wildl}'j!e, I.L-4 -/- aDd IL--'Ra. _/_ mice: a t 
" «10. -' p OSI InfKlino. Isol:ued splcflO(:ytcs were n:"Slimulalcd with anti-CD) and 
C)toldnc productioo was measured by ELISA. Dala pl'C"Sented as mean +1_ SEM. 
StatistICal s.ignlficanee w-as assessed between wildlypc and knockout mice. · , 1'<0.05; " . 
1'<0.01; "' , 1'<0.001 
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Figure 2A.I I. T h2 cylokinc5, but nOI [f'N-1 or [L-IO, ~r(' incrcwst'd ~I week" in 
wildtYPf mice. Pooled spl¢nocyles (n ~ 4) or individual splcnocytcs (week 4. n ~ S) 
were rcslimulalCd with anti·CO) , Cytokine proouclion ",-as measured by ELISA. Daw 
presefllcd as mean +1. SEM. Statistical significance on comparison with sh~m -i nfcclcd 
mice (day 0) is shown. " P<O.OS; " . P<Q,OI: ••• . P<O.OO I. 
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Figun' 2 .... 12. Kinetic§ or l,},tokinc production in 11.-4 -/- lind Il --Iltn - /- micro 
Splcnocylcs were pooled (0 m 4) and restimulated with anti·CD3. Data prcscfi!t'(\ as mean 
+/- SEM. Statistical significance on comparison with sham-infected mice (day 0) is 
show1l. · , P<O.05; '., P<O. OI ; •• ' , P<O. OOI. 
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Figurr 2A.lJ. Anlibudy produflion a rk r Allisukis infetlioD. Antibody levels were 
measured in the serum ofwildtypc. lL-4 _1- and lL-4Ra -1- mice post infection (n· 4). 
Results DTe representative of 2-3 experiments. Data presented i1S mean +1- SD. 
" 
uvels of all I gO isolypes began 10 rise III about wc~k 2 post inr~'Ction.IL-4Ro. -/- mie!: 
prodoced even higher levels of all the IgO isolypes measured. commencing at about week 
2. Ig02a and Ig02b levels remamed fai rly constant frcm abcut week 3 on ..... ards ...... hil!: 
IgO I and Ig03 levels reached a SCl:cnd peak: at ,-veek 6. IgM in Ihis sira in peaked at about 
week 2 POSt infection and then began to slcwly decl ine. Total lind specific IgE were not 
detectable in this Strain. 
lL-!3 -/- mice were nOi always available and a lcng-Ierm study of antibody isctypes was 
therefore not performed in thi s stram. Hcwever. at week 5. IL-13 -f- mice sho .... 'Cd an 
intermediate profile ccmpared In cther mains. IgO I was high. as in wild type and lL-4Ro. 
.,. mice. whi le Ig02a and Ig02b were Icwer than in IL-4 -t- and !lARa ·f- mice but 
hIgher than in wild lype mice. Total IgE WlIS present but at largely reduced levels 
compared Ie wild-type mice. 
2.4.7 A IIlibody n:~ponses a rler ff ·infeclion wilh A nisukil' la rva, 
Mice .... 'Cre rc-infcctcd wilh IWO live Ani.fa~is larvae III week 8. After re-infcctien, 
..... ildtype mice sho ..... ed an extremely sirong memo!), response in terms of anlibody 
production (Fig. 2.4.1 4). with a sleep increase in IgOI that ..... as un paralleled by any 
increase in an IgO isctype in IL-4 -t- or IL-4Ro. -f- mice (fig. 2.4.15). IgO I levels peaked 
IIpproxim:uely 2 weeks after fe-infection (week 10). This ..... as accompanied by a rise in 
totlll IgE (peaking al 3pproximmcly one week after rt-infection, i.e . week 9) and a 
gradual and Sleady increase in specific IgE (Fig. 2.4.(4). In IL-4 ·f· mice there was a 
gradual increase in all measured IgO isotypes after fe-infection (lgOI. Ig02a. IgG2b. 
Ig03)(Fig. 2.4.15). In contrast, there ..... as only a slight increase in 19OI and Ig02a a fter 
re-infection in IL-4Ro. -f- mice. TomllsE was extremely low or undetectable atlllJ time-
points measured in lL-4 -f- and IL-4Ro. -f- mice (Fig. 2.4.16). In cne experim~nt specific 
IgE ELlSAs indicated the presence of very low levels of A"i.takis·specific 19E in lL-4 -f-
mice at three weeks POSt re-infection cnly. In other experiments specific IgE lewIs were 
below the detection limit in knockout sirains, although occasionally an individulI1IL-4 -/-
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Figurt' 2..4.14. Wildl}pe mice u.hibi l Slrong IJ-«U memory r~pon~ 10 ~l I1UakU. 
Wildl)"pe mice (n - 4) were infecled with 2 Anisaki.s lanlle at week 0 and re·infeclc:d 01 
"ieek 8. Anlibod} re5ponses "'-c:re measured by ELISA. Resull5 are n:prt'$entauve of 2·3 
e>tjX'riments. Data presc:nIOO as mean +1. SD. 
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Figu re 2.4.15. II!G i501r~ producli.o n dfCr rf-inrCC fi on. Mice were infected willi 2 
Anisakis ian'u at week 0 and ~-inrectcd at "~ 8. Antibody responses .... -ert measured 
h) ELISA. Resuhs are repn-semati\c or 2·] experiments (n - 1-5). 0.113 prescmed (IS 
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Figu r ... 2.4.]6. IgE product ion afttr re-infcct ion. Mice were infected willi 2 Allisaki:r 
Inrvae at week 0 and re-infected at wcck 8. a) Antibody responses in individual (total 
IgE) or pooled (speci fic [gEl scm '''crc measured by ELISA. Results an: rcprescnlalivc of 
2-3 experiments (n = 3-5). Data presented as mean +/- SD. b) In one experiment ILA -1-
mice prodllCoo low levels of sp"cific 19B (blll nol lotal IgE}(n ~ 4). Dalll prescllled lIS 
mean +/- SEM. Statistical significance belWCeJ1 wildtypc and knockout mice is shown. " 
£><0,05: .0" [><0_001. 
2..1 .11 Anlibody responses aflH on L re-exposure lo A" isukis proleins 
Patients may re-cnCoUllter Anriokis proteins in the nesh of fish after they have had live 
inlections with Anisakis larvae_ therefore previousl)' infecled mice v,ere boosted orally 
wilh 3 small dose (SOOf1g) of Anisakis eXlract and subsequent :1fltibody responses were 
examined. Inlerestingly. lhe mOSt notice3blc change in :1fllibody levels was a strong 
increase in 19A in 1L-4Ro. -1- mice (Fig. 2.4.17). This did nOI occur when mice we~ re-
infC(:ted with live larvae (Fig_ 2"; .18). There was also a slightlrend towards decreased 
IgG2b and IgG3 in IL-4RIl -J- mice. Wildtype mice did not show the same dram-ltic 
increase in IgGI levels :IS they did after intraperi toneal Ie-infection with li\'e larv~e . 
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..... Wikltype -o-IL-4 -f- -0- iL-4Ra -1-
Figure lA.17. A ll isakil'_~ p«ific IgA ri~e~ ~Ignificant ly in IL-4RIl -f- mice after an 
oral hoosl wilh Allisakis extract. Mice (n - 4-5) were infected with 2 Anirokis larvae al 
wcek O. and boosted orall)' wilh SOOfig of Ani.<akis eXlract al week 8. Antibody responses 
were measured by ELISA. Results arc representative of 2 exprnments. Data presented as 
mean +f- SO. Statistical signifteance hetwt'en "~el: 0 and Olher timcpoints is shown .• , 















Figure 2.-1 .18. Comparison be tween AII;slIk,s-s llcd fic antihody responses lifter re-
in r":l;o n with IIYe lan'ae and ord . hoost with Ani~llkis eXln et. Results are 
represcotaliv.: of2 experiments (0 - 3-5), D~18 presented a~ mean +/- SE:>'1. 
.. 
2.4.9 A lIergi( rUNion, d li t 10 ing(5 lion of A nisakil' proteinJ 
It is contrQversial whether live Anisakis is needed in order to produce allergic reaction.<:, 
or .... 'hether ingestion of proteins alone can cause reactions (AudicaM 2002). To 
in\"estigme whether Anisakis proteins (an cause allergic reactions, wildtype mice .... 'erc 
infected .... ith Auisakis larvae (wk 0), re·in fected to boost responses (wk 8), and then 
orally ohallenged with 5mg Qf Allisakis extnlct (wk I 1)(Fig.2.4. l9). Sham-infe( ted mice 
challenged with Anisakis extract were used as a control for the effects of Ali/sakis extract 
administration by or~1 g~vage. 
At week II. levels o f type 2 antibodies (IgE. IgGl) were high (Fig.2.4.20a) and Th2 type 
q10kincs wc['e present (Fig. 2.4.20b). Ingestion of Allisaki.~ pruteins by previously 
sensitized mice induced mi ld allergic rea(tions within an huur. including scratching, 
irritllbility. reduced activity. di arrhoea and puffiness around eyes (Fig. 2.4.218). Levels of 
serum mouse mast cell protease (MMCP)-l, a marker of mast cell degranulation, and 
plasma histllmine. a vasoactive mediator, were increased after rc~infeetion and furt her 
boosted after oral challenge (Fig. 2.4.21b). Lung histopathological analysis showed that 
ingestion induced mucus hypersecretion by goblet cells and cellular infiltration, both 
common signs of airway hypersensit ivity (Fig.2.4.22a). Levels of MMCP-l were also 
increased in lung homogenate samples of the experimental group as compared to sh"m-
infecled controls. while EPO and eotaxin levels \\ere not increased. These results 
demonstrate that infection with Anisakis e:1II predispose to Anlsakis alkrgy. and th~t 
proteins of the dead larvae ulone IlTC sufficient to cause alJergic reactions in sensitized 
mice. 
2 . ~ .1 0 I L·~ , I L· Il and 11 ... ~Ra II re imllortanl in An/sakis- in duced hypel"Sensil ivi ly 
lnfeclion with AniSDki.~ followed by oral challenge with Anisukis extracl resulted In 
visibly reduced signs Qf allergy in IL-4 -/- mice cQmpared \0 wildlype controls (Fig. 
2.4.23a) Irritability WIIS present. but diarrhoea occurred l~ss frequently than in wildtyiX' 
mice and was less severe. Activity was nonnal. In line will! this. serum ~tMCP-l and 
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Figur~ lA. I!1. "rolm:o! (or chalkuge uptrhntnlS. Mice were infecled "llh 2 Ani.rukis 
larne III week 0 and re-mfeclcd wilh Ihe same III "'eel.: 8. Smg of An/suklS extfllCl .... 'as 
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Figurr lA.20. AOlibGd)' and c)" lokloe r~ponu~ 00 the da)' of challenge. a, Levels of 
'Yre 2 anhbodies are h'Gh as the time of challenge. b. Splenocytes from individual 
splccns (n" S) restimulated IO.lth ilIlli-CD3 tend lowards a predominant Th2 profile. Data 
pKSCntcd as mean +/- SEM. Sutistical significance between PBS- and Ani$akis 
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fi igu r~ 2.4.21. Allergic n:aCfions hi Allisakis or sham-sensi l ized mice. Mice were 
inr~'(:!cd with 2 Anisaki!i LJ (week 0). rc·infl"Clcd ("cek 8) and challenged orally with 
Smg A"isaki$ extract ("'eek II). a , Allergic reactions after oral challenge were scored. 
Opcn cirdcs represent individual mice (combined results of)-4 e.~pcrimcnls), b, MMCP· 
I (a) and hi~lamine release (_) in naive. infected and challenged mice (representative of 
2 e"perimcnlS). Dala prescllIcd as mean ~I- SEM. Statistical significan,e between nal"': 
and infected or infcctcdkhallenged mice is shown . • • P<D.05; ' • . P<O.Ol: ••• . P<O.OOl . 
'"' 
b 
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Figure 2A.n. Lu oj', pa tllolog,\' a rtu AniSill is eha IIf nge in " 'ild I) ~ mice. Mice \\eI'C 
infe<;:l~ "ilh 2 Aniwhs lao'llC Of WIn·infected I'oith PBS ~1 "lX'k O. and challenged II} 
oral gavage .. i \h Ani.wkis c"tract Sol wed. 11. a, Lungs were suuncd ",ilh PAS for mucus 
prodLIClion. Goblet cell h)perplll5ia. mucus hypcrsecretion and inflammalOI) infihnn~ is 
set'n in Aniwkis-llCnsitizcd and challenged mi~. b, MMCP- I. EPO and oolaxin levels 
"'en: measured in lung homogcnau:s from challenged mice (n .. " ). Data presenK-d u 
mean -.-/. SEM. Stu,istical si~ificance bet\",'cn PBS- and AnisukiJ'·sensi l iztd mic~ is 
sho .. n • . P<O.05. 
'" 
cell hyPerplasia and mucus secretion sometimes occurred it was both less prevalent and 
less pronounced than in wildtype mice (Fig. 2.4.24a). The pictured IL.", -I. lung shows 
the highest degree of mucus hypersecretion ever seen in this stmin. In some mice, mucus 
hypersecretion was scant)" or absent. Funhermore, while many cosinophils and 
neulJophils were seen in bronchiolar lavage fluid from wlldtype mice. the infiltrate in IL-
"' -I· mice consisted primarily of macrophages and lymphocytes (Fig.2.4.24b.c) 
In IL-4Ru .1. mice. allergic reactions were CQmpletely abolished and serum MMCp·1 
and plasma histamine levels were impaired (Fig.2.4.B). Mucus was never present in the 
lungs. which showed dear aim1'lys comparabk !O llIose found in sham·infected controls 
(Fig.2.4.24a). Only small numbers of cells were found in bron~hiolar lavage fluid (Fig. 
2.4.24b,c). These cells appeared!O be resident alveolar macrophages. 
Local antibody production was examined in lung homogenalcs. and skewing IOv .. ards 
type 1 antibodies was found in IL-4 ./- and IL-4Ru -/- mice, with reduced and impaired 
IgO 1 respectively. but increased Jg02a (Fig.2.4.25). Total IgE production was impaired 
!II the luoJ:S of both kno.kout strains. At the week of challen!!:e. systemic antibody 
production was strongly skewed tov .. ards type 2 antibodies in wildtype mice, while 
knockout strains produced high levels of Ig02a and Ig02b in addition to IgGI 
(Fig.2.4.26a). Total IgE "'as extremely low in the knockout strains, and only low levels 
of specific 19E were dr/ecred in IL-4 -1- mice (Fig.2.4.26b). 
Cytokine production by splenocytcs restimul~led with ami-CD3 was exwnined at week 
11 (Fi-ll.2.4.26c). Sp[enocytes from wildtype mice showed a stronger skewing lov.1'lrds 
Thl cytokinc production than either knockout. ItA Ilr1d lL-!3 were produced by IL-4Ru 
-/- mice. though thts strain would not be expected tn r~pond to these cytokines. 
Splenocytes from IL-4 -/- mice produced decreased lImounts of IL-13. lL-5 production 
was similar in all strains. while there was a trend towards dc~reased IL-9 Ilr1d increased 
IFN-y prodllction in the knockout strains 
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_ Wildtype [;ii;I [1.-4 -/- D IL-4Ra -/-
Figure 2A.23. Allergic react ions were rctiuct'u in 11..-4 -/- 9ud I L-.ma -,- mice. Mice 
wcre infected with 2 Anisakis lan'at (week 0). re-infected wilh the same (wet'k 8) and 
challenged oraUy wilh Anisakis extract (week II). Y, Allergic reactions wcre 9con:d ($te 
Mcthods~ Open circles represent mdhidual mIce (pooled from J experiments. n · 4-S ). 
Data presented as mean +t. SEM. b, Plasma hislllJ11ine was reduced in lL-4 -1- and lL· 
4Rn-' · mice. c. Serum MMCP~l kl'els were reduced m IL-4 ./. and IL-4Ra -1- mice. 
Dal3 presented as mean -f/_ SEM. Statistical Jignificance between wildtype Dnd knockout 
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Figur~ 2.4.24. Lunf.: Ilalho lugy is rcdu~cd and abroga ted in I L-4-1- lIntl I L-4 I~I1 _I_ 
mice res~c l i\'C lr. Mice were inf"cted with 2 Anisakili larvae at we.>k 0, re·infectcd at 
"l-ek 8 arId challenged orally ... illt 5mg Animili, extract. a, Lungs VIer .. stained willt 
PAS for mucus. h, Bronchiolar lavage cells (200x). c, Bronchiolar lavage cells 
(lOOOx). 
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Figun' 2."'.25. Trp~ 2 antibodies were reduced in lung hOlllogenlilu or IL- -I and IL· 
-IRa knockouts. Lungs were homogenized in PBS and antibodies were measured by 
ELISA. Data prcS~l11ed as mean +1- SEM. Statistical significance between wildtypc and 
hllockout mice is shown .•. P<O.05. 
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a Anisakis-specific IgG 1 Anisakis-specifk: IgG2a Anisakis-specific IgG2b , , , 
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b TotallgE Anisakis-specifk: IgE , ' 
C Splenocyte cytokine production 
figure 2.4.26. S}slemic anlibodies and cytokin ... prod uction in wildly!' ... , I L·~ ./. and 
[L· ~ I~a -1- mice al week II post infection . Serum [gO Ca) IUld IgE (n) IUllibodics were 
me(lSuted by ELISA (n = 4-5). c) Cytokinc production by spleoocytes (n = 4·5) 
restimulated with anti-CD} \.\'35 measured by ELISA. Data pr\!Semcd as mcWl +/- SEM. 
Statistical significance between wildlypc and knockout mice is sho\\TI. N. not delectable; 
' ,1'<0.05: " , 1'<0.01; ••• • P<O,OOI. 
'" 
2,"' ,11 0l"1li1 sensiliJ::u ion \\ ieh A nisuku n !ntt 
Weekly doses of Img An/s(Jicls exeruc! or PBS were administered 10 wildlyJX' BALBlc 
mice by oral glI,,-age for 5 weeks. On the 6" week mice were challenged oraUy I'i tll Smg 
An/juku extract 01' intravenously with 7SO)lg of Anisolcis extmcl. NeltMf oral nor 
mtra"enoll'i challenged mice appeared to have allergic reaction,. 
By the lime of challenge (week 6), serum I(\'els of Ani.$akis-specilic 'gGI. IgG2a. IgG2b 
and total and sp¢(ific filE were raised in Anisukls-doscd mice compared to PBS dO!ICd 
controls (Fig. 2.4.27). This is different to the isotype profile seen afler live Ani.mkis 
infection. in which Ig02a and IgG2b n:main low in I"ildtype mice (Fig. 2.4.13). 
However. in both cases [gG I is the predominant [gG iSOlype produced 
SpleOO<.:}1es from Anisolli·dosed mice restimulated with ronA or anli·CD3 did nOI show 
any significant differences in production of ILA, IL·5, It.-IO or [L-13 compan:d to PBS-
dosed controls (Fig 2.4 28). IIOI'·e'·er. [FN·y producuon WillS silpllliclintiy reduced in 
Anisokis-oosed mice, Other oral $l'nsitil.alion protocols tested (data not shown) also did 
nOI show an)' significant differences between 1hl type c)'tokirw: production of 
splcnne)1es from AniSllklS- lind I'SS-dosed mice. 111i!i is unlike the strong llI2 cytnk.irw: 
production stimulated by live Anisakis larvae. 
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Figu re 2.4.27. Anlibodie!l induced by ora l .le nsi l i~llli"n with A"isDkls t:ltroCI. Weekly 
doses of lmg of Anisalc!s e~lracl was administered to wildtype mice by oral gavage for 5 
w~...,ks. SCfUm antibodies were measured al week 6 (n .. 4) Dalo presented as mean +/-
SEM. Statistical significance between PBS· and Anisakl.!"-scilsilized mice is shown. " 
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Figure 2.4.28. IFN-y I,ruduclion b)· R~imulaled splenocyteJ wu dtcrusf11 in mict 
sensitized or~lIy with ,."i-fllA:;$ U lracl. SplellOCytes (pooled. n • 4) were plated in 
triplicate and restimulated \lo11h a.mA or anti-CD3 and supcmatant eytokincs were 
measured by ELISA Data presented as mean +1- SEM. Stllustical significance between 




In this study, a murine model was used to gain a better understanding of the underlying 
immunological mechanisms of Anisakis infection and related allergic responses. The 
results show for the fIrst time that infection with Anisakis induces strong, systemic Th2 
respo:pses which can sensitize mice to react to subsequent oral challenge with Anisakis 
proteins, and that IL-4, IL-I3 and the IL-4Ra. are critical in this process, 
Anisakis infection was performed by intraperitoneal injection, as in previous studies 88,89. 
Immune responses of wildtype BALB/c mice were compared with those of mice deficient 
in IL-4, IL-13 and the IL-4Ra. subunit, required for signaling of both IL-4 and IL-I3, in 
order to determine the importance of these cytokines in Anisakis-related disease. Anisakis 
infection was transient in all mouse strains, with the death of the larvae occurring within 
approximately 3 weeks, which corresponds to previous fIndings 88, 89. There was no 
obvious difference in the time of larval survival between mouse strains, but as only a few 
larvae could be located, no conclusions are possible concerning the role of IL-4, IL-I3 
and IL-4Ra. on larval survival. 
In all strains except IL-I3 -1- mice, peripheral eosinophilia rose after Anisakis infection 
with peaks of varying intensity around 3 to 4 weeks post infection, which is in correlation 
with the approximate time of larval death. Conversely, a previous murine model found a 
slight drop in peripheral blood eosinophils in the early stages of infection, but this study 
was performed with CBNJ mice 88, Peripheral blood eosinophilia in human anisakiasis is 
similarly variable 35, 37. InfIltration of eosinophils to the area of the larval invasion is 
thought to be more important, with eosinophil products such as eosinophilic cationic 
protein, major basic protein, nitric oxide and peroxidases thought to be primarily 
responsible for the destruction of the larvae 42, 72, 83. In all strains of mice, peritoneal 
lavages taken after infection showed increased numbers of eosinophils starting as early as 
one d~y post infection. Experiments have shown Anisakis e~tract to be chemotactic for 
eosinophils 81,82, Neutrophils were also found infiltrating the peritoneal cavity, as early as 
day 1 post infection. At a later stage, approximately 2 weeks post infection, numbers of 
III 
infiltrating macrophages and lymphocytes were raised. IL-4Ra -/- and IL-13 -/- mice 
had particularly high numbers of infiltrating cells, and displayed enlarged spleens. 
In wildtype mice, Anisakis infection induced Th2-biased immune responses with elevated 
synthesis of IgE and IgG 1, little IgG2a or IgG2b, and increased splenocyte production of 
IL-4, IL-5, IL-9 and IL-13. In contrast, IL-4 -/- and IL-4Ra -/- mice had elevated levels 
of IgG2a, IgG2b and IgG 1, barely detectable IgE levels, and reduced Th2 type cytokine 
production compared to wildtypes. Re-infection of wildtype mice with live larvae 
resulted in strong memory responses leading to vast increases in IgG 1 and IgE, and 
susceptibility to food-allergic type reactions following oral administration of Anisakis 
extract. Histological examination of lung tissue demonstrated that the airways of orally 
challenged mice were obstructed by inflammatory cells and displayed profound goblet 
cell hyperplasia and mucus. Respiratory symptoms, including mucus hypersecretion, are 
a common feature of food allergy and increase the risk of fatality, although the 
mechanism by which ingestion of allergens induces lung pathology is unknown 100.103. 
The recruitment of Th2 effector cells to the airway has been associated with eosinophilia 
and mucus hypersecretion 104. Several of the Th2 cytokines induced by Anisakis infection 
(IL-4, IL-5, IL-9, IL-13) play unportant roles in airway hyperreactivity lOS, 106. This m~y 
explain cases of asthma thought to be related to .consumption of Anisakis-contaminated 
fish 13. However, the airway pathology after oral ingestion of Anisakis proteins in this 
model is stronger than might be expected, raising the possibility that minute amounts of 
Anisakis antigen may have directly reached the airways by aspiration. If the pathology is 
due to inhalation, rather than ingestion of allergens, this would indicate that Anisakis 
proteins additionally have the ability to cause asthma if inhaled by pre-sensitized mice. 
Recent studies performed in our laboratory confirm this ability (Kirsten et ai., 
unpublished observations). Furthermore, in certain protocols, mice infected with Anisakis 
exhibit some mucus hypersecretion in the lungs even prior to challenge with Anisakis 
extract (Kirsten et al., unpublished observations). This may be due to high levels ofTh2 
cytokine production. 
112 
Sensitization by oral administration of Anisakis extract alone induced Anisakis-specific 
antibody production but did not lead to the striking increase in 1b2 cytokine production 
elicited by live infection. Furthermore, orally sensitized mice did not react to an oral 
challenge despite the presence of 19B antibodies, suggesting tolerance. This may indicate 
that live infection with Anisakis pegreffii bypasses oral tolerance, inducing strong 
systepric Type 2ffh2-like responses that predispose mice to develop allergic reactions 
upon subsequent ingestion of Anisakis proteins. Taking into consideration that the 
sensitization was performed in the absence of an adjuvant (to better reflect a typical 
human situation), the observed allergic reactions in mice after sensitization with live 
larvae were strong for a food-borne allergen. Most animal models for food allergies 
require adjuvants such as cholera toxin or alum in order to trigger allergic reactions 99, 107. 
A recent study sensitized mice intraperitonea1ly with a combination of Anisakis simplex 
extract, pertussis toxin and alum 108. These mice reacted to an intravenous challenge with 
anaphylaxis, but showed no reactions after oral challenge. 
It has long been debated whether infection with live Anisakis larvae is required for 
sensitization and/or allergic reactions S, 109. This study demonstrates that whilst infection 
certaihly produces the potent 1b2/type 2 response which is'likely to be responsible for 
sensitization to anaphylaxis, exposure to Anisakis proteins alone may be enough to elicit 
allergic reactions in strongly sensitized individuals. Whether or not allergic reactions 
occur in response to Anisakis proteins probably depends upon the balance between 
exposure to live larvae and larval proteins alone, as well as on the genetic disposition of 
each individual. Frequent ingestion of Anisakis-contaminated fish may boost antibody 
and cytokine responses, contributing to chronic urticaria. 
In contrast to wildtype mice, IL-4 -1- and IL-4Ra -1- mice did not demonstrate strong 
increases in antibody production after re-infection. Furthermore, allergic reactions were 
reduced and absent in IL-4 and IL-4Ra -1- mice respectively. In IL-4 -1- mice, lung 
mucus hypersecretion was decreased, and inflammatory infiltrate into the lungs was . . 
composed primarily of lymphocytes and macrophages. This probably reflects the 
importance of IL-4 in the development of 1b2 oells producing 1b2 effector cytokines 
113 
such as IL-5, IL-9 and IL-13. Production of these cytokines was diminished in this strain. 
Some allergic reactions such as diarrhoea did occur (at a reduced prevalence) in IL-4 -/-
mice, probably due to IL-13 mediated responses, since IL-4Ra -/- mice, which lack both 
IL-4 and IL-13 signaling, did not show reactions. Furthermore, in IL-4Ra-/- mice lung 
pathology was entirely abrogated. This supports recent findings that IL-13 plays a key 
role in mucus hypersecretion in mice 110-112. In humans, the role of IL-13 may be even 
more significant because unlike mouse B cells, human B cells possess a functional IL-13 
receptor 113. These data indicate that the IL-4Ra may playas crucial a role in food allergy 
as it does in allergic asthma, with important therapeutic implications. 
The results of this study show that wildtype and IL-4Ra -/- mice have polar immune 
responses to Anisalds. Wildtype mice show the least inflammation as a result of Anisalds 
infection but exhibit the strongest memory responses after re-infection and demonstrate 
allergic reactions following oral challenge with Anisalds extract. In contrast, IL-4Ra -/-
mice show the strongest inflammatory response to Anisalds infection, but little memory 
response upon re-infection, and do not react after oral challenge. Extrapolating these 
results to humans may suggest that prior infections are more likely to be asymptomatic in 
individuals experiencing allergic reactions to Anisalds. This is in line with the fact that 
individuals experiencing allergic reactions to Anisalds for the first time typically do not 
recall prior episodes of gastric or intestinal anisakiasis, despite the fact that they already 
have Anisalds-specific IgE, and so must have had previous exposures 43, S3. Furthennore, 
gastrointestinal pain is normally far less severe in these patients than it is in patients 
without allergic reactions, and may even be absent. Interestingly, gastroallergic 
anisakiasis patients often have no prior history of allergy 114, but Anisalds is unusual in 
that it is both an etiological agent of allergies and a parasitic helminth. 
The excretory-secretory products of helminths such as Anisalds spp. are particularly good 
at eliciting Th2 responses liS, Parasitic helminths release large amounts of proteases 
which facilitate the penetration (lfhost tissues and the digestion of tissues for nutrients 1!6. 
117, Proteases are therefore amongst the first parasitic antigens to which the host is 
exposed, and a growing body of data on allergens indicates that proteolytic activity may 
114 
be a key biochemical property in conferring upon a protein the ability to elicit IgE and 
Th2 cytokine responses. Important allergens which are proteases include Der pI, Fel d 1 
and Bla g 2, the major allergens of house dust mite, cat and cockroach respectively, as 
well as major allergens of moulds and fruits, and the strongly allergenic bacterial 
enzymes found in detergents (reviewed by Donnelly et al.)1l6, Protease allergens such as 
Der p J have the ability to cleave proteins that make up .the tight junctions between 
epithelial cells lining the lungs, nasal passages and gut. In this way they bypass the 
physical barriers of the body and gain abnormal access to subepithelial immune cells, 
Access to subepithelial immune tissue rich in antigen-presenting cells is considered a 
primary risk factor for the development of allergic sensitization, The secretion of 
proteolytic enzymes may therefore explain how Anisakis larvae and proteins bypass the 
tolerance mechanisms associated with responses to most ingested substances. Proteolytic 
activity by allergens can also directly influence immune responses by cleaving various 
receptors and costimulatory molecules on dendritic cells, T cells and mast cells (reviewed 
by Donnelly 2006)116, Experimental data demonstrates that concomitant administration of 
Der p I or mould proteases with normally tolerogenic antigen renders it allergenic. 
Therefore the allergenicity of Anisakis extract may be due to its protease content. Other 
parasites such as Nippostrongylus brasiliensis, Ascaris lumbricoides and Toxocara canis 
also exhibit allergenicity 118-120, 
Despite the fact that parasites are particularly good at eliciting Th2 responsesl21, many 
studies have paradoxically indicated that parasite infection may protect against allergic 
disease 122-124, Experimental mouse models indicate that this protection is mediated by 
IL-IO and/or regulatory T cells 125. 126, However, in some studies helminth infection 
shows no correlation with reduced atopy, and may even demonstrate a positive 
correlation 127, 128. A recent review of helminth-allergy studies performed between 1962 
and 2006 (comprising 25,753 individuals) indicates that while hookworm appears to 
reduce asthma or wheeze, Ascaris lumbricoides may exacerbate it 129. Furthermore, 
several helminths actually induce allergic reactions themselves, including Anisakis, 
Echin~coccus 130 and Ancylostoma caninum (dog hookwo~) 131, It has been suggested 
that a prolonged, heavy infection eventually induces T -regulatory cells and IL-lO, 
115 
providing protection against allergies, whereas a light, transient infection stimulates Th2 
responses, exacerbating allergy 132. This hypothesis may explain why Anisakis causes 
allergies, as this parasite is not adapted to living in hwnans, and infection is usually 
transient and involves one to several larvae but no adult wonns. In our animal model, 
Anisakis infection was similarly transient and consisted of only two larvae; this protocol 
resulted in potent Th2 responses and type 2 antibody production. While IL-IO was 
produced in the early stages of infection, it then subsided and did not show a secondary 
late increase in response to the release of dead larval proteins like IL-4, IL-5, IL-9 and 
IL-13. The differential response to live larva and protein products suggest the route of 
exposure to Anisakis allergens may playa role in the different immunological responses 
elicited. Future studies will aim to isolate Anisakis pegreffii allergens, and to detennine 
whether different routes of exposure result in different profiles of allergen recognition, 
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3.1. SUMMARY 
Background: The fish parasite Anisakis is an important cause of anaphylaxis in 
populations in which large quantities of fish are consumed. Reactions to Anisakis are 
thought' to caused only by live larvae. Therefore, a model . was set up to compare 
Anisakis- and ovalbumin (OV A)-induced anaphylaxis in mice. IL-4 and IL-13, which 
both signal via the IL-4Ra., have been shown to exacerbate anaphylaxis, but the cell-
specific requirements for IL-4Ra. expression are not known. This study investigates the 
relative importance of IL-4Ra. expression on macrophages and T-cells in systemic 
anaphylaxis. 
Methods: Wildtype mice or those possessing a null mutation (IL-4Ra. -/-), T cell specifIC 
(LckCfCIL_4Ra...JIOX), or macrophage specific (LysMCfCIL_4Ra.°/loX) deletion in IL-4Ra. were 
sensitized by intraperitoneal injection at days 0 and 14 with Anisakis extract or OVA 
adsorbed to alum, and challenged intravenously at day 21 with Ansiakis extract or OVA. 
Anaphylactic scores, rectal temperatures, gut pathology, mast cell proteases, antibod£s 
and cytokine production were evaluated. 
Results: Anisakis proteins were able to cause anaphylaxis in mice, comparable to bat 
caused by OVA. OVA-induced anaphylaxis was found to be dependent upon the 
FcyRIVIII and associated with mast cell degranulation. Expression of the IL-4Ra. OIl T-
cells, but not macrophages or neutrophils, was required for systemic reactions. T-:ell 
specific IL-4Ra. knockout mice demonstrated both Thl type and Th2 type responses, but 
were protected against anaphylaxis. IFN-y was found to be crucial for this protection, as 
its depletion led to high rates of mortality and exacerbated intestinal pathology. 
Conclusions: Anisakis proteins may cause anaphylactic reactions in sensi:ized 
individuals. IFN-y serves an important protective role during the effector pha...coe of 
systemic anaphylaxis, possibly by direct inhibition of mast cell degranulation. 
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3.2 INTRODUCTION 
Anaphylaxis is a severe, systemic immediate hypersensitivity reaction affecting multiple 
organ systems, and is potentially fatal. Severe anaphylaxis affects 1-3 in 10 000 people: 
and the risk of death from anaphylaxis is approximately 1 % 1.2, The recent rise in the 
prevalence of allergy has been accompanied by an increaSe in the incidence of 
anaphylaxis 3, An Australian study found that 1 in 170 schoolchildren had experienced 
anaphylaxis 4, Common causes of anaphylaxis include insect stings, food and drugs I, S, 
Peanuts and tree nuts cause the majority of fatalities due to food-induced anaphylaxis 6-8, 
Other foods often implicated in causing anaphylactic reactions include fish, seafood, egg 
and fruits 7, However, in certain regions the parasitic nematode Anisalds is also an 
important cause of anaphylaxis 9, 10, In an epidemiological study conducted in Spain, 
Anisakis was found to be the third most common cause of anaphylactic reactions, 
following drugs and Hymenoptera stings and preceding food II, 
3.2.1 Symptoms of anaphylaxis 
A wide ,range of anaphylactic reactions are possible, dependi~g to some extent on the 
route of allergen exposure. Symptoms of anaphylaxis can involve the skin and 
cardiovascular, respiratory and gastrointestinal systems. They often begin with a metallic 
taste in the mouth, tingling and wannth, and can proceed to angioedema, urticaria, 
bronchospasm, diarrhoea, hypotension, shock and/or circulatory failure and cardiac arrest 
12. Death may result without rapid injection of epinephrine, and replacement of blood 
volume with a drip is often required due to the severe extent of vascular leakage, Keeping 
an anaphylactic patient in the supine position (or left lateral position if vomiting is a 
symptom) is critical to retain blood flow to the brain, and can prevent death 13. 
Corticosteroids and anti-histamines are often co-administered with epinephrine in order 
to suppress ongoing immune reactions, but there is limited evidence that this is effective. 
Anaphylaxis accompanied by bronchoconstriction may requue inhaled bronchodilators -
this is more common in food-induced anaphylaxis. Asthma is associated with an 
increased risk of death due to anaphylaxis 7. 
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3.2.2 Pathology of anaphylaxis 
It is accepted that symptoms of anaphylaxis are a result of the release of vasoactive and 
inflammatory mediators from mast cells and basophils, including histamine, platelet 
activating factor (PAP), serotonin, leukotrienes and prostaglandins I, s. Originally only 
IgE-mediated reactions were termed "anaphylaxis", while non-IgE mediated reactions 
were called "anaphylactoid". Ho~ever, as the two forms of the disease are clinically th~ 
same, the term anaphylaxis is now used to describe both 14. In IgE-mediated anaphylaxis, 
inflammatory and vasoactive mediators are rapidly released when IgE binds to the FceR! 
receptor on the surface of mast cells or basophils, triggering degranulation (FigJ.2.1). 
Non-IgE mediated mechanisms of mediator release can involve IgO or complement or 
even direct stimulation of mast cells or basophils. Sometimes the cause is unknown, in 
which case it is known as idiopathic anaphylaxis. 
The release of anaphylactic mediators causes vasodilation, increased vascular 
permeability, increased mucosal secretions and smooth muscle contraction. 13. Dilatation 
of arteries and arterioles causes increased blood flow to the organs, resulting in 
reddening. Fluid leaves permeal,>le vessels through openings in intracellular junctio~ 
caused by vasoactive mediators and enters surrounding tissue. This vascular leakage 
causes local oedema, which is especially dangerous when it affects the larynx and lungs 
as it may cause asphyxiation, as can bronchospasm and mucus plugging of the airways 8, 
13. Due to fluid extravasion, blood flow through the organs is slowed and congestion and 
pooling of blood occurs, leading to a build-up of deoxygenated blood and a blueish tinge, 
known as cyanosis. Venous congestion can enhance the escape of fluid or even red cells 
to the surrounding tissue due to increased pressure on the vessel walls. In addition, the 
anoxia resulting from slowed circulation increases vascular permeability. Anaphylaxis is 
therefore a self-perpetuating and progressive condition. Blood pressure and temperature 
drop, and ultimately circulatory failure can occur. 
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3.2.3 Anisakis-induced anaphylaxis 
Anaphylaxis due to Anisakis is currently considered to be primarily caused by an acute 
infection, with removal of the worm (if visible) forming part of the treatment. The disease 
is therefore termed "gastroallergic anisakiasis". Symptoms such as urticaria, angioedema, 
bronchospasm and/or anaphylactic shock predominate, with or without gastro-intestinal 
discomfort 9, 15, 16. The disease is rarely fatal, but can be severe and extended 
hospitalisation may be required 15. In oral challenge studies, ingestion of lyophilized 
larvae or larval antigens did not cause reactions in Anisakis-allergic individuals, and 
many patients who have experienced gastroallergic anisakiasis can continue to eat deep-
frozen or well-cooked fish without reactions 17-19. Therefore many physicians consider a 
live infection necessary to elicit allergic reactions. The allergic symptoms are proposed to 
be a combination of a memory response to a prior infection (as Anisakis-specific IgE is 
typically present) and an acute inflammatory response to a current infection IS. However, 
as live larvae are not always detected, it cannot be ruled out that Anisakis proteins alone 
can cause anaphylaxis in the manner of a conventional food allergen such as egg or 
peanut. The fact that anaphylaxis can occur after skin-prick tests for Anisakis illustrates 
this possibility 20, and angioedema/anaphylaxis has occurred after the ingestion of cooked . . 
fish and pizza made with canned tuna 21, 22. In the previous chapter it was shown that 
infection with live larvae strongly predisposed mice to subsequent allergic reactions upon 
ingestion of Anisakis proteins. This chapter investigates whether Anisakis proteins alone 
are able to cause anaphylaxis in a traditional murine model of anaphylaxis, using the 
model allergen chicken egg ovalbumin (OVA) as a positive control. 
3.2.4 Mouse models of anaphylaxis 
Experimental models of anaphylaxis have illustrated that two pathways of anaphylaxis 
exist in mice: one mediated by IgE and the other by IgO 23·28 (Fig. 3.2.1). IgE-dependent 
anaphylaxis is dependent on antigen-crosslinking of IgE bound to the FceRl receptor on 
mast cells, and subsequent release of mediators such as histamine, serotonin and P AF 24, 
25, 29. Systemic shock in this system is believed to be mediated predominantly by 
histamine, with PAF playing a exacerbating role 24,25, although in penicillin V induced 
anaphylaxis, PAF-inhibitor was able to completely block reactions 27, Intestinal reactions 
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and diarrhoea are histamine-independent but dependent upon serotonin and PAF released 
by mast cells 25,30,31. The release of mouse mast cell protease-I (MMCP-I) also increases 
intestinal penneability 32. 
IgO-dependent anaphylaxis can occur independently of mast cells in a mechanism 
dependent on macrophages, FerRIn and PAF 23-25. Whether IgE- or IgO-dependent 
anaphylaxis occurs appears to be detennined by the quantity of antigen-specific IgO 
present and the challenge dose used 25. The fact that human anaphylaxis is usually IgE-
dependent may therefore be due to the low concentrations of antibody and antigen that 
are usually involved. In mice, antigen-specific IgO can inhibit IgE-mediated anaphylaxis 
when both IgO and IgE are present 33. This blocking effect is only detennined by 
measuring mast cell degranulation, as physical effects are masked by the fact that IgO 
can induce anaphylaxis itself. In humans, the ratio between Ig04 and IgE is thought to 
determine whether allergic reactions occur, as these isotypes may compete for the same 
antigenic targets 34. As cross-linking of bound IgE molecules is responsible for 
degranulation of mast cells and basophils, the presence of Ig04 may cause a physical 
interference or reduce the amoun~ of free antigen. 
It is not known whether the FcyRIIIfmacrophage pathway exists in humans. In vitro, 
antigen-specific IgO is able to cause human basophil/mast degranulation and release of 
mediators 35, 36, The same mediators are released by both IgO- and IgE-mediated 
degranulation 36. Furthermore, IgO-mediated anaphylactic reactions have been reported 
in humans 37-40. Clinically, IgE-mediated and IgO-mediated reactions are virtually 
identical 14, Similarly, in mice the outcome of IgE-mediated and IgO-mediated pathways 
is much the same, with involvement of the same target organs 24. Therapies relevant to 
mice may therefore have possible application in humans. 
The Th2 cytokines IL-4 and IL-I3 play an important role in both IgE- and IgO-mediated 
anaphylaxis in a STAT6 and'IL-4Ra. dependent manner 41. These cytokines both 
influence the initial accumulation of antibody and effector cells, and enhance the 
biological effects of vasoactive mediators. Accordingly, mice deficient in the ILARa., 
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IL-4RIl expression on s~ific cell-IYpes is unknown. For this reason the presem study 
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Figure 3.2.1. Cllrrent mudrl of .naphrla~'i( path .... )·! in mice. This figure from 
Finkelman t"I aLl> out lines pathways of anaphylmds tlmt have been experimentally 
demonslrak-d in mice. In tile first pathway (Jell). alk-rgen binding cross-links IgE bound 
to th ... F,&R.l TC,cptor on mast cells, cau;;ing mast cell degranulation and tl\c: release of tlK: 
vasoactive mediators histamine and pJalekt-acti\'ating factor (rAF). Histamine is the 
central mediator o f anaphylaxis in this path ..... 'lIy. In the second pathway (right). allergen-
IgG compl~xes binding to FC)'R111 on the surface ofmacrophagcs cause the release of 
PAF. 
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3.3 METHODS 
Mice 
BALB/c wildtype mice and IL-4Ra -/- mice 47, macrophage/neutrophil specific IL-4Ra -
/- (LysMCreIL_4Ra-1l0X)42 and CD4+ T-cell specific IL-4Ra -/- (l.£kcreIL_4Ra-1l0X) mice 43 
on a BALB/c background were housed under SPF barrier conditions using individual 
ventilated cages (lVC). All experiments complied with the South African Code of 
Practice, and were approved by the University of Cape Town's Animal Ethics 
Committee. 
Anisakis extract 
Anisakis pegreffii larvae (L3) were collected from the intestines of parasitized fish 
(Thyrsites atun) with forceps, and extensively washed in 4% acetic acid and phosphate-
buffered saline (PBS) (see Appendix A). The larvae were frozen, homogenized in PBS 
and sonicated with a Microson ™ ultrasonic cell disrupter (Misonix)(Long Island, 
U.S.A.). to lyse cells. The extract was pi petted into 2m1 eppendorf tubes and centrifuged 
at 14000ipm for 20-30 minutes to remove particulate matter, then filter-sterilized through 
a 0.20J.lm filter (Sartorius, Goettingen, Germany). Protein concentration was measured by 
BCA test (pierce, Rockford, Illinois, U. S.A.) according to the manufacturer's protocol. 
Sensitization and challenge protocol 
Mice were injected intraperitoneally with 50J.lg ovalbumin grade V (Sigma, Steinheim, 
Germany) or Anisakis extract adsorbed to 0.6mglml aluminum hydroxide gel (Sigma) in 
200J.lI of PBS at day O. The same preparation was used for the boost at day 14. At day 21, 
mice were challenged intravenously with 200J.lI ovalbumin or Anisakis extract. Doses of 
500J.lg, 750J.lg or Img were initially tested before a dose of 750J.lg was settled upon for 
use in all experiments. Mice that survived challenge were anaesthetised with 200J.lI of 
ketamine' (Anaket-V; Centaur Labs, Johannesburg, South Africa)/xylazine (Rompun; 
Bayer, Isando, South Africa) anaesthetic (see Appendix A) in order to take blood and 
were killed by cervical dislocation. 
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Anaphylaxis score 
Mice were observed up till 70 minutes post challenge, and signs of anaphylaxis were 
scored using a modification of a previously described scoring system 48. 0, no symptoms; 
1, hypersensitivity to touch, irritability/aggression; 2, diarrhoea, pilar erecti, reduced 
activity and/or decreased activity'with increased respiratory rate; 3, weakness, cyanosis' 
around mouth and tail, lying flat but upright; 4, lying sideways, no. activity upon 
prodding, loss of grip, loss of consciousness, tremor or convulsions; 5, death. Mice 
experiencing convulsions invariably died soon after, and were therefore euthanased for 
humane reasons and scored as 5. 
Temperature measurement 
Rectal temperature readings were taken every 10 minutes using a mouse rectal 
thermometer (VetTech, Cheshire, U.K.) lubricated with Vaseline™ petroleum jelly 
(Unilever, La Lucia, South Africa). 
Antibody depletion 
The following rat anti-mouse antibodies were purified by affinity chromatography using 
Protein G Sepharose (Sigma, Steinheim, Germany) and used in antibody depletion 
experiments: anti-CD4 (GK1.5), anti-IL-4 (11B 11), anti-IgE (EM95.3 or the other), anti-
FcyRIIIIII (2.4G2), anti-IFN-y (ANI18KL6), anti-ckit (ACK-2 ) provided by Dr. Richard 
Grencis (University of Manchester) and control rat IgG (GLI13). For IgE, FcyRIIIIII and 
IFN-y depletion, mice were injected intraperitonea11y with Img of antibody at days 18 
and 20. For anti-IL-4 and anti-CD4 depletion mice were injected intraperitoneally with 
Img of antibody at days 0 and 14. For anti-ckit depletion mice were injected 
intraperitonea1ly with Img of antibody at day -1, day -1 and 3, or day -1,3 and 14. 
Collection of serum 
Blood samples taken before challenge were collected in serum separator tubes (BD' 
Microtainer™ SST, BD, Franklin Lakes, U.S.A.) by tail vein bleeding uneier an infra-red 
heating lamp. Alternatively, blood was taken from killed mice after cervical dislocation. 
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Blood samples were centrifuged for 15 minutes at 3000 rpm before being placed at -80°C 
for storage. 
Antigen-specific antibody ELISAs 
Nunc Maxisorp ELISA plates (Nunc, Reskilde, Denmark) were coated overnight at 4°C . 
with Anisakis extract or ovalbumin grade V (Sigma, Steinheim, Germany) at 5Jlg/ml (for 
IgGl, IgG2a, IgG2b) or Img/ml (for IgE) in PBS, then blocked in ELISA blocking buffer 
(Appendix A) for 1 hour at 37°C. Plates were washed 3x with ELISA wash buffer 
(Appendix A), and serum samples serially diluted in ELISA Dilution Buffer (Appendix 
A) were added. Plates were incubated overnight at 4°C, then washed 4x. Alkaline-
phosphatase (AP)-labelled goat-anti-mouse IgGl, IgG2a, IgG2b or IgE, 0.5Jlg/ml, 
(Southern Biotechnology, Birmingham, Alabama, U.S.A.) was added for 2 hours at 37°C. 
Plates were washed 4x and 4-nitrophenyl phosphate disodium salt hexahydrate (PNP) 
(Sigma, Steinheim, Germany) substrate was added (Appendix A). Absorbance was 
measured at 405nm with 492nm as a reference wavelength using an ELISA reader 
(VERSAmax tuneable microtitre plate reader, Molecular Devices, Sunnyvale, California, 
U.S.A.) .. 
Total IgE ELISAs 
Sandwich ELISA was performed using purified anti-IgE from clone 84.1 C as a coat 
(lJlg/ml) and AP-labelled goat anti-mouse IgE (Southern Biotechnology, Birmingham, 
Alabama, U.S.A.) as a secondary antibody, according to the protocol outlined above 
("Antigen-specific antibody ELISAs"). Purified recombinant mouse IgE (BD 
Phanningen, San Diego, U.S.A) was used as a standard, starting at a concentration of 
10Jlg/ml. 
Mouse mast cell protease (MMCP)-l ELlS As 
MMCP-l levels were measured in serum and tissue homogenates by ELISA according to 
the mamifacturer's protocol (Moredun Scientific Ltd, UK). For'serum MMCP-l, blood 
was centrifuged in separator tubes (manufacturer) for 15 minutes at 4000rpm to isolate 




PBS, then centrifuged at 12000rpm for 20 minutes to remove debris. Supernatants were 
removed for analysis and the results were adjusted for organ weight. 
Isolation of splenocytes 
Spleens were aseptically removed from mice with forceps, and splenocytes were isolated 
by pressing through a metal si~ve in 10ml Iscove's Modified Dulbecco's Medium 
(IMDM)(Gibco, Paisley, Scotland). The cells were centrifuged at 1200rpm for 5 minutes, 
and the pellet was resuspended in 3-5ml of ice-cold red cell lysis buffer (Appendix A). 
After 2-5 minutes on ice, the cells were centrifuged at 1200rpm for 5 minutes. Pelleted 
cells were resuspended in 10ml of IMDM supplemented with 10% FCS (Delta, Kempton 
Park, South Africa), 2mM L-glutamine (Gibco, Paisley, Scotland), 100J.1g/ml penicillin 
(Gibco, Paisley, Scotland) and 100J.1g/ml streptomycin(Gibco, Paisley, Scotland). The 
splenocytes were then filtered through a 70J.1m cell strainer (BD Falcon, Bedford, 
Massachusetts, U.S.A.) to remove debris, and diluted 1 in 10 to 1 in 30 with Trypan Blue 
(10J.11)(Sigma, Steinheim, Germany) and PBS for counting. 
Splenocyte restimulation 
Splenocytes were diluted to 4 x 106 cells/ml with IMDM (Appendix A), and cultured in 
48-well plates (Costar, Corning, New York, U.S.A.), with 250J.11 of cells added to one of 
the following: 250J.11 medium, wells pre-coated with anti-CD3 (clone 145-2Cll; 
10J.1g/ml) overnight at 4°C to which 250J.11 of medium had been added, 25J.1g of conA in 
250J.Ll medium, 250J.11 of200J.1g/ml Anisakis extract in medium, 250J.11 of200J.1g/ml Grade 
V ovalbumin (Sigma, Steinheim, Germany) in medium. The cells were incubated at 37°C 
with 5% CO2, and supernatants were collected after 48 hours and stored at -80°C. 
ELISPOTS 
Multiscreen plates (Millipore, Cork, Ireland) were coated overnight at 4°C with 5J.1g/ml 
rat-anti mouse IL-4 (clone llB1~, 25J.1g/ml) or rat anti-mouse IFN-y (R46A2), in PBS 
(see Appendix A), then washed 3x with sterile ELISA wash buffer (Appendix A), patted 
dry, and blocked for 1 hour at 37°C with 5% BSAlPBS (filter-sterilized). Plates were 
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washed 3x, patted dry, then incubated for 10 minutes in IMDM at room temperature. The 
medium was removed, and splenocytes in IMDM were added at a concentration of 5xlOs 
cells per well, then incubated at 37°C for 40-48 hours. Cells were then removed by 
washing 9x in ELISA wash buffer (Appendix A) and Ix in distilled water. The plates 
were incubated for 3 hours at room temperature with O.5)lg/ml biotinylated anti-IL-4 or 
anti-IFN-y (BD Pharmingen, San Diego, U.S.A.) diluted in 1% BSAlPBS). Then the 
plates were washed 6x, patted dry and incubated for 2 hours at room temperature with 
0.5)lg/ml AP-Iabelled streptavidin (BD Pharmingen, San Diego, U.S.A.), following 
which plates were washed 5x with ELISA wash buffer and Ix with PBS. Sigma Fast 
BCIPINBT (5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium) (Sigma, 
Steinheim, Germany), made up according to the manufacturer's protocol, was added. The 
plates were incubated 5-30 minutes until the desired colour change was achieved. The 
reaction was stopped by washing 3x with distilled water, plates were allowed to air-dry, 
and the spots were counted using a dissecting microscope. 
Cytokine ELISAs 
Sandwich. ELISAs were performed to determine cytokine levels in cell supernatants. 
Nunc Maxisorp microtitre plates (Nunc, Reskilde, Denmark) were coated with purified 
anti-IL-4 (clone IlBll, 2)lg/ml), anti-IFN-y (clone An18KL6, l)lg/ml) or anti-IL-5 
(l)lg/ml), anti-IL-9 (2)lg/ml), anti-IL-13 (l)lg/ml), anti-IL-IO (l)lg/ml)or anti-TGF-~ 
(O.5)lg/ml)(all BD Pharmingen) diluted in PBS, and incubated overnight at 4°C. Plates 
were blocked with ELISA block buffer (Appendix A) for 1-2 hours at 37°C, then washed 
3x with ELISA wash buffer (Appendix A). Serially diluted standards (purified 
recombinant IL-4, IL-5, IL-9, IL-13, IFN-y, IL-IO or TGF-~ (all BD Pharmingen, San 
Diego, U.S.A.) or cell supernatant, all diluted in ELISA dilution buffer (Appendix A) 
were added to the plates, and incubated overnight at 4°C. Samples for the detection of 
TGF-~ were pre-treated with acid to unfold the protein for antibody binding to unfold the 
protein for antibody binding (Appendix B). The plates were washed 4x, and biotinylated . . 
goat-anti-mouse IL-4 (0.5)lg/ml), IL-5 (0.5)lg/ml), IL-9 O)lg/ml), IL-13 (O.5)lg/ml), IFN-
y (0.5)lg/ml,), IL-IO (0.5)lg/ml) or TGF-~ (0.5)lg/ml) antibodies (all BD Pharmingen, San 
145 
Anaphylaxis Chapter 3 
Diego, U.S.A.) diluted in ELISA dilution buffer were added for 3 hours at 37°C. Plates 
were washed 4x and lllglmi AP-Iabelled streptavidin (Pharmingen) was added for 1 hour 
at 37°C. Finally, plates were washed 4x and (PNP) (Sigma, Steinheim, Gennany) 
substrate (see Appendix A) was added. Absorbance was measured at 405nm with 492nm 
as a reference wavelength using a VERSAmax tuneable microplate reader (Molecular . 
Devices, Sunnyvale, California, U.S.A.). Cytokine levels in supernatants were 
detennined by reading from the standard curve. 
Statistical analysis 
Values are given as mean ± SEM and significant differences were detennined using the 
unpaired two-tailed Student's t-test using computer software (GraphpadPrism TM), For 
allergic score graphs, the Mann-Whitney test was used for two experimental groups, and 
the Kruskal-Wallis test with Dunn's post test for three or more groups. Values P< 0.05 
were considered significant. 
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3.4 RESULTS 
3.4.1 Anisakis proteins can cause anaphylaxis in a murine model 
Using previous publications as a guideline 49, so a model of antigen-driven anaphylaxis 
was set up using Anisakis crude extract, OVA as a positive control or PBS as a negative 
control. Wild-type and IL-4IIL-13.deficient mice were sensitized with two intraperitoneal. 
PBS/alum, Anisakis/alum or OV Alalum injections, and then challenged intravenously 
with Anisakis or OVA in PBS (Fig. 3.4.1). 
I DAY 0 I 
200IlII.p. 
50J,Lg antigen 
in 0.6% alum/PBS 
control: 0.6% alum/PBS 
I DAY 14 I 
Repeat Day 0 
Figure 3.4.1. Sensitization and challenge protocol. 







The rectal temperatures of both Anisakis and OVA-sensitized wild-type mice began to 
drop within ten minutes of intravenous injection, while PBS sham-sensitized mice 
maintained relatively constant temperatures. (Fig. 3.4.2). Hypothermia was accompanied 
by a loss of activity, but did not always correlate with the severity of anaphylaxis, which 
was better evaluated using a scoring system (see Methods). Mice experienced systemic 
symptoms ranging from diarrhoea and decreased activity to cyanosis, loss of 
consciousness and death. The presence of intestinal oedema and hyperaemia, likely 
driven by mediators of vascular permeability and vasodilation, was associated with 
certain fatality (Fig. 3.4.3a). Circulatory failure due to hypovolaemic shock was the likely 
cause of death in these mice. Figure 3.4.3b shows the intestines of a control-sensitized 
and an OV A-sensitized mouse after intravenous injection of OV A combined with Evan's 
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Blue. The dark blue colour in the antigen-sensitized mouse indicates the vascular leakage 
caused by the challenge. 
Anisakis sensitized and challenged IL-4IIL-13 -/- mice experienced a smaller decrease in 
temperature than wild-type mice, accompanied by a substantial decrease in symptom 
severity (Fig. 3.4.2). However, OVA-sensitized and challenged IL-4IIL-13 -/- mice 
showed hypothermia and reactions of approximately the same degree as wild-type mice. 
Anaphylaxis on the whole was more severe in OV A- challenged mice than in Anisakis-
challenged mice, with mice succumbing more rapidly to shock. Based on the severity of 
the reactions, even in the IL-4IIL-13 -/- mice which are typically used for a negative 
phenotype in allergy experiments, it was decided that a lower challenge dose would be 
preferable. 
3.4.2 Dose-dependent responses in wild-type and IL-4Ra -/- mice 
Challenge doses of 500llg and 750llg of Anisakis extract were compared in wild-type and 
IL-4Ra -/- mice (Fig. 3.4.4). The IL-4Ra has been shown to serve an essential role in 
various models of allergy, and IL-4 and IL-l3, which both sign~ through this receptor, 
have been shown to exacerbate anaphylaxis 25,41. 
When challenged with 500llg of Anisakis extract, IL-4Ra mice did not develop 
hypothermia or show signs of anaphylaxis. In contrast, when dosed with 750llg of 
Anisakis extract, IL-4Ra -/- mice showed a temporary decrease in rectal temperature and 
activity, but did not demonstrate the severe shock phenotype of the wild-types During 
the post-mortem, the intestines of IL-4Ra mice appeared normal and there were 
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Anisakis OVA 
WT 32+---r----,.--..,..--.., 31+---r----,.--..,..--.., 
o 5 10 15 20 o 5 10 15 20 




o 5 10 15 20 5 10 15 20 
Time post cballenge (min) TIme post cballenge (min) 
-<>- Control .... Anisakis ___ OVA 
Figure 3.4.2. Antigen-induced anaphylaxis in wildype and IL-4IIL-13 -/- mice. Mice 
were sensitized intraperitoneally at day 0 and 14 with 50J.lg of Anisakis extract or OVA 
adsorbed to alum, and challenged intravenously at day 21 with Img of Anisakis extract or 
OVA. Rectal temperatures were measured Qver 15 minutes. Data presented as mean +/-
SEM. Statistical significance between control and antigen-challenged mice is shown. ,., 
P<O.05; •• , P<O.OI; u., P<O.OOI, + death of a mouse. 
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a 
b 
.'igu~ JA,J. VI"'fUI~r luk.gt ~rltr IIQligeQ challeQgr iQ ..-ildtypr mif f, 
a) Intestinal odema Wld hyperaemia occurs in WlligCll-scnsitil'.ed mice (righl) but oot 
PBS-sensitized mice (left) challenged intravenousl) with ilIltigen. h) lnl~tim:s from 
t\'an's Blue irtiected mice. Antigen for challenge .... 'as administered in a 1% Evan's Blue 
d)1.' J;()lulioQ In orda to monitor vascular penneabiJily. In antigcn-scnsitil'.ed mice {righl) 
Lhl' intestinl!$ arc coloured dark blul.'. illustrating \'ascular leakage and exooatioQ of 
E\'an'slJlue dye. 
'" 




-+- Wildl)'pe .{)- ILARa KO 
figurt JAA. C hallr ng<, dflsr fomparisDn in " 'ildl) ]le and I L ... m a -I. IlIke. 
Refl:;d tcmpcnllufes were measured POSI Illtravenous challenge wilh 200141 of Alli.mkis 
elllme!. -, dealh ofo mouse. Data presented as mean +1. SEt.l 
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110 signs of the «<Icma or vasodilation that was found in \\ildtype mtce. This 
mtcnnediatc phcnot)-pe was dearly distinguishable from the more severe phenotype of 
the lIildtype mice, but left a margm for studying ..... ays 10 completely abrogate 
anaphylwns in fuLl.lre e~perimem,. The 750J.lg dose wa, therefore IISed in subsequent 
expcrlments . 
• 1.-',3 IL-4Ra uprtJJ ion on ell-" T-~cll~ phl)'J a uuciol rille in gn~[lhylui 5 
While it has been previollsly shown th:u the IL·4Ra pla)'ll on imponant role in 
wraphylaxis 1'. as It doles in our model (Fig.)4.4). the cell-spccilic reqmreml."nts for IL· 
4Ra I."xpression are not known. The a\-ailability of CD'" T,eell spr:clfie II."';Ra ./_ mice 
in our laboratory emlble<! 05 10 disscd the role of IL-IRa on CD4' T-cells In nntigen· 
induced l\Ilaphyla.~is 
Aller intravenous challenge. m,ce \\hich complC1c1y lad.cd IL·"Ra once again 
demonstrated markedly less SI."\'{'TC re.1Ctions than wildlype mice. \lnh a rectal 
temperature drop thaI was both less el(trcme and shaner-lived (fig. 3A.5). Intesllnal 
vasodilation. hyperaemia and <:>edema wa$lIOt found in these mice. imcrestingly. delC110n 
()f the IL-IRu on CD'" T -cells a.lonc also R'$ulted in striking protection against 
anaphylaxis in both the Anisakis nne:! OVA models (Fig. 3.4.5). Often thiS protecuon was 
better thun thm afforded by complete IL·"Ra knockouts. Once: again. reacllOns in all 
strains \I"(TC dose dependent. At low challengc doses (SOO,.,g .Allisubs), llC'ither IL-IRq.-/· 
nor CI).l" T·cell spttific IL·4Ra ./. micc demonstrated any signs of ani!phyhl.~is (dab 
not 5hown) At modmlt(' doses (750,.,g Anisnkis). l.L...fRu mice showed a tl"llllSient 
tcmpel1nure drop wllh I"«Ovcry, wbilc C[)4' T ,"",ell spectfic IL-l Ro: -,. mICe did not react 
(FI, J 4.5). At high doses (750",g OVA). bolh IL-4Ru -/. and C[)4' T-cd spr:cific IL· 
4Ra - - mice showed lemperatu~ d~rea.se and Signs of anaph)'la~i.s (generally milder .n 
C[).l' T-cell 11.-1 Ra-l· mice)(Fig.3.4 .5). Over scvcrm eXJ'('rimcrrts.. C[)4 • T-cell sped fie 
11.·"Ro: ddicienl mice consi5tently drtnonslrntrd either complete abrogation of 
:m3phylaxis Of transIent temperature 1o:s5 and reduced activity without Intestinal 
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Figure 3..1 .5. An3ph) l3 ~i~ i~ st rongl" reduced in CD~ ' T-<:ell S p~C ; r; [ IL-lKu ./. 
mk~. Recl31 I~mp<:ratu",s wcn,; measured aller intravenous challenge wilh 750fl& of 
antigen (Allisakis extract or OVA). Reactions \lere scored according 10 a modification of 
a previously published symplom scale (see Methods). +. dealh of a mouse. Data 
pU'5cnted as mean +/. SE~t 
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CD4- T-tcUs plays a CfUciai role in meditUing M3p/1yi3.'(is 
, , 
J ...... C U·" T -ullsprcific IL-IRa ./. mi« uhibil miud type lilYI'd rdPons~ 
Amlysis of antibody i50Iypc production alkr mtrupcritoncal 5ensitization "ith alum-
adsorbed A,,;sak;s showed that CD4- T-cell specific 1L-4Ra .f. mice had rJised levels of 
both !he type 2 antibody IgG I and the t}-pe I antibodies IgG2a tlI1d IgG2b (Fig. 3.4.6), as 
wdl as nilsed tOial [gE ( Fig. 3.4.7). In contmst. wildtypc mice produced predominantly 
type 2 antibodies (lgG I and IgE) while complC'le IL-4Ra -f· mice produced mainly lype 
I nntibodit's (lgGla aoo I~G2b). TotnllgE lewis followed a similar trend to levels of 
MMCP-I in the senlm (Fill 3.4.7. 3.4.8), with CD4' T-cell specific lL-4Ra ./. mice 
h.wing lower levels of both than II lid-types. and complete I L-4Ra -f· mice showing ouly 
very low M1-1CI' -1 levels and undctectab lc tOIU) IgE.. 
ELISPOT analysis (Fig. 3.4.9) demonstr:ned Ihal the CD4' T -cdl specific Il-4Ra .f. 
mice h:Jd sigmficant populations of both IFN-y and IL-4 prodocing cells, in eonlf:lSt to 
"ildt}'JlC:$. in "hieh IFN-y prodUl;ing «,lis v.ere absent. ComplC'le knock()ll1S also 
possessed both lFN·y and lL-4 prodUl;ing cells. though wlthoullhe IL-4Ra w()llid oot be 
able to rt'spond 10 the IL-l, resulting in the obsm,ed type I anlibody pheootypc. llIe 
incl'i'QSe in IFN·y producing cells In A,.isokis·~nsitized CD4' T-cell spttilic IlARa -1-
mi« as compared 10 PBS-scnsitiztd controls com:iJted wi,h a treoo towards mcreased 
IFN-r production by spl~n celts restimulated with anti·Co) (Fig 3.4. 10). In adJ ilion 10 
rt~-y. anti-CD3 restimulated cells from 1lI111gen-sensnroCl.'d mice produced the Th2 
effector cytokincs Il·13 nne:! IL-5 in simi l1ll' amounts to v.ilJtype mice: however. 
production of IL-4 and IL·9 appeared to be dl'Creased. In OVA-restimulated ce ll s.. lL-5 
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Fil:un.' J.4.6. Cl}~ ' T. rtl l $pl'C;n~ I L·~R(l -/. miCl." nhihil mi,ud 1}pt'I/ I)pt" 2 
aUlibod)' res p<lnsCli. Al'lIsakiS-spel:irlC anlibodie!l .... ere measured al dJy 21 In 
An!5<l.bslalum S\'nsi lized mice by EUSA. Oau 1'ft'5rnleci as mean +f- SE.'I 
". 
TotallgE 
_ Wikl rypc OILARa -/- ~T -cell IL· 4Ra -/-
Figu~r l .-l.7. Toll.1 1\: .; in OVA- amI , tllisllkiJ_5tMiti7.td mict. Anlibodies were 
measured in St."I'tlm tak~n after the chl.Jjcnge. using ELISA IgE k"ds of gelle dc/ieiem 
mice were compar~"(1 to those o f wildtype mice Data presented as mean +/- SEM. 
Statist ical significance lx1"ccn wiJdlypc and knlxkoul mO\I$C slmil15 is shown . • 
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I'ft...,"" 110- "Ie" C"h:ollu~~" 
_ Wikltypc o 1L-4R« -/- EZ2IT-ceU 1L-4R1l-I-
Figurf l .-l.S. M~t CP- 1 Ir .ds in St' rum or AlliJllk/s and OVA s('n siti7.~d nllee. S~rum 
MMCP-\ was measun..-d !lefor.: and after illtr~venous chaUengc. Pre·ch~l1 enge values 
\'o en: compared 10 post-challenge yulue!, ilIld wIldlyIX' mice wcre compared to gen e 
deficicnt micc. Dm!! presenloo as mean +/. SEM. Statistical siSIl.fic.1llce between pre-
.md pos t-Challenge yaJucs is shown . • . P<Q,OS; " , P<OO l. •••. P<O.ool. 
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eh.pI"-) 
IL-4 ELiSPOT IFN~f EllS POT 
•• • , 
l'US 
_ Wildt),pe DIL4Ra -I· ~T-ccn IL-IRa -/-
.-igLire JA.9. C D·r T-cell sprcifk IL-4Ra -1- mice han both IL-4 and IrN-y 
producinj: ccll~. ELiSPOTS .... 'Cre performed (0 dC1cc( IL-4 and IFN-y produdng cells 
amongst plated splcnOC)'ICS from PBS and Anisakis-scnsinzed mice. Data presented as 
mean +/. SEM. Statistical significance between PBS and Anisakis-challengcd mice is 
shown . .. . 1'<0.01 . 
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Figure 3A.IO. CylQkin~ [lrollu~lioll by reslilllul:.lcd s [llcno~yt (5 in wi ld-tY[lc, IL-
4Ra -/- and C1l4' l'-~cll s p~cifk IL-InCl ./. min. Splcnocytcs were isolmcd on Ihe day 
of challenge and restimulat~"<l with ami·CD) or amigen (IQQ~g/ml Anisakis or OVA). 
D~ta presented as mean +/- SEM. Statistical signific~lIce between wildtype ~nd knockout 
mouse strains is shoWll. ' . P<Q.05; " . P<Q,Ol: " ' , P<OOOI. 
'" 
Anaphylui. Chop!<r J 
3 .... 5 DcpktioH of CD~ - cells reduces tbe st>\'erily of anaphylax is 
Neutralizing antibody was used to deplete CD~' cells at days 0 and 14 using the model of 
.~nlsakis-induced anaph)laxis. Fig. 3 .... 11 sho\\''S that antj-CD4 depletion decreased levels 
of IgG antibodies to barely detC'\:l3ble. allhough lotal IgE n-mained preset1t. In anti -CD4 
treated CD4- T-cell specific [L.JRo -/- mice, lOIallgE was reduced compared to that of 
control antibody treated mice. 
ELiSPOTS demonstrated the presence of many IL-4 producing ce!ls in both treated and 
untreated mice (too [lumerous to count data not sllown) while IFN-y producing cells 
were slmost entirely absent from anti-CD4 treated mice. apm from a small population 
remaining in the complete IL-4Ra -I- slrain (Fig. 34 .12a). Restimulated splenocyles 
from all antj-CD4 treall'd slrains did not prodllCe delectable levels of cytokines (data not 
shown), while cells from comrol antibody treated strains showed the same pauern of 
cylokim: production as in previous experiments (Fig.3.4.12b). Together these data 
indicate tltat CD4' cells are primarily responsible for producing the high IFN-r levels in 
CD4 ' T·cell specific IL-4Ro. -/_ mice. 
Anti·CD~ Ireate<! wildtype mice stil! displayed anaphylaxis after intravenous challenge. 
though with a detreased degree' of severity (Fig.3A. l3). This might be due 10 
maintenance of the [gE-mediated response, as demonS1TlIted in Fig. 3.4.11. sincc in lL-
~]{u -I- mice. in which no IgE or IgG was detected. anti-CD~ treaunent resulted in 
com pI etc obrogation of anaphylaxis. CD4-dep!eted CD4- T --cell specific IL-4Ru -/- mice. 
whiCh had Igl! antibody. experienced a transient temperature drop which soon returned !O 
Ilormal. This lemper3ture drop \\"1I5 reduced b~' lIlui-CD4 lrealmem. tl ow"v~r. ~v"" 
controltreale<! mice of this strain did not experience reactions or the same grade !IS mite 
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Figure 3.4.12. IFN-r Ilroducing cdb . nd f)" l(lkint production by ~limul3led 
s l,lcnocr1es in lI nti· C04 trU led m icro I.) ELiSPOTS WeTC' performr-d 10 compare 
number$ of 3mi-1FN-y producing ~plrnocytt'!i in oontral antibody and 1ll\\i-CD4 treated 
mice. Control antibody treated groups w~ comp.'ln:d wnb anTi·CD4 tJealed groups. b) 
Rcsi,mulattd splenocyte, from controllmlibody treated mu::e showed the same p:lllml of 
c)1Ol. inc production 85 in previous experiments. St:lUstlcal Slgmlican«' between wildl)'JlC 
and knockout mouse S(",:IIlS mice is shOlm. Data presented as mean +1- SEM. ' . P<O.05~ 
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Fil-:.,rl' JA. IJ. "ypolh~rrni,. was rrd., eM in wild l) pt.1L-"Ra -/. ~nd ell'" T-cell 
~Jlc(jfjc 11.~Ra-/· lUke trut td "ith ~"li·CD~ . Mice wcre treated at days 0 and \4 "ith 
corllml anti body or an ti·CD4. TempcrolUl't's were measured post challenge and reactions 
"' .... re scored as dcscnbcd In the methods, +. II ~ death. 
'" 
3 .... 6 IFN-y dql lclion lIbroj!ales IlrO I ~'C:l i on 1II;:l1in) \ an:lph, lull; in CD~· T- c~1I 
specific IL~R cr. -1- mice 
As the pre~ious experiments demonstrated that T·cell specific lL·4Ra knockout mice 
possessed high numbers of IFN-y producing cells (Fig, 3.4.9 and Fig }.4.12). and 
restimulated splenocyu:s proouced high lewis of IFN·-dFig. 3.~.10 and Fig. 3,4 12). it 
was hypothesized that IFN-y was n:sponsibk- for abrogation of anaphyl[L~is in this strain. 
lFN-y depletion studies were therefore pcrfonned on "ildtypt. IL-4Rcr. -J- and CD·" T-
cell specific ILARa -/- mice, using the OVA·induced anaphyla'lis model. Following 
intravenous OVA challenge. wildtype mice treated ,\lidl anti-IFN-y experienced similar 
temperuture loss to controltreatl'd miel' but had slight ly iocre~ morlal ity (Fig. 34.14). 
In contrast. CN' T-cell specific IL-4Ra -1- treated \,ithcontrol antibody had ~irtually no 
loss in temperature. but upon IFN·y depktion these mice experienced rapid hypothermia 
and death. Scoring of anaph}'lactic reactions illustrated a significant increase in severity 
in lFN·y depleh:d COol ' T·cell spe<:itic IL-4Ra -/- mice (Fig. 3.4.14). In n different 
rcpresentation of these data. Fig. 304.! 5 iUl.lStmtes how ant;·IFN-y treatment removed 
differences in temper~ture loss between strains. However death still did not occur in My 
IL-4Ra -f· mice. probably because of their inability 10 respond to IL-l lind lL-IJ. which 
are known to e.~acerbatc anaphyb)[is. 
MMCP-I Icvels in serum. 1\ marker of systemic mast cell degranulation. were initially 6 
times lower in comrol-treml'd COol ' T-cell specific 1L-4Ra -f- mice than in both control 
and anti-IFN-y treated \\ildtype mice (Fig. 3.4.16). After IFN-y depiction. levels of 
MMCP-I rnse to the equivalent of wildtypc levels. indicating an effect of lFN·y in 
inhibiting mast eel! degranulntion. 
In addition to havin!l e.~acerbated systemic shock. lFN-y depll'ted COol' T-cell specific 
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Figu~ ... 3.4.14. Anti · IFN ·y abrllgatc! prolcrti(lll against anaphylaxis ill C 04' T·("cl i 
specific lL· 4Ru -I· micc. Tempcrntures were measured post challenge (left hand 
co!wnn) and anaphylact ic reanions were sc;:o rcd (middle column). Survival curves oppcar 
to the right hand column. Data presented as m~all ~,- SEM . • P<O.05 . •• P<O.01. t . a 
m('HISC death Data representative of2 experiments. 
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r", .. IM'_" ch~IIen::' (min) Tim. "".<' oh.llrn~. (min) 
....... WiklLype -0-- IL-4Ro: _/_ -0- T ceU IL-IRa -/-
F"i l:ure J A. IS. Anl;- IFN-y IrC:LlmCIII r ( mo"es diff~rcnn·s in l C mper~llIrc loss 
bcrwee n sin lins. TIlls reprCSC!l1Hlion afthe dala. comparing CQn(rollrealed and anti_tFN_ 
y treated mice, shows ho\\ the dilTeren~s in temperature 10$s between the strnins are 
abrogulNI by anll-IFN-l' treatment Dala presented as mean +/- SEM. +, a mouse death . 
Serum MMCP-1 
_ WT ~T-cell IL-4fb -1-
figure 3...\ .1 6. ,\nlj·IFN-,( tn'91ment b a_~sod alcd with denied serum MMCP-1. 
MMCP·I Ic\'cls ' .... ere mt'asured in serum by ELISA, and. lel'els in control-treated mice 
wen" compared slalislkllIly ",jill levels In !lJlli· II'N·'Y treated mice. Data presented as 
mean +/- SEM. Statistical s igl1lfic:Ince belween control and aUli-JFN-~ tTl'Hled mice is 
ShOWl1. 04. 1'<0.01. 
'" 
Analysis of cytolnl\eS produced by splc.-nocylcs resllmuloleu with anli·CD) was 
wiJertaken !O dc:lerminc.- whethe r antl-1FN-r treatment. c,'en at a lOll' staG .... could alter 
Thl /Ttt:! protiles. (Fig. 3.·t17J LewIs nfTh2 cytnkines and Im·y produced by control 
antibody and 3Il1t- IFN-g treated spleooc>1es were not significantly differenl in eitller 
"ildtypo: a:od CD4' TecH specific IL-4R(l _/_ mice. 
Wildtype C04' T -ceII IL-4Ra-l· 
:~ i lio n , 





Fig u ~ ).~ . 1 7. T hl n h2 (,flnkines produced by "", Iimulatcd s (l len oC)Il"~ a re nOI 
a h erNI ill 1. 111 ;, 1 FN-r I rea led mice. IL-l 0 le\'('15 were incrNscd In atlll-IF'l-y treated T· 
cell specific IL-4R(l .1. nllce. but did fIOl reach wildt)"pe 1<'\'..,15. Data pt\'5enlcd as mean 
+/- SE:-'1 
'" 
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Anaph)iaXL< Chaplet 3 
Antibody EUSAs did not show any significant differt'llc~ in prodllction of type 2 or type 
I antibodies between control-antibody and anti -IFN-1 tre3led mice (Fig. 3.4.18; Fig. 
). ·U9). lIowever. the levels of specific antibody d<"1em'd were very low EliSAs for the 
detection of specific 3ntlbodies in this model often showed only low antibody levels 
because tJ1e intrJv~nous antigen challenge bound to serum an.tibodies. resulting '" a 
reduction in free antibody available for detection (Fig.3.4.20). Anempting to bleed mict' 
on<' day prior to the challeng~ resulted in an alter;'llion of the severhy of umphybxls 
(tempemture drop and symplOrns) du~ to the mice having decreased starting blood 
voilime. Therefore. in order to obtain more reliable antibody results it would be necessary 
to conduct an experiment with sensi tization and depletions but no antigen challenge 
specifically for the purpose of obmining serum. Ilowever. specific IgO\ levels followed a 
titration curve in both slrains. and IOIaI IgE was not afiecled. so the resll\t~ strongly 
suggesl that ami-JFN-1treatmem did not affect lllllibody levels. 
J A.7 I< inNic.< of OV A-a III rn ~t· n .• itilalion 
Previous experiments found an important protective effect of deletion of lL-4Rll on 
CD4- T-cells in WI IFN-1 dependent mechanism in a model or anaphylaxis using IWO 
differem antigells . In order 10 pUI these da\.'l. into context. an in\eslig~tion of the 
mechanisms of anaphylaxis in this model "'"liS nl.'eded. As the previous experiments 
demonstr~ted tMt OVA and AII;sakjs behave in the same manner in this model. it IV3S 
decided that the modd allergen OVA would be used in subsequellt experiments to 
investigate mechanisms of anaphyla.xis As a protein. OVA is more easily available and 
has 1\ knov."f1 compositioll. whereasAllis"kis extract is produced ill limi ting ql.lalltilies and 
contains many dim'rent allllgens that have not been characterized ill de!ail . OVA is the 
standard allergen llsed in the literature, which would allow us to compare results obtained 
in our laboratory with results obtained ill Olher laboratories. 
The antibody and cytokine responses of wildtype mice sensitized with OVA adsorbed to 
alum according to the esmblished protocol (FigJ.4.I) were followed over 21 days. 
Samples were taken at day I. 3 and 10 after the initial sensitil.l1tion. as well as at day 15 
(one day a1\('r the day 14 boost) and at day 21. the challenge lime-point in the Olher 
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Figure 3...1.20. [nlrll\'cIIOUS anligen ~hallcn!:e ",UH'S a t1~crcast in l lie amount of 
serum :tnlthotl)' mC9 .• unUlc h)' ELlSA. Antibody levels measu~d in challenged mice 
were substantially lower than antibodies measured in llOChallengcd mice which had been 
sensili1..,d in parallel. This can be ;mributed lO bmding of free anlibody by intravenously 
adminislcred antigen. Dil!;1 presented as mean +/- SE~. " , P<O.OI. 
." 
t:.~perimcnt5. PBS-alum sensitized mice were used as controls. 
TIll! resul1S showed a predommant type 2 response. WIth hIgh levels of IgOI. very low 
1C\'ds of Ig02a. (md undetectable IgG2b (Fig. 3.4.21). OVA-specific IgO \ began to rise 
bet".:en day 3 and 10. then In'dled off unlll tllc boost a1 day 14. after which it incre~scd 
"Gain. Sm~1I amounts of OV "-specific Ig02a also began to appe~r ufter the boost. Totul 
IgE ulsa bcgllf\ 10 rise within 10 days after scnsitizntion. und remained fairly 5mble 
around the boost at day \4 . 
The kinetics of cylOkinc production from ami·C03 restimulated splenoqles indicated 
lhal production of bolh IL4 und 11.-5 increased after the inilial scnsi liwtion (by day 3) . 
.... "I!re d<:creased ugaln by Ihe tunc of the boosl, and increas.L-d again after the boost (Fig. 
3.4 22). SplenOl:ytes tuhn at day 21 produced significantly higher level$ of both IL-4 
and [L-S levels than splcn~ytes taken from day I. or from PBS·alum sensItized mIce. A 
similar Irend to .... wds increased 11.·13 and 11.·9 was observed. whtle IFN·y production 
remained fairly constant throughout Ihe sensitl7~1lion rrgimc Interestingly. aner Ihe 
boost. levels of IL-l0 and TGF·p were ulsa raised. It is poSlible lhat repealed 
sensitization would lead to a regulatory response and inununologicaJtolerooce. Though al 
day 21 Th2 cytokincs "ere $Ii ll raised. sampling at more time·points before and ul1er day 
21 would show whether Th2 levds W"ft' still on lhe InereaS(' or beginmng 10 d('(~a5C by 
day 21 due to Ihe rise in regulatory cytokines_ 
3.-1.8 I L4 tlfll ift ioo tlu ring sensitization \"Wllt"J the JC' erity or IInllph} hui, in wild-
tHIt' nl if" 
Anu-IL·4 treatment dunng lhe sensil;7.mion plmse in wildrype mice led 10 a signific:ml 
~reasc In hypothcrmlu and severity ofanal'hyla.~is (Fig. 3.4_23). This com:lated with a 
decre~ III IL-S. IL-9 and IL-lJ and no H1crease in the amounts of 11_-10 and TGF.p 
rroduced by restmlulnted splcnoc)1cs {Fig.3A.24). In addihon. levels of the type I 
nnnbOOy IgG2a werc u!Creascd after 11_-4 depletion, whil" tOial Igf was decrc:l.o;I.:d 
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Figur~ 3.4.21. Anlibody kinetics du ring ;nlraperiloncal sensnullolion. Mice were 
sensitized intn<pcritone~lIy at day 0 with alum-adsorbed OVA. and again at day 14. 
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Figure 3.4.22. Cylokinc productio" by rc~ limu l pted splen (l~rl eS a t different lime 
Iw illlS du ring illlrnpcritoncul ~CIl<iliz9tion. Mice were sensitized imrapcriloncally ~{ 
day 0 with alum-adsorbed OVA, and again 31 day 14. Cylokinc production was measured 
from r"slimubt~'tl splenocytcs taken at various points in the sensili1.ation schOOul ... 
Cytokini.' levels wert! statistically c\"aluak>d against cytokino: levels produced by PBS· 
sensitized mice. Data prC$Cnloo as mean +/- SEM. Slalisiical sign ificance was calculated 
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Figure 3.4.23. I L·~ t1Cf'letion <iu ri ng .• crui IU.:ltiOI\ n'tiuc<'$ tile , cnr ily of OV A-
induced an:ll'hyluis. Micc weI'c' sensitized :ll day 0 and day 14 With alum-adsorbed 
OVA. and lJealed 31 day 0 and day 14 with anli-[L· 4 or a contro l antibody. Intravenous 
challenge wilh OVA .... l1S pcrfonnoo 31 day 21, Rectal Temperatures were measlll\."() and 
anaphylactic reactions \Vere scored (set' MctllOds). Data prescntoo as mean -tf- SEM. 
", (><0.05: +, a mouse death. 
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Figur~ 3A.H. "nli-lL-I In'a ,"l ~nl during ~~ n~iliz:l l ioo anUI~ antil!<)tiy !~n!$ a nd 
C)tokin~ prodll~ l;on by r l':l limllla itti , plenocll~~. Mice were sensitized al day 0 and 
day 1.1 with alum-adsorbed OVA, and treated at day 0 and day \4 "ilh 9!1li-IL-4 Of a 
control antibody. Antibodies were measured in serum talen at day 21 after inU'lll'e!lOLIS 
challenge "ilh OVA. and C}lokine produclion was mcasull'd from restimulated 
splenocytes talen 3t day 21. Data prt'SCntoo 8.'1 mean +/- SEM. Stati$lital significance 
between control and anh-J.L..4 treated mice is shown. '. P<O 05; " . P<O 01 
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J .... 9 OV ,, -induced ~nllphylll.tis i~ ~brogn ted by f C1Rllnt I tieplction 
Some models of sYSlemlc anaphylnxis ;n mice are mediated primarily by IgG and the 
FcyRIlIIIIl:! 1'. "'hilc Olhers arc IgE-mediatcd lU I. To delennine whelher anaphylnxis In 
our model was IgG- or IgE-mediotcd. we pcrfonned depletion studies lIslng anti-
FC1 RIIIIIL antl- I"E or II control rat IgG antibody. FigJ.4.2S 5110"'5 tha! anti-lgE 
treatment effect1\'ely depicted IgE but did not slgl1i fieantly alter IgG levels. Anti-
FI:..,RIU!II treatment did nOt affect IgO levels. b\ll rnexplicably seemed to rt"dlll:e 19E 
ICI·e ls. However the an!i-lg£ group could act as a contrul for any effects due to depiction 
of IgE ~nd not bJockmg of PC'/RIlIllI in this group. 
Following i!\lrnvenous challenge. rectal temperatUTCS dropped in both the control group 
and the IlI1li-lgE treated group. bllt did not drop III Ihe antl-fqRll1 11 tremetl group {FIg. 
J.4:!6). FU11hennore. signs of nool'h)luis "''eTC almost C(Jmplctely abrogal~-d in anti-
FcyRlIlIIJ treated mice. "'llh only 21'9 mice having mlld reacnons in pooled d.d.lI from 1"0 
e"pcttments (Fig. 3.4.:!6). In contrast, anh·JgE lrelUed mke had Similar monaltly ralC1 
and lIIlaphyloctk scores 10 controls. Mouse mast-cell protease-I "'iU measured In the gut 
ancl serum as II measure of mrull cell depulation (Fig. 3. -4 27) ~plCli(ln or FcyRJLl lI 
correlated ""ith a stronl; decI'C1I5C in Il1I»I cell degranulation in the iut 8.$ compared 10 
control antibody and anll -lgE lrealed ml~. thouGh serum MMC!'-I was decreased III 
both the anli-FcyRU/]] 1 and the anti-II;E ~tcd mice. The decreased MMCP·I le\'Cls in 
anti-FC1Rll IIll !re~ted mice may be anributed to lowered II;E levels (Fig' 4.26). It 
should be noted howe\cr that lhe 10"'ef le\ds of MMCP-I measured in the gw of 
J .·u o Anaph~ luiJ is nOI significanlt,' . ffeeled by Ih~ Ib~fn(r or 1I., ... mu 011 
macrophlgt$1nrul rophib 
In prevlOu~ publications, t,",o research groups rotmd a role ror m3CTOphages in IgG-
mediated a:oaphyla."is n. 10 It is knoY.n thaI macrophages, c~n be polarized into two 
different metabolic stlltes depending on ",hcther they are in a Iype I or Iype 2 
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figurr 3.4.25. Tile errcct or an.i_lgE ynd an'i-F'~RIIII1l on SHUn! antibody !tHis. 
Mice werc ~ensi'iu:d al day 0 and day 14 with alum-adsorbed OVA. and treated a. day i" 
and day 20 with anti- lgE. anti-FC')'RIl!l[1 or a COll11'01 anlibod>' Anubody levels were 
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Figu re 3A.26 A nli-F'1RI IIl II Irtalment abrogates an "pll} luis. Mice were sensitized 
mtrllperiumeally PI day 0 and d3}' 14 with alum-3dwrbed OVA. ami challenged 
101r.!' enously at day 2! ''lib OVA. Tempemlures were measured by r~'Clru Ihcnnomelcr 
WId reacliol1$ were 500red as described '" the Methods.. 
serum MMCP-1 gut MMCP·1 
_ Control Ab D AI'u;"F(:,,(Rllflll [:!] Ant~lgE 
Figure ,\.4.27. Tht drteb nr an li. lgE and ~nti-FC1'R I1Il I1 IrnU1Ifnl un strum and 
gut i'lli\l CP-1 [I' I dt, MMCP-I !eve!, were measured In Sl'TlJm laken after dtallengt lII1d 
in gut oomogmalcs. Data I"ll,!'s..-nted as mean " /. SEM. Statistical SIIPlIficanct· bet"em 
[mce treated wnli conlrol anubody ami them' treated wlIh nl."lltmhzing antiboJ) is shO\.,n 
·,1"<0.05: •• , P<O.OI 
'" 
Choplo. J 
phenolYpe known a, the altemallvely aClivated macrophage. In order !O detemline 
whether alternatively acti\'8ted macrophages playa role in anaphylaxis. experiments were 
performed using previously charncteri7.ed tell specific knockouts scl(Xtivdy lacking Ihe 
IL-lRn on macrophages and neutrophils (LysMc"'IL-4R(('''''' mice)~l. 
The antibOdy responses in macrophage/neutrophil specifir IL-4RO: -/- mice we.e vit1ually 
idenlical 10 Ihose in wild type mice (Fig. 3A.28J. Sensilization with OVA-alum resulted in 
hIgh levels of IgGI and raised 10lal IgE. Restimulaled splenocytes from Ihis strain 
addilionally produced a simil:l.r profile 10 restimulated splenocyles from wildtypts.. 
al1hough bolh IL-4 and IFN-y were produced in higher amounls in sp1enocytes from 
macrophage/neutrophil specific IL-4Rn -/_ mice (Fig. 3.4.29). After intravenous 
challenge with OVA. macrophage/neutrophil specific IL-4Ro. -/- mice developed 
anaphyla'l:is to more or less the S<lme extem as wildtype mice (Fig. 3.4.30). There WlIS a 
non-signiiicant trend towards a very slight decrease in hypothermia and symptom score 
in macrophage/neutrophil specific lL-4Ru _1_ mice (Fig. 3.4.30). accompanied by a 
SIgnificant decrease in MMCP-l Icvels in the serum (Fig. 3.4.31). However, as 
macrophagelnemrophil specifie IL-4Ra -/- mice still undef\\.~nl se\'en: and of len fatal 
arl3phylaxis. overall it could be concluded that IIARo. on macropbages and neulmphils, 
and by inference the presence of alternative macrophages. do not play a stgnilicant mil,' in 
this mQ<\e1 ofanaph)"laxis . 
• '..1.11 The t'ffe~t of must cell depiction on anaphylaxis 
Unfot1unately the anti-ckit treatment did not completely deplcte mast cells. and there was 
not enough antibody 10 repeat the experiment. However. there was a trend to""Jros 
decre;'!sed MMCP-l levels in serum with lI1creasing anti-ckit injections (Fig. 3.4.32)_ 
indicating that panial depletion was obtained. Interestingly. nuce in groups receiving 2 or 
3 anti-ckit injeclions had significantly increased survival rates and r~-duced symptom 
scores compared to mice which had beeo given 0 or I injections (Fig.J.4.33). In conlfllSt. 
both groups of mice experienced simi lar lempemture loss These results may indkil.te that 
mast cells pl;'!y a role in increasing the severity of ;'!naphylaxis and risk of death in this 
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Figure. 3.·1.28. Anrihody producrion in macrophaj!cfncutrophil specific IL-·II{a. -I-
mice. Mice wcre S<.'"nsitiz<,d immpenloneally at day 0 and )4 with alum-adsorbed OVA 
and challenged Intnl\'cnously at day 21. Antibody levels were measured by ELISA. N. 
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Figu rt JA.29. Cytokinr product ion II)' r tl l lRiulaled ~ plrnocyle! in wildly~ li nd 
lIIacl'1}phll::~n~ut rophil sp« ific 1I ...... lta 4· micr o Micc ",'cre scnsuized 
lnlnlpcrilOneally with alum-adsorbed OVA at day 0 and day 14. and challenged 
intravC'OOusl> with OVA 01 day 21 Spcnocylcllakcn afu:r challenge were n:~imula,ed 
",ilh an1J-CD3 or OVA. Data presented a~ mean -+1_ SF~\t. SIa1islical significance 
between witdlypc and " nockoul mice is shown .• , P<O,OS. 
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Figure 3. -1.30. /IIacroph:.gcincUlrnpllil speci fic t1d t tion of IL-IRu doe.~ no. 
!ignificantly ~rfcd 3naph}' l a~ is . Mi" .... IV!;"!e Sfnsili7xd intmpcritoncolly with alum-
adsorbed OVA 3! d4ly 0 and day 14. IUld dnlleoged intravenously with OVA at day 21. 
Temperatures were measuroo wilh a rtxtal thermometer and re:l<: tioll$ were scored as 
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Figure J . .i.Jl. Serum MMCI'-Ile\-ds d CfrtaJfd .. ith innraJinl: anli-fkit illjrftions. 
n B the number o f serum samples obtained. II is often impossible 10 obtain blood from 
mice "hieh have had severe anaphylaxis due 10 eluensiv( vascular lealmge ClIusing II IQU 
nf blood volume. No serum "1l'lobtained from any of untreated mice, renecting (he 
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Figure 3.4.33. Partial m:ul cell depletiDn ""a.~ assoc;:tleU wilh on in rrt"ased surv;I'aJ 
nIl' li nd d~creased sympfom score. "lice were sensitiZed inlwperiloneally 31 days 0 
and 14 Wilh alunHKisorbed OVA, trealed wilh arIti.ck'l at days 18 and 20. and challenged 
wilh OVA at day 21. Temperature,<; w<'re measured wilh a rectal thermometer and 
reactions "ere scored IICcording 10 Ibe system described in Ihe Methods 
'" 
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3.5 DISCUSSION 
Understanding the immunological mechanisms surrounding anaphylaxis is essential for 
the design of better preventative and therapeutic strategies. Certain substances, such as 
peanuts, egg, seafood, Hymenoptera venom, antibiotics and latex, are more prone to elicit 
anaphylactic reactions than others. Anisalds has recently received much attention for its 
ability to cause anaphylaxis, but it is uncertain whether live larvae- are required to elicit 
anaphylaxis or whether Anisalds proteins themselves are intrinsically allergenic. The data 
presented in this chapter show that Anisalds extract behaves similarly to the egg allergen 
OV A in a model of systemic anaphylaxis. Furthermore, this chapter explores mechanisms 
of anaphylaxis, using cell-specific IL-4Ra. deficient mice to show that IL-4Ra. expressed 
on CD4+ T cells but not macrophages and neutrophils is critical in mediating responses 
that lead to antigen-induced anaphylactic shock, and that IFN-y plays a key role in 
protection against anaphylaxis. 
In this model of antigen-induced anaphylaxis, Anisalds extract was able to elicit the same 
type of reactions as the model-allergen OV A. At equal doses, OVA elicited slightly more 
severe reactions, but this was likely due to the fact that it is a single allergen whereas 
Anisalds extract contains a wide variety of proteins, only some of which would be 
allergenic. Recently, a similar study was published in which Anisalds-induced 
anaphylactic reactions occurred following intravenous challenge of mice sensitized 
intraperitoneally with Anisalds simplex extract, pertussis toxin and alum S2. The authors 
additionally challenged sensitized mice orally with Ansialds extract, but no reactions 
occurred through this route of exposure. This suggests that live infection with Anisalds 
larvae is more effective than Anisalds extract at sensitising for ingestion-related allergies 
in mice. 
Despite the fact that live larvae appear to be stronger sensitizers than extract alone, the 
data presented here and in chapter two indicate that certain Anisalds proteins have 
allergenic properties, as opposed to the view that allergic reactioD,s to Anisalds are based 
solely on an inflammatory response to a live helminth infection IS. This is supported by 
the fact that the same anaphylaxis model was tested in our laboratory using pilchard 
185 
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extract, but reactions did not occur after intravenous challenge 53. Furthennore, both 
human and dog hookwonn can cause an eosinophilic, allergic-type response in the 
, , b 'th 'all" th A' lei d 54 55 mtestme, ut net er causes systemIc ergic reactions e way msa s oes ' , 
It has been proposed that proteolytic enzymes of parasitic wonns are particularly 
effective at eliciting Th2 responses, Several important allergens from house dust mites, I 
moulds, cats and fruits have protease activity that is thought to enhance their allergenicity 
and trigger sensitization to concomitantly administered antigens 56, Anisakis secretes 
proteolytic enzymes in order to burrow into the submucosa, some of which may be 
allergenic and enhance the allergenicity of other Anisaleis proteins by allowing them 
access to subepithelial immune tissue. The allergenicity of certain Anisaleis proteins 
suggests that reactions to Anisaleis should be considered a genuine allergy, and not only a 
pseudo-allergic inflammatory response, This would be compatible with case reports of 
allergy due to airborne Anisaleis proteins 57.59, As previously suggested, chronic urticaria 
may be as a result of constant exposure to Anisakis proteins in food in sensitized 
individuals, and not only repeated infections with live larvae 60, 
Subsequent to the establishment o'f a model of anaphylaxis, we aimed to elucidate the 
role of IL-4Ra functioning in certain cell types, The IL-4Ra plays an important role in 
several models of allergy by mediating signaling of IL-4 and IL-13 61-64, IL-4 and IL-13 
signalling is important for creating the environment required for allergic responses, 
including B-cell IgE and IgG I secretion, Th2 differentiation and associated accumulation 
of effector cells such as mast cells and eosinophils 50,64, 65, Both IL-4 and IL-I3 also exert 
effects upon epithelial, endothelial and smooth muscle cells by promoting chemokine 
production, vasodilation and contractility, and can exacerbate anaphylaxis by increasing 
cellular responsiveness to vasoactive mediators and shifting the balance of ion and fluid 
flow 25,41, 64, 66-68. IL-4, but not IL-I3 increases intestinal mastocytosis, while IL-I3 
increases susceptibility to fatal anaphylaxis by contributing to lung pathology such as 
goblet cell hyperplasisa, muc\l& hypersecretion, fibrosis and eosinophilia 64, 66, . 
Accordingly, the present study and others 41, so have shown that the IL-4Ra plays an 
important role in anaphylaxis, with null mutant mice maintaining resistance to death and 
186 
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intestinal pathology except at very high challenge doses. Unlike anti-FcyRII/III 
neutralization, the absence of IL-4Ra did not abrogate anaphylaxis entirely, but rather 
reduced the severity of anaphylaxis. This is consistent with a role for IL-4 and IL-13 in 
exacerbating anaphylaxis 41. The cell specific requirements for IL-4Ra surface 
expression in anaphylaxis have not been previously investigated. 
Alternative activation of macro phages is induced by IL-4 and IL-13 and is thought to 
playa role in chronic allergic disease46• However, the role of alternatively activated 
macro phages in acute allergic diseases is unknown. The results of this study show that 
macrophage and neutrophil activation through the IL-4Ra is not essential for pathology 
and mortality in this model of anaphylaxis. This demonstrates that alternatively activated 
macrophages do not have an important role in this type of allergic reaction, if any. A 
previous model of anaphylaxis found that macrophage production of P AF was the major 
pathway for IgO-dependent murine anaphylaxis 24. While macrophages were not depleted 
in this study, the data here indicate that if macro phages do play a role in this model, it 
would have to be via classical activation by IL-12. The recently discovered role for NO in 
mediating the vasodilation associated with anaphylaxis would support this conjecture 69, . . 
as classically activated macrophages are an important source of NO 46. 
Deletion of IL-4Ra from CD4+ T-cells alone abrogated or strongly reduced anaphylaxis, 
despite maintenance of a Th2 response and the presence of antigen-specific IgE and IgO. 
Experiments using different challenge doses demonstrated that protection against 
anaphylaxis was dose dependent in both IL-4Ra -/- and CD4+ T-cell specific IL-4Ra -/-
mice, and that CD4+ T-cell specific IL-4Ra -/- mice were more protected than IL-4Ra -/-
mice. As CD4+ specific T-cell IL-4Ra -/- mice consistently had high numbers oflFN-y 
producing cells at the time of antigenic challenge, it was hypothesized that IFN-y was 
able to protect mice against anaphylaxis even in the presence of an established Th2/type 2 
response. Indeed, IFN-y depletion led to a phenotypic switch to lethal anaphylaxis, 
. . 
similar to that seen in wildtype littermates. IFN-y was neutralized only when sensitization 
had been completed in order to specifically target the effector phase of the immune 
187 
Anaphylaxis Chapter 3 
response. The treatment did not significantly alter levels of IL-4 or IL-13 produced by 
restimulated splenocytes or serum antibody levels. Susceptibility to anaphylaxis after 
anti-IFN-y treatment correlated with a significant increase in mucosal mast cell protease 
levels in the serum and intestinal tissue, normalising levels to those seen in wildtype 
mice. 
Several studies show in vitro inhibition of mast cell degranulation by IFN-y , mediated by 
nitric oxide (NO) 70, 71, The source of this NO is thought to be accessory cells such as 
macrophages, as it is known that IFN-y binds to the glycosaminoglycan dermatan sulfate 
on mast cells, and is then presented to the IFN-y receptor on macrophages to induce NO 
72. The loss of resistance to anaphylaxis in anti-IFN-y treated mice was associated with a 
six-fold increase in serum MMCP-l, a marker of mast cell degranUlation. In this model 
unlike in the model used by Strait et al 33, IgG-dependent anaphylaxis was not associated 
with suppression of mast cell degranulation and mast cell degranulation occurred in anti-
IgE treated mice, indicating that IgG-mediated mast cell degranulation may have 
occurred. Previous studies have shown that a functional FCERl is not required for mast 
cell degranulation 23and that Fcy~II-dependent mast cell degranulation can occur 73, 
Preliminary data from an experiment where partial mast cell depletion was achieved 
indicates that mast cells may mediate anaphylaxis in this model. Therefore, it is feasible 
that IFN-y reduced the severity of anaphylaxis by inhibiting mast cell degranulation. 
Recently it has been shown that MMCP-l directly increases intestinal permeability 32. 
The observed association between fatality of anaphylaxis and intestinal oedema indicates 
that the suppression of MMCP-I levels may provide a mechanism through which IFN-y 
reduces the severity of anaphylaxis, 
In humans, successful allergen-specific immunotherapy is often associated with increased 
IFN-y and IL-lO, rather than a decrease in 1b2 cytokines 74-76, Recombinant IFN-y has 
been used in clinical trials to treat atopic eczema, where it proved effective at alleviating 
skin symptoms and led to an une~pected improvement in concurrent rhinitis 77-80. The 
therapy did not decrease IgE levels, but was associated with a decrease in eosinophil and 
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lymphocyte counts 77,78,80. Our data suggest that more studies are needed on the effector 
mechanisms of IFN-y in allergic responses, as CD4+ T cell IL-4Ra. -/- mice were 
, 
protected against anaphylaxis even in the presence ofIgE, IgG 1 and Th2 cytokines. 
Several factors could contribute towards the high levels of IFN-y found in CD4+ T-cell 
specific IL,-4Ra. deficient mice. Anti-CD4 treatment indicated that the primary source of 
IFN-y was CD4+ cells. Naive CD4+ T-cells in these mice are unable to respond to IL-4 
and IL-13 signaling 43, and are therefore likely to differentiate into Thl cells. Non-CD4+ 
T cells bearing the IL-4Ra. remain IL-4/IL-13 responsive, and IL-4 is known to instruct 
dendritic cells to produce IL-12, which would strengthen the Thl pathway 81,82. Raised 
numbers ofIFN-y producing cells and increased IFN-y production in CD4+ T-:-cell specific 
IL-4Ra. -/- mice were found not only in our model, but also in other disease models 
studied in our laboratory, including Leishmaniasis and Schistosomiasis 43, 83. Despite 
experiments designed to explain this, the reason is as yet unclear. 
Future experiments will attempt to clarify whether anaphylaxis in this model is mediated 
by mast cells or macrophages. At present, the data show that IFN-y depletion restores in . . 
vivo mast cell degranulation and anaphylactic reactions in generally resistant CD4+ T-cell 
specific IL-4Ra -/- mice. This strongly suggests a protective role for IFN-y at the effector 
level in anaphylaxis and highlights the importance of IL-4Ra signalling on CD4+ T-cells 
in anaphylactic pathways. 
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Ihtkgrou nd: Larvae of the roundworm ,.Jul:wHs arc commonly found parasitizing fish. 
and can cause dermatitis in people frequently handling or exposed 10 fish, such as 
seafood processing workers. 
?llctb"d5: A murine model was established to Sludy local pathology and syst..'TI1ic 
senll\i~.ation following epicutancous exposure to ;In/suKis larval nnl!gcns Biologically 
relc\'ant sensitization was assessed by intravenous challenge with AnisaK;s proteins. 
Several different gene deficient mice were used to eharact~ri7.<: the rol<:5 ofIL-4, ]L· IJ 
and the lL-4Ra, while recently gcnemtcd CO·t' T·eell specific lL-4Ra defIcient 
(Ld""IL . ./Ra-llo,) and macrophage/neutrophil specific lL-4Ru deficient (Lys,,-"f"]L. 
'/Ra..rm.) mice "ere used 10 delermine cell-speci"c requirements for [L-4flL·13 
I~e~uhs: Epicutaneous sensitization with An;saKis larval ant igens induced local 
intlammatioll. ('Pidern1;lJ hyperplasia, Th2 eytokines. and production of IlJl1i·AnisaKis JgE 
and JgG I. Intravenous challenge of sensitized mice resulted in anaphylactic shock. Skin 
Inflammation was IL·4 indepcndel11 but 11.·13 dependent. while systemic anaphylaxis 
reactions were partially JL·./ dependent. MacrophageJneutrophil specific expression of 
the [L·4Ra was not required for anaphylaxis but exacerbated skin inflammation. T-cell 
specific IL·4Ra dcficient mice experienced partial inhibition of systemic anaphylaxis, 
despite showing skin inflammation comparable \Q that of wildtypc micc. lbis illustratcs 
the necessity for cell specific cvalu.1lion of I L·~![L·13 responsiveness during allergic 
responses 
COlldus;on s~ IL·./. iL·13 and the IL-4Ra. play importall1 and distinCl roles in Al1iJakis· 
induced dennatitis and associated systemic sensit il.alion in mice. Cell·specific IL-4Ril + 
mice may aid in the elucidation' of the mechanisms of eczema and systemic sensiti:attion 






















Figure 4.2.1. SlrucluR of the skin . The top layer of the skin is ealk'<lthe epidermis.. and 
pro\'ide~ a barrier against injury and harmful microorganism~. Tit.) <,pidennis consists of 
seye .... 11 layers of cornifying epid<'nnal cells (keratinocytcs). The lowest layer is the 
stratum genninati\"wn Or stratum basale. mlldc up of columnar epithelial edl~ which 
gradua!ly grow closer to the surface and cornify (keratinize) to fonn the stralUm corneum. 
the hardened topmost layer of the skin. Below the epidennis is the dennis, composed of 
connective tissue and penetrated b~' sebaceous glands. sweat glands. hair follicles.. nerves.. 
blood vesscls and lymph ducts. Oil SCCn::tl'<l by the scbaceous glands helps to lubricate 
the skin and contains antimicrobial molecules thai help protect against infection. Finally. 
below the dennis is the hwodennis. containing subcutaneous fat which provides 
insulation and a cushion for the internal organs. Figun: from: 
www.agen.ull.cdul-chyn/age20621lectl1cct_19il7-l.gif. 
.u INTROI}UCTION 
.-l"i$akis si",pl('¥ Ius been implicated in aUergic skm di$ease. mcluding urticaria. cont~ct 
dennlllitis an..! atopic dennatitis P [11 a r«enl cros!Hrecliona[ epidemiological siudy of 
57& fish processing ,'orkcl'S pcrfonnoo by the Occupanonal and EII,ironmenla[ Hca[lh 
Unil of the University of Cape Town. workers sensilized to Anfsair./J were almos"wke II.S 
likely 10 report skin symploms upon direct COninel with fish than non-sensitized woi'ken 
(Odds Rallo (OR) 1.9: Ccnfidence imerval (e[). 1.0·).6) 1 Not all woO:el'S sensitized 10 
AnisaA:is demcnstr:u~-d allergic symplcms. but atopic workers (pos tli'e SPT 10 one or 
mOre inh:l!anl alle rgens) had a )·fold I'll' more increased rist.. of presenung w'lm an 
A IlIS11kls·relaled al1eflpc disease than non·atopic worl.:t'T1I_ 
This indicates that workers frequently handling or exposed to fish could be at an 
Increased risk of becoming semilized to Anisuus, and tltat sensitization is a risk factor fot 
ol lersic disease Possible routes of sensitization include ingCSlion of infested [ish I. J, 
mhalalion of airborne Anisakis allergens I. ~ or dlle",' conlact wilh Anis(lkls protem! in 
Jish I. I. As it has ne"eT been directly demonstnl1oo th:u direct contaci wuh Animkis 
protems can cause sensltizalion. our laboratory decided 10 lInempi 10 set up an 
e:'lpcnmentalmouse mO<k1 of Anlsakfs·imluccd dermatitis . 
. U . I ,\ lIergk skin di~C:lst 
1ne skin fonm Wl Important physical and protecti"e barrier between the body and the 
surrounding en' ironment. and eneoumel'l a large number of an tigens at its surfnce ! ~ (Fig 
<I 2_1). In order to deal with lhelle Onllgl'ns the skin rehes on components of the irulllit Wld 
adapli"e immullC S)$tem. both well-represented in this tissue II (Fig. 4.2.2). Responses 
arc regufaltU by a Wide army of e~ tokiTltS and chcmokines Il. If d)'sregulalion occurs. 
allergiC d1sease mp), l't'Sult. AlleTgie lii~ases of the skin can be broadly dh'ided imo 
unicllI13.. plierglc contact dermatlt!! and eczema/atopIc dennamls ". lJ. 
" .2.2. Urtica ri~ 
Urticaria is an outbreak of cutnncous '\he~Js caused by transient. localized artas of 
oedema within the s~in dllC to mast cell degranulation and hi~tamule release. and rna)' be 
'"' 
acute or chronic II , I' Il ChroniC unicana refers to 1.1I1karia that has rec~ at least 
i";ce a week for at least 6 ,,~ks. The "heals mitially ruwe pale centres surrowtdcd by 
erythcmll., subsequently becomina mOIl: unifonnly pink. in colour. A .... heal IS USU311) 
pruntic. WId resolves witJun 24 hours of onset in most cases II . u. When oedmatous 
lesions affect the deeper la)1'1S of the s~in or the mocous membrane tissue, the)' lire 
refem:d to as angioedema This can be dan~erous if it alTects the oropharynx. ClIITetlt 
trcaunrnl. in order of "reference. Includes avoIdance of triggers. rlOn-sedatma anti_ 
histamines. sedaring :lIui-hist3IT\m~'S and immwlOsuppressivcs such as cortIcosteroids and 
c)'tlosponne 11 
Factors that can trigger mast cell delVOnu!~tion wiihin ihe skin to cause unicana Inc:lude 
phYSical (actolS such as cold. heal. sunlight and prcssure. medications. mfections. roods. 
and chronic inflammatory, autoimmune or sytemlc disc3liCS. Approximarely half of 
chronic urticaria cases DTe idiopalhic II. I. II In about 30-50"4 of pallmls. autoantibodies 
against the alpha subunity of the hIgh affiMy IgE m;o:pLOI" (FecRI) are im"licated II. 16 ". 
Imcreslingly. 0 recent study found ihat Ani.wki! was g leading <:ause of chrome idiopalhic 
unicaria in an endemic area J. Pre\'iol.l5 studies had a5SQ1,;lated Anisukis sensniz:llion \>,;th 
acute outbreaks. ofunicana due to ing<!!il1on offish and other seafoods t.1. '. 
~ .LJ Contllc i dermatitis 
('ontaet dermatitis refcrs to WI eczematous skin disease cllaracterized by inflammation 
and I.tchini: II . It !lrimanly affects adults. crut be initiated by p wide range of irritants and 
allergens, and is particularly important in (he occupallooal setung. In many countries it is 
tile leading cause of occupational disease. WId is a major cause of lost working lime and 
morhidlty. especially when chronic II. II. It Combined \>,;th medical expenses, tlllS places 
financi al 51111in on both Ihe patIent WId the employer 
Contact dennatlus can be broodly divided mto irritantlnonallerillc contact dermatilis and 
anergic contact dermatitis II . l1. tl . IrriUlI\t con\lI(\ dCtm:ltll15 (the more common disease) 
is CBusN b) Wlllgcn non-specific C}10toxicity. while a]lerg)C eontad deml atitis is llie 
result of an antigen-specific I}m!lhocyte-medl.ated hyperscnsi1i vity reaction, also !mown 
--_. 
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Figlll'l' 4.2.2 ImmuDe fe lls in Ih t . k ln. Anlig\'n-pl'\'S'l'nling (ells called Lal'll;l.'rhans cells 
inspe<! liM: epidermis ior antlsens 1001 may pem'H-al~ the prou,'(:livt upper layers of the 
epidermis through m«:hanical damage The dennis. ulKkrlying the- epidermis. is 
iniillr.tled by blood and I)'mph H~S$orls ihroullh "hieh immune cell, such as lymphOC)'les. 
mllS! ceUs and eosinophil! rna) enter the skin. FiGure.' modi lied from: 
bnp) mrJanoma.b!ogsomc com~OO6i03 
and ""\\ '" .lM:althandage. C'Qtn/hlml/resi pO mer/skUl. h\ mn 
'" 
epidermis 
as COflIIlCI MnsitivilY (CS). CS has be~n considered a subtype of delayed type 
hyperscru;iti\'ity (OTH) as both a~ T-ccll m~dialed 11.20.21. Howcver, ~ccmly it has b«n 
shown thai the mechanisms In~oJ~ed in CS and OTH IIrc different 21. 11. OTH is 
dependent on CD4 ' T cells, whilc CS is dependent on COS' T cclls with CD4' T cells 
performing" regulatory function :u. 11 Furthermore. antigens Ihm cause OTH ore 
typically lurge. solublt proteins. while CS is caused by baplClls such as small. 
hydrophobic. eleclrophilic mokcules or metal ions (e.g. nickel) lhat become 
IInmwmgenic after bmdlTlg to host pruleiru; or peptides II. 2'. ~ 
Most cont:lCt allergens are also lmtants ", alld seem 10 pro,'oke II cascade of pro-
Inflammatory c)'tokines thlll causcs activaled I..anGerham cells or dermal dendntic cells 
10 Imgrnte to the skin dminmg lymph nodn, where they mediate thc diffemlliation of 
tllihe T cell' mto memory CDS' T cells 11.22. 2., Memory CDS' T cells circulate In the 
blood urlli! a second exposure 10 the sensitil:ing Ill1tigen, .... tlich causcs them 10 home to 
the antigen·exposed skin The cytotoxicity of the CDS' effector cells appears to play the 
he) role in cauSIng comacl dermtllius. as well as tMir produclion of ]Mie amounts of 
IFN·)'. w)uch stimulates kel"lltinoc)·te apoplosis II.~. CD4' T cells IlTC thought to playa 
rcgulamr)" role:J. In mice. C04' Th2 cells downregulau Inflammation in CS m a manner 
Ihal appears to be regul9tcd b)" Th2 C)10kirltS such as IL.1J 2', "hill' CD4' Thl cells 
contribute to the pathology o f comact dermatitis by increasmg inflammation 21. 
OccasioTlally the lileTlltw"c refCTllto "protein contllCt dermalll;s" This is an IgE-associaled 
disease caused by tM absorption of protein through danmged s lln, and is th~trorc lthly 
to be a (onn of eczema and 001 a subMt ofaUerglc Contacl dermalitls, ..... hlch Is kIlov.ll to 
be media/ed by CDS' T cells and TIll cells IJ.,..JII. 
4.2.4 Atopic dtrm:..t il i~/caema 
Atopic dermatitis (AD) has been described as II "chronic, ~!apsing inflrunmator) 5kin 
. disease thai is characterized by puritic ec1.CTl\3l.0US lesions" 11. It can appear in mild forms 
(a f(""o\ dT)' eczematous patches) to se\"~e forms (e~ tensi\"e erymcmalo\l! rash) and is 
often associated "1m olh~ allergic diseases such lIS Muml;S and asthma II. 12 Ingestion of 
'" 
food allergens and exposure to aeroallergens are two common causes of eruptions 32-36, 
Around 70-80% of adult patients have AD that is associated with IgE production against 
environmental allergens, labelled "extrinsic AD", while the remaining 20-30% have low 
IgE levels, do not show sensitization to allergens, and are classified as having "intrinsic 
AD" 37, Recently the term "eczema" has been proposed by the World Allergy 
Organization to replace "atopic dermatitis", with the term "extrinsic AD" to be replaced 
by "atopic eczema" and the term "intrinsic AD" to be replaced by "nonatopic eczema" 13, 
This is perhaps a better terminology, as the term "atopic dermatitis" may be slightly 
misleading in that not all sufferers are atopic, Therefore from hereon the new terminology 
will be used, 
Eczema often begins in infancy, frequently in individuals with a family history of atopy, 
and resolves around puberty but may reoccur in adulthood 31, While eczema can also 
appear for the first time in adulthood, individuals with eczema in early life are at an 
increased risk of developing work-related eczema later on 11, 18, The lifetime prevalence 
of eczema is 1-3% in adults and 10-20% in children 38, 
Eczema is a genetically complex, familially transmitted disease 32, Genetic linkage 
studies have identified several chromosomal regions with linkage to eczema 39, These 
include regions which contain a clustered family ofTh2 cytokine genes (IL-3, IL-4, IL-5 
and IL-13), and genes believed to be involved in skin inflammation, amongst others, 
Eczema patients frequently have intrinsic defects in the lipid composition of the skin that 
result in increased transepidermal water loss, severe dryness, and impairment of the 
barrier function of the skin (reviewed by Novak et al, 2003)32, In the working 
environment, "wet work" or chronic friction can cause similar disruption of the epidermal 
barrier, In both cases, the result is a higher permeability to irritants and allergens as well 
as increased susceptibility to microbes such as Staphyloccous aureus and yeasts that 
contribute to inflammation in the skin 11,40,41, The mechanical damage to the skin caused 
by scratching during the active inflammatory phase of eczeIJ1a (which is accompanied by 
severe pruritis) further disrupts the skin barrier and triggers release of various 
inflammatory mediators, making eczema a self-perpetuating disease32, Furthermore, in 
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severe eczema certain intracellular proteins released from cells through mechanical 
damage can function as autoallergens, exacerbating the inflammation 42. 
4.2.4.1 The burden of eczema 
Spergel and Paller (2003) review the effect of eczema on the quality of life in infants, 
children and adolesce~ts 43. Chronic itching and scratching as well as disrupti~n of sleep 
combine to adversely affect school performance, sports and social relationships. Children 
with eczema frequently display psychological abnormalities, behavioural problems, mood 
changes and hyperactivity, anxiety, distress, poor-self esteem, lack of self-confidence and 
embarrassment over their disfiguring lesions. The disease also places a burden on the 
caregivers and families of patients, resulting in stress and disruption of sleep in the 
caregiver, family dysfunction, and financial strain due to medical expenses, the cost of 
special food, bedding or clothes, and interference with the employment of the caregiver. 
Occupational skin disease can also strongly impact the quality of life and is the most 
frequently reported occupational disease in many countries 44. Workers may require a 
change of environment if the disease is due to an allergen that cannot be avoiqed or if the 
job involves repeated, unavoidable exposure to cutaneous irritants such as water, soaps 
and solvents 45. If alternative jobs are not available this can result in unemployment. 
Food-related occupational eczema has been associated with a higher risk of job loss, 
particularly as hygiene regulations may restrict people with hand eczema from working 
with food 46. Sensitization to common environmental allergens such as nickel, rubber or 
foods means that the disease can persist even after removal from the working 
environment 18. Furthermore, a delay in treatment can allow the dermatitis to develop into 
an endogenous, self-perpetuating disease from which recovery is limited, even if the 
original sensitizing agents are avoided 18,42, 
4.2.4.2 The atopic march 
Eczema is often the ?rst manifestation in the typical age-related sequenc~ of atopic 
diseases known as the "atopic march" 43. It commonly occurs in the early years of life 
and then regresses, while respiratory diseases manifest later. Eczema occurs within the 
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first 5 years in 85% of individuals, and within the first year in 60% of individuals 47, 
Approximately half of all eczema patients go on to develop asthma, while as many as 
two-thirds develop allergic rhinitis 43, The severity of eczema has been related to the 
likelihood of developing later respiratory allergy 48,49, 
As the elinical signs of eczema pre-date the development of otlter allergic diseases, it has 
been suggested that eczema could be an "entry point" for subsequent allergic disease, 
with cutaneous exposure acting as an important route of sensitization to allergens 27,43, so, 
5 I. The fact that one of the cardinal features of eczema is a genetic defect in skin barrier 
function which allows for penetration of allergens into the immune network lends support 
to this theory 38. Lack et al found that atopic children exposed to peanut oil in baby 
creams had an increased risk of developing peanut allergy 51, In another study, non-
asthmatic patients with eczema and sensitization to house dust-mites (HDM), 
demonstrated airway hyperreactivity to HDM challenge, suggesting that the skin could be 
a site at which primary sensitization occurs 52, Similarly, in mouse models, epicutaneous 
application of ovalbumin (OV A) results in elevated serum IgE levels, Th2-skewed 
responses and airway hyperresponsiveness to OVA 27,53, while epicutaneous sensitization 
with Aspergillus fumigatus strongly predisposes mice to nasal responses 54, 
It is thought that memory Th2 cells generated through epicutaneous exposure to allergens 
circulate in the body, passing through sites such as the lungs and nasal mucosa 27,43, 
Eczema patients have increased numbers of Th2 cells and decreased numbers of Thl 
cells in the peripheral blood 55, Inhalation of allergens could activate these memory cells, 
resulting in an environment rich in Th2 cytokines 27, Presentation of allergen by dendritic 
cells to rullve T cells in such an environment would cause further Th2 skewing 27, 56, 
Together this would promote allergic responses such as eosinophilia, mucus 
hypersecretion and mast cell proliferation, If the cutaneous route of exposure to allergens 
does play a primary role in the development of allergic diseases, it is possible that 
interve~tion at the eczema stage could prevent or reduce su~sequent forms of allergic 
disease such as asthma, a disease which can be life-threatening and for which there is no 
cure 43, Already, recent trials have investigated the effects of anti-histamine 
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administration on preventing the development of asthma in eczema patients, with 
promising results in certain subgroups of patients (reviewed by Sperge12003) 43, In order 
to optimize preventative therapies, it will be necessary to understand the mechanisms 
controlling the sensitization process 27, 
4.2.4.3 The immunopath'ology of eczema 
Immunologically, eczema is characterized by inflammatory cell infiltration and 
upregulation of inflammatory cytokines in the skin, accompanied by raised levels of 
serum 19E in the case of atopic eczema 57, In acute lesions the infiltrate is composed 
primarily of CD4+ memory T cells, while in chronic lesions there is a marked 
inflammation composed of eosinophils, lymphocytes, monocytes/macrophages, 
Langerhans cells, inflammatory dendritic epidermal cells (IDECs) and mast cells, 
accompanied by epidermal hyperplasia, spongiosis, dermal thickening and parakeratosis 
11,31,32, 57, 58, Both atopic and nona topic eczema have associated eosinophilia 38, 
The process of eczema is thought to begin when allergens entering a barrier-disrupted 
skin are carried to the skin-draining lymph nodes by antigen presenting cells such as , , 
Langerhans cells or IDECs 32, Here the antigen presenting cells cause the differentiation 
of nai've T cells into CD4+ memory T cells with the skin homing receptor CLA 38, These 
cells circulate until a second encounter between the skin and the sensitizing antigen, In 
acute atopic eczema, Th2 skewing is seen, with low levels of IFN-y and high levels of IL-
4, IL-5 and IL-13 produced in the skin, and increased numbers of IL-4 and IL-5 
producing Th2 cells in the blood 11.38, In contrast, less IL-4 and IL-13 is produced in 
nonatopic eczema 38. 
Upon a second exposure to antigen, Th2 cells release an array of cytokines and 
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Figure -\.2.3 ImmunF mechanisms in CC7.Cma. From Leung (200.J)J'. T cells cxp~ssing 
the skin homing receptor CLA ci rculate through the skin. In the pn.:scnce Qf IL·..\. 1112 
differentiation occurs. resulting in Ihe recruitment of dfo:ctor cells and thc release of 
inn~mmalOry mcdimors from mast cl."lIs. Scratching and exposure to mic robial toxins 
acti>'atcs kcralinOC)1eS to release proinflamm3lory c>1okincs and ch~'T11okincs !hal 
facilil3lC the cXlra\'asion of intlnrnmatory cclJ~ ,mo the skin. including IDEes. 
macrophagcs (MojI) and eosinophils. Inflammmory cells produce IL-12. resulting in a 
switch 10 a Thl-c)10kim: environment wilh increased IFN-y expression. 
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rosinophlls. mononu.cll'at cells. dendnl;e cells and masl cells. Chronic eczema IS 
associated wilh increased numbers of IIlflamm:llOl"} cells that produce rL-12, resulting in 
11 switch to H Thl cytokine environment with increased IFN-y production l ' (Flg- 4.22). 
Chrnlllc lesions undergo tissue remodelling wilh oollagen dl'posnion, resulting in the 
fOnTIation of thicken cd. hchl."nificd plaques and dry fibrotic papules 1', These lesions have 
fewer IL-4 and IL-U mRl>1A C'Xpressing cells. but mol\" IL- 12, IFN-y. IL-S and G\-I-CSF 
c:<o;prcslllg cells than in ocute AD 11 . .\1 O\'Crnll, studies III mice ha\e indicated thai boll! 
Thl and 1h1 cytokines play important roles in dennall1is, as do a wide vanct} of 
chcmokines (e.g. rola.~in. RANTES. TARC) thaI stimulate migralinn of inflammmory 
cells inlO the sb.in II.ll.!J . .I9. 
4.2.-1.4 IL-4 and IL- 13 in eCUIII~ 
Specific polymorphisms in Ihe genes for IL--I, !L--IRa and Ihe Th2-associated 
trnnscription factor STA T6 are significantl} associated with eczema 39. Sl. 6Q, 61. However, 
STAT6 _f_ mice rClallllhe abilit) to develop eczema despne defects in ru responses ... · 
62. Recently , un ilSSociation has been found between dIStinct polymorph isms III the Il-
4Ret and atopic \'ersu~ nonatopic eczem~ 61. Together lhese dala suggest Ihat IL-4. Il- L) 
andlor the IL-4Rn may be of Sp«:ial impnnance in the atQllic fonn of eczemll.. which is 
llSSOCiatcd Wilh other atopic diseases such lIS allergic rhinitis. IlSthma and food allergies 
11. This would indicate a particular importance in sensitization to allergens and associuted 
alkrgic responses, in addition to any possible role in the pathology of AD lesions. 
;"1ochanisms of eczema are currently being investigated in various Inbornloncs using 
OVA-based models. These models commonly involve repealed epiculanenus application 
of OVA. resulting in local dcnnatilis with intilnntion of eo sino phi Is and CD"- T cells. 
increased Th2 mRNA e:<o;prc:ssion in Ihc skin and rdisoo levels of total and specific IgE in 
the senml n. In these ways this model succcsfu!ly mimics atopic eC7.1:ma. and i$ 
therefore useful for elucidallng the roles of various C} tokines and ch~mokincs in thi$ 
disease. To d91e, several pubhcation.~ have c.~plored the roles of IL-4 HnJinr 11.-13 in 
murine models of c:czems. 
'" 
Spcrgel el al found lhat eotaxin lORNA expression and eosinophil infiltration was 
decreased in the sensitized skin of IL-4 -/. mice. while numbers of infiltratmg T cells. 
particularly CD4· T cells. were grealer 6J. Serum IgE levels were dras tically reduced. 
while Ig02a levels were increased. ilnd Thl cytokille expression was inc reased in the 
skm. I~owe\'er. IL·4 -f- mice had normal thickcnin.g of the skin. and equivalent blood 
eosinophil !c~'els when compared to wildtypc mice. lntere<;tingly. transgenic mice 
conslitutil'dy expressin.g 11..-4 in. the basal epidermis spontaneously developed n skin 
disease resembling chronic ecz.ema in humans. complete ",jlh [gE production "'. One 
could th~rcfore speculate that delltlfttitis in IL-4 -1- mice r\'semblcs nonatopic eczema in 
humans. "here inflammatory skin di sease is present without rJised levels of serum 19E. 
whereas eczema in the presence of [1..-4 marc resembles atopic eczema. 
Herrick N al investigated the role oflL-I and 11..- 13 in the generation ofTh2 responses 
and ai rway hyperreactivilY following epicutaneous sensitization 11.~~. They found that [L· 
4 ./. mke maintained airway inflammation (increased total cells and eosinophils in BAL. 
mucus hypcrs~cretion) and Th2 aClivation (cells producing lL-5 and IL-13 in the lungs) 
after inhalational challenge, though IgG2a was increased and IgE and IgO I decreased as 
in Ihe research by Spergel et ai, 61. This "'as in comrast 10 mice' that w~re initiully 
sensitized by the inhalational route. which sho\\ol'd dependence on IL-.j for Th2 respCllI5es 
and airway hyperreactivit)', Additional studies showl"d that lung inflammatory responses. 
IgO I production and 11. -5 produced by skin-draining I}'mph nodes \\'cre decreased in IL-
\3 depiction and IL-13 -f- mice. lbis led the authors to conclude thaI lL-13 was the key 
cywkin\' involved in gCOI:ralion ofTh2 activation aftcr epieutancous sensitization n. 6!1 • 
.1.2.5 ,\ im s (If I he cur."nt s t ud)' 
fhe first aim ofille current sludy Wd.5 III J~l~rminc "~lh~r Anil'ukis pWlein,; are able to 
cause dennntitis and/or systemic sensitization Ihrough epicutaneous exposUfl". To date. 
models of eczema or protein contact dermatitis have primarily used OVA, and it has been 
shown that responses to other allergens or 10 crude extracts can differ from TI."SPOllSl'S to 
OVA S-I Until recently it was assumed that inhalational exposure 10 a1krgcns was the 
cause of sen~il1Zntion leading to diseasl'S such as rhinitis and asthma 61. However since 
2t5 
m:ent data has indicated thaI epicutaneous exposure could lead to reSpltlltOI') 
hyp:moactivity, it is important to determi~ how relevant epicuat~nous sensitization is in 
terms of the risk of developing allergic disea5e In temlS of Anl$(lk/s exposure. fish 
pro~"ing workers arc- at panicuJar risk, as are people who frequently prepare fish in the: 
domestic en,ironment, In thc: course of a study of occ,upalion~l diseases in local $CafQOd 
processing factones undertaken. by the Occ~tional and Environmenlal Heahh Unit IJf 
UCT. it became clear that not all workers use glOl'es while processing fish. Reasons for 
this include disromfon caused by sweating inside tlK: glo''es or by liquids enlenng the 
gloves while working. al lergy 10 the gloves lhemseh·es. or reduced e!lSl!" in handling !ish 
or processing machines. In addition. workers wflo wear glo>es still often have Vare nrm~ 
and can easily be splashed wilh fish JUICes containing various allergemc prote ins. In the 
domestic en'·lmnmall. prople do not usually wear glo"cs when handling fish Man) 
people I ha,'e spoken to have reponed 5eelllg "'-OmtS while prepanng snoek. a fish thaI is 
eaten 1000aJly and IS commonly infested wllh Anuat!$. 
The second 31m oflhe study was to funher elucidale the differenual roles of IL-4 and IL· 
l3 in local pathology and systemic sensitization caused by epicutaneous !llkl'KC11 
exposure. and in addition 10 ddenmne !he role of the: IL-4Ra in these proces!iC.'s. As the 
immunopathogerrsis behind protem-induced dennatitis remams undrar, the Import:lnCr 
of IL-4Rn expres,ion on specific crll typcs ",as also in\"e5ugated. PreVIous models of 
eczema in mi~ have demol'lSU'lIted that cell! inliltr.Jtmg mto 1M drrml5 are 
predominantly CD4' T cells and macrophagrs 'l Therefore tbe fole of IL-4Ro. 
expression on CD4' T cells and on macropllages "'as invcstigated using CD4' T cell 
specific IL-4Rn . /. mice (Lck"·IL.4Ra ..... ) and macrophagr neutrophil sJ'ttlfic 
1L-4Ra.f- mice (I.ys~tcIL_4Rn·1o·). 
"'ic~ 
OALBc mtC~ (8-10-" k-old) and 1l-4 _/_ 0Ii_ Il.U ./. ", IL-41J3 ./. ~I , IL-4Ra _/ ... , 
(,D4- T ull spa:ilic IL·4Ra -/. (LckCIC IL-4Ra"""j 13 and macrophage/neutrophil Sj)«tfic 
IL-4Ra -I. (LysMt " IL.4Ra ..... • )'t mice (a ll BALBfc background) were used from in. 
hoous~ breeding colomes. All mice were housed under SPF barrier conduions using 
iruh~idu:tt vcntitatf:J cages (lVC) in the animal facility at the UniH'rsilY of Cape To"n. 
South Africa. All experiments comphed "ith the South African Code of Practice. III1d 
were approved by the University of Cape Town Ethic R~arch C(Hnmiuee (ERC). Mice 
were i:cnotyped by PCR b)' staff of the Division o( Imrmmo!og,)'. 
An/S(lkls prgrl!bil lil/'Vae (Ll) were collected from the intestines of parasitiud rish 
(ThyrsiuJ IIIUIl ) "ith forceps, and ex tensIvely washed in 4·~ acetic acid and phosphnte· 
buffered salme (PBS) (Appendtx 1\). The ll\f\'x were (rozeo. homogroized in PBS and 
somcatro to lyse celli The extract ,,-as ptpened Into 2m! eppcndorfs and ccntrifuged al 
14000rpm for 20·30 minutes 10 remo\c part iculate maUer. then li lh:r·steril ized throuGh n 
0.20,lm filter (SmtorilJ:!;. Goetlingcn. Gennany). PrOlein concentralion was measured by 
Bel\ lest (Pierce. Rockford. llhllOis, U.S.A.) according 10 the manufacturer's prolOcol. 
Sl'nSilizlll ion !ichwull' 
Mice wert anaesthetized wllh 2()(\11 of kctaminc (AMket·V; Cent:lur Labs, 
Joo!l!lllCsburg. Soulh Africa)! xylazin~ (Rompwl; Bayer, lsando. South Africa) 
anaesthetic (Appendix A) and a small mca of rhl' abdomen was sha~ed, A volwne of 
100[J1 conntimng 200[Jg of filter·steri liz~d Allisakis protein e)(trllCl was applied \0 a ] )( 
lem gauze patch secured to Ih~ skin with t ran.sp~ renl hypoallergtnic plaster (B:md·A1d~. 
Johnson and Johnson, .. 'ustralia). Afi er one "'eek Ihe patches "ere removed. Two weeks 
later a second p~tch was applied in the same location, A tOlal of Ihree- p~lches were 
applied, separated by two· week imen'als. 
m 
A shoncnt'd version ofthc protocol was found to )'icld lite same results. and this protocol 
was sub!lequently used In experim('l\lS In whitll the endpoint 1'0115 an mll'D~enoU3 
Chalk-fiSC In thIs protocol. the first patch was apphed for S da)'s. followed by II 5 day test 
period. This was re~81ed with a second p;!lch. Fin3l1). a third patcll 1'0"11$ llpplied for 5 
days. following ""filch mice werc challenged Intflt\'rflOllSJ) witll 7S0~Lg of Anjsokis 
CXlroC!. 
T flll lle ralUrf rn fas 11 rt'rn ... nt~ 
Rccl:Il temperature r .. adings ""ere taken every 10 mlnutcs using a rnollSC rectal 
themtomC1er (VelTceh. Cheshire. UK) lubrklltcd wllh Vasclin"TM petroleum jdly 
(Urnl ... , er, La Lucia. Soulh Africa). 
Anaph} I~~is Koring Jystcrn 
Mice were observed for 60-70 minute'! post challenge, and signs o f anaphyJaxu Wet ... 
~cored using a modification oh pre~iously descnhed scormg system n. D. no symptoms; 
I. irTl\abi lily. scratching andfor hypcrscnsitl\'it) to touch; 2, reduc.-d attj~ity, pilar tt«1i, 
and/or diarrhoea; 3. lying !lat but Upright. w~alme$$ andlor C)'llIIOSlS around the mouth 
and \ail; 4. lying on side. no activity upon prodding. loss of grip, loss of consciousness 
"ilh or WlthOUI convulsiun,: 5, dC~lb. Mice hcginnlng cOIlVulsioilS in"ariably dial soon 
after, and were therefore euthan.:lsW for hllmll.llC rea.~oll.'l and scored as 5. 
lI istology 
Skin taken from the .'lile of epkutnneoU3 ex~urc was preserved tn 4% phOSphllh:-
buffered fonnahn for at lc:aJt 24 houn and then embedded in wax Paroiftn scclinns of 
SJ.llIl wat cut and fixed 10 slides, and stained wilh haemoloxylin and eosin. 
,\nli-lgE st~ jflinl! 
Tissue samrles were embedded 111 TIssue-Tek oxaea.lcmiol (0C1) compound (Sakllnl 
Finelek U.S.A Inc, Torrence. California. U S.A.), frozen on ill) ice and stored ot-80"C 
Sections of SfIITl were CUI using II LeicH LM ] SSO Cryostat (l.cIea in$l.rumtnl$. ]'o:U$stocll, 
Gcnnany). pluad onlO slides and dried overnight Ot 4"C. The slides "ere fixed in IICC101le 
". 
for 10 minutes at room temperature and allowed to air·dry for 5 minutes. then washed 
4x5 minutes in PBS (Appendix A). Following this the sections WerC blocked for )0 
minutes al room l~mpera\Ure in l<flo rat serum diluted in PBS. The slides were rinsed in 
PBS. then 100).l1 of I Ol-lg/ml PE·la~l1ed anti·lgE (clone 2.3m. Southern Biotechnology. 
Biffilin!;ham. Alabama, U.S.A.) diluted in !'BS was pbced onto the sections and the 
slides were incubah!d for 90 minutes al room temperature. The slides were washed 4x5 
minutes in ]'DS. mounted usi ng fluortscr,nt mounting n~dium (Dako CylomaTion. 
Carpintena. California. U.S.A.) and vie\\ed under a fluorescent microscope. 
RNA ext raction 
Each section of skin was homogeni7.ed in Iml Trizol (Sigma. Steiriheim. Gemmny). The 
oomo,genate was mixed with 1001-11 of49: 1 chlorofonnlisoamyl alcohol. incubated for 15 
minutes on ice and centrifuged for 20 minules at 12000rpm. The upper aqueous phase 
was transferred \0 a new tube and mi~ed with an equal volume of isopropaool \0 
precipiTaTe the RNA . Samples were placed at · 80"( for a minimum of)O miout~s, then 
cenTrifuged fOf 10·)0 minUTes at 14000rpm. The supemlltants were discarded. and the 
pellets Wefe resuspended in 75% alcohol and incubated al room temperature for 15 
minutes. The samples "'ere then centrifuged for 5 minutes at 14000rpm and the 
supernatants were discardrd. Tlw p<'Jlets were air-dried for 15 minutes. and then 
dissolved in 1001-11 DEPC·m:ated water (.o\ppendix A). R.J'<A concentration lind purity 
were assessed by taking readings lit 200·300nm on a sp<'!CtrophOTomNer. following which 
th~ RNA inTegrity was checked by gel electrophoresis. 
RN A gel d cdrophores is 
A fOffilaldehydc denaturing 1 % agarose gel was prepared (App<'!ndi); A) and placed imo a 
gel tank containing MOPS electrophoresis buffer (Appendix A). Samples "ere: prepared 
by mixing 2.61-11 of R.NA (1·2)J.g) with 7.4fd of loading buffer (see App"ndix A) and 
incubaTing tor 5 minutes al 65"C to heat denature the RNA. The samples were cooled on 
ice fOf 5 minutes and loaded 00\0 the gcl in parallel with a bromophenol blue dye running 
marker (Appendi:..: A). then electrophoresed nt 40V until the bromophenol blue dye had 
migrated npproximatd)' Scm. The RNA \0,'35 visualized by plncing tbe gel 00\0 • UV 
transi Iluminalor 
DNAse IrUlmenl of RNA 
DEPC-!realed WIlier (App.-ndix A) was added to I-lOllS of RNA to make up I final 
volume of 4Slll. The RNA W!IS then mixed with 521li of a D~ase I cocktai1 to provide> a 
final concentralion of Ix Firs.! Su-and Buffer (Gibeo. Paisley. Scotland>, 1.0lJllli Roche 
RNAse-free DNAse (Roelle. Mannheim. Germany) and O.4UfIlI Promega RNAsin 
(N25 I I )(l'romq;8 Corporation. Madison. Wisconsin. U.S.A.). The mix ..... as incubated 31 
37"C for 90 minul('S, following ..... lIlcll the D~Asc I was heat deactivated by incubation 81 
6S·C for 15 minutes. Punfication of RNA was perfonned using the RNeBS}' MmElule 
Cll'lnup Kit (Qiagen. !-lImburg, Germany). The concentration and purity of RNA wtte 
assessed h laking readings at 200-JOOnm on a 3j>Cctfopbotometer, and Ihe RNA integnly 
was checked by gel ekctrophore!lis. To test that the RNA "'IS free of genomic D:-<A. 
i'CR WIS performtd using beta·acttn primers that bind 10 lind amplify lip genomic DNA 
(S'-TGGAATCCTGTGG CAT CCAGMAC-3' and S' -TAAAACGCAOCTCAGT 
AACAG·3'). Gmomic DNA was included in Ihe PCR rttn as Q positi \'e control 
eDNA s~ nlhe;,iJ 
The Promega lmProm_I!TM Reverse Trnnsciplion Syst<'Tn (Promega Corponllion. 
Madison. Wisconsin. U.S,A.) wa5 used to synthe5is cDNA. Bndl)·. I ,Sllg of RNA was 
combintd with Olgio(dT)15 printer (O.5/iglreaction):md DEPC water to a 10lal volume of 
2O/i1.:md incubated in It 7{/'C heal block for 5 minutes. The tubes "'ere then chilled for at 
least S minutes ilfld spun in a microfugc to .oliect the condensate A 20j.1l ~olume of 
re\<CTSe InlJIscriptase (RT) cocktail was added 10 each lube and pipelltd up and down to 
mix. 'The samples were incubated In a 25"C heat block for .5 minu[cs to anneal the 
primers 10 the mRN,\. and Ih~n incubated in a slfc waler bath [I) allow extension to take 
piKe rol1O"lng e~tension. the reverse trnnscriptMl: was heal delll:livattd by incubation 
at 7S'C for IS minute!!. The resulting eDNA was aJiquoted and Siored at -20·C. Working 
aliqllOls were storl-d lit 4"C. 
n. 
PCR 
Capillary tubes. caps, tube holders and cppendorfs were UV cross-linked prior 10 uS<:. A 
2) .. tI volume of eDNA sample. diluted standard or ;lutoc[nvcd ddH20 (ncgatiw control) 
was added to 18J.11 of master mix in each capillary lube to yield a final concentration of 
Ix Senslmlx d('J ) (Ulolabo SCientific lnslfU1lll"nts SA. Chatel-SH JclIIs. S,,"lIzerl!llld). Ix 
SYBR green (Bio!lIoo Scientific Inslrumcms SA. Chatel·Sl-Denis. S"ilzerlana). O.5I-lM 
fOrl'.'3rd primer (University of CapC' Town). O.5flM reverse primn (University ofC:spe 
Town), 0.1 mglml BSA (Promega Corporation. Madison. Wisconsin. U.S.A.) and 1.5mM 
MgCb (Promcga COJponl1ion. Mudison. Wisconsin. U.S.A.) . The capillary lUbes (Roche, 
MaJmlieim. Gmuany) were capped and centrifuged for 10 sccond$ at 1000rpm 10 5CUle 
the samples. Capillary tubes were pll! mto the Lighlcycler (Roeh .... M:umheim. G~mlany) 
and processed IlI:cording to th" follo wing progmm: 95"C for I 0 minlll~S 10 activale the 
enzyme. thm 50 cycles of 94"C for 5 sec. 60°C for 10 sec nnd nOc for 15 sec. using the 
follOWing primers: IL-4. 5'-TCGGCAITJTGAACGAGGTC·)' and 5'-
GAAAAGCCCGAAAGAGTCTC-)': IL· 13. S· ·CTCACTGGCTCTGGGCITCA-3' and 
5' -CTCATTAGAAGGCiGCCGT GG·]': lFN·y. 5'-GCrCTGAGACMTGAACGCT-)' 
and 5'-AAAGAGATAATCT GGCfCTGC-)': IL-IO. 5'-
AGCCGGGAAGACAATAACTG-)' and 5' -CATTTCCG ATAAGGCITGG-3·. Data 
were analyzed using Ih,' "fil poinls" and "standard curve method" using the p·2-nctin as a 
hOU.'iekecping gene. 
CulirCliun ur SHurn 
Blood s.amples tnken before challenge were wHeeled intO serum sepnrUloT tubes (BD 
l'>'licrotnincr™ SST. BD. Frankl in Lakes. U.S . .'-\.) by tail vein bleeding und ... r flO infra_red 
healing lamp. Altem3tivcly. blood was tnken from killed mice after cervical dislocation. 
Blood samples were centrifuged for 15 minutes at)ooo TJlm before being pllll:ed at -SO"C 
for storage. 
l\ll\1 CP- 1 ELISA 
MMCP-I levels in serum IICrC measured b) ELISA acrordJnI! 10 the manuflU:turer's 
protocol (Moredun Scienlific Ltd. Midlothian. U.K.). 
Antlgl' n-sptcifk an l liJonly ~:L I S,\ ! 
NuIX Mll)[isorp ELISA plules (Nunc. Reskilde. Imimntk) "ere coated o\'ermght al ~"C 
wllh AniSDkis ('XlTaet or 0'.1 A in PBS ~t 5)Ig/ml (for IgG I. II:G2a. IgG2b) or I mg/ml (rOT 
IgE). then blocked in EUSA block buffer (Appendix .\) for I hour 81 37"c. Plate:'! were 
washed h with ELISA wash buffer (Appendix A). and serum samples small)' diluted In 
ELISA dilulion buffer (Appendix A) were added. Plates were incubated overnight al 4"C. 
then "-ashed 4'( I\tkalinc:·phosphatase (APj.labelled goat-nnll-mouse IgG\. !gG2a. 
IgG2b or IgE. O.S)lglml. (Southern l3iole<:hnology. Bimlingham. Alabama, U.S.A. ) was 
added ror 2 houn al 37"C Plates were washed 4~ and 4-nitrophen)1 phosph~te disodium 
salt hexah)drate (PNP) (Sigma. Steinheim. German)') substrate (SCOI: Appendill AJ was 
added Absorbance WlL'5 measured lit 405010 with 492nm lIS a reference wavelength. using 
a VERSAma.~ tuneable microplate reader (Molecular Devices, Sunnyvale. California, 
U.S.A.) 
Total l j:E EL.lSM 
Sandwich ELISA wa s performed using purified anti-lgE from done 8·UC as a COlIt 
( l)lg.ml) and AP·labelled goat unu-mouse IgE (Southern Biotedmolog). Binningham, 
Abbama. U.S.A.JIIl! a second:l1) 1l1ll1body. according to the protocol outlined above 
(M Antigen-spedfic antibodl ELISA!"). Purified recombinant mome IgE (BD 
Phanningcn, San Diego, US.I\ .) was used as a §tandlrd. 
b(lbti(ln of spltn(l~)"In 
Spleens were asepllcally Tm1O\ed from mice with forceps. and splenocytes were isolated 
b) pressing through a metal sic\(' in IOml I5co,<e'5 !»"odified Dulbecco's Medium 
(IMDM){Gibeo, Paisle)', Scotland). The cells were emlrifuged at 12~nl for 5 minutes.. 
and the: pellet "-as resuspended 10 3-5ml of icr-cold red cell lysis buffer (Appendi~ A). 
After 2-5 miDllI~ on itt, the cells .... ~ centrifuged al l200rpm fot S mlflUles, l'elleted 
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cclls WeTe resuspended in IOmI of IMDM supplemented with I~. FCS (Della, Kcmpton 
I'arl.. Soulh Africa), 2mM 1.+glutamine (Gibro, 1'3ish."Y" Scotland)" 10001g:'ml pt'rucLilin 
(GibeD. Paisley. Scotland) 3Ild lOOllgfml streptomytin{Gibro" Paisley. Scotland) -IlK 
splenocytes Ilere then filtered through a 70llm tell str3rn~r (BD Falcon" Bedford. 
Massathusens" USA.) to remove debris. and diluted I in 10 10 I 1n)0 111th Trypan Blue 
(Sigma. Steinheim. Gerrminy and PBS for counting. 
SJlI"n o~) I t rl'Sl im ula t ion 
Spleooq1es were diluted to ~)( Ht cells/ntl with 1I1--lJ)M (Appendi)! A), and cullllred in 
..18-1'1,:11 plates (Costar. Coming. New York. U.S.A.). with 2S01l1 of cells lIddetl to onc of 
the following: 250111 medIum. wells pre-coated with anti-CD) (cionI.' I~S-2CII: 
IOllglml) o\'Cmight at "oC 10 which 250IlJ of medium had been added. 251lg of conA In 
250J.1I medium. 250j.lJ of200j.ll!:/ml ~"isukl.f e)!lract in medium, 250j.ll of200Ilg/ml Grade 
Vovalbumm (Sigma. Stcinhcim. Gmn3lly) in medium. The cdls were incubated at 31'C 
with 5% CO:!. and supernatants were collected after 48 hours and stored lit -80"C 
Cylokin t ELlSt\s 
Sand"'"1ch ELiSAs were performed to (!ctermtllC eytolo:ine le\tls in cell supernatants. 
Nunc Ma)!isorp EUSA plates (Nunc" RL:"$kilde" Denmark) were coated "1m purifted anti-
11..-..1 (clone IIBII . 21lS ml). anli-IFl\-y (clone An 18KL6, Illg/ml) or anll-Il-5 (I j.lgfml), 
III1ti. IL_9 (2]1giml). ann·1 1..·1) (Illg/ml). llI\ti·[L·I 0 ( 1 j.lgfml)or antl_ TGF.p (O.5Ilg/ml)(all 
SD I'harmingen) diluted in I'BS, and incubated o\"emight at ..I"e. Plates were blo.;ked 
wllh £ 1 ISA I>lnck bum.'r (Appendi)! A) for I hour at rrC. men washed ))! wnh ELISA 
113Sh buITer (Appendl)! A). Serially dtluted standards (purified recomhinant IL-". 11..-5. 
11.-9" 11.+13" IFN-y. 11..·]0 or TGF·p (all SD Pharmingen, SllI\ Diego. U.S.A_» or cell 
supern31l1111, all diluted m ELISA dilutton buffer. w\."re add\."d to the plates. and incubated 
o\·trnight at ,,"C Samples for the detection ofTGF"~ were pre-treatcO wttb a.cid 10 unfold 
the protem for 3ntibody binding (Appcndi)! B). The plates "ere washed 4.~" Wld 
biotinylated goat-3nu-rnousc IL-" (O.5J.lglml). [1..-5 (O.Sj.lg/ml), lL·9 (lj.lgfmJ). [1.+13 
(O_51lg/ml). IFN·y (0.51lg/ml.). IL·IO (O.5Ilg/ml) or TGF-p (O.S]lglml) anlibodie! (all 81) 
I'harmingen. San Diego. U.S.A.) diluted in ELISA dilution buffer were added for) hours 
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:It 37"C. I'bles were washed J x and l)lglml AI'-labelled streptavidin (BD I'harmlngen, 
S~n Diego. U.S.A.) was added for I hour at 37"C. Finally, plates were washed 4x and 
PNP (Sigma. S!einheim, Germany) substrate (Appendix A) was !ldded. Absorb= "as 
measured at J05nm with 492nm as ;I referffic<, wavelength using ;I VERSAmax tunenbJe 
microplate reader (Mol<'Cular Devices, Sunnyvale. California. U.S.A.). Cytokine levels in 
supernntan!s "erc determined by reading from lhe standard cun'e. 
Sta tisTical a llalY5iJ 
Values are gillen as means ~I- SEMs. and significant differences were determined wilh 
the: unpaired 2-tailed Student I test using computer software (GraphPa<iPrism .f.O, 
GraphPad Soflware Inc., San Diego, California. U.S.A.) For allergic score graphs, the 
Mann-Whitney test was perfonned for two experimental groups, and the Kruskal-Wal1is 
tesl wilh Dunn's post tesl for three or more groups. Values P < 0.05 were considered 
significant. 
4.4 RESULTS 
4.4. 1 Epicu t a n cou~ upo~u n to Anisakis ell,.,. CI ind u ces loulized denu9tit is 
Gau7.e JXltches conl9inin,!! PBS. OVA or An/sak/s extract were afli:<ed to small shaved 
areas on Ihl" abdomens of wildtype mice. After epiclltaneous application of both An/sakis 
extract and OVA, a localized dermatitis was Set'll. characterized by epidermal 
hyperplasia.. demlal thickl"ning and infihnuion of immune cells (Fig. 4.4 .1). The 
inflammatory infiltrate consisted primaril}' of mooonudear cells. oeulrophils. 
lymphocytes and eosmophils. No differences were observed belweeo local pathology dlle 
!oJ OVA application and An/sakis application. Mice Wilich were exposed 10 PBS alone 
occasionally showed a very slight increase in epidemlal thickness, possibly due 10 
shaving and application of Ihe patch. Staioiog with anli·lgE revealed the presence of an 
iocreased number of 19£·bearing cells in the dermis of AniS(lkis·sensitiled mice as 
compared to PBS controls (Fig. 44.2). In addition. Anisakis-sensitized mice 
demonstrated an increase in IL-4 and 11. .... 13 mRNA expression, but no change in IfN·)' Or 
IL·IO mRNA expressiOn, as compared to PBS controls (Fig. 4.4.3). 
4 .4.2 Epieul alleous eXflosure 10 A llimkis nt ract causes system ic sensitiza tion 
Followiog cpicutaneous application of Amsakis extract. mice had incr~ased lewis of 
Allisakis·spcdlic IgG 1 und IgE. as well as rais~d total 'gE (Fig. ·1.4.4). Then: wa~ also a 
slight but significant increase in IgG2b levels. Levels of AII/sakis·specific fgG2a were 
barely delectable. .'vIice epicutaneollsly sensitized with OVA produced tile same pattern 
of IgG antibodies, althOUgh total IgE levels were lower than in Allis"ki~··sensitized mice 
(Fig. 4.4.5). The higher levels OflOtal lgE in the Amsakis model may be due to the ability 
of helminth protdns to st imulate a pol}'clonal lgE responSe 7J 
4.J.3 Epieul~neous ClpoS" ~~ to AIJ/.mki,~ u tract caU5~ ~ystem ie Till 5kewing 
Cytokine production was evaluated in skin-draining lymph nodes and splenocytes 
re51lntulaled with antl·CD} or antigen (Anisakis or OVA) (Fig. 4.4.6). Ami·CD3 
restimulated lymph node cells and spl~llOCytes from Allisakis- and O·VA·expo~ mice 
showed a trend towards increased production of Th2 cytokines, but no difference in 
production of the Th I cytokine IFN-)" compared to PBS· exposed mice. Restimulation of 
PBS Anisakis 
OVA 
figure -1..1 .1. Uistoh)gi tal futures of mou~ 5kin epi~ulan",usl} ('JJI'Ised h' PHS, 
Alli"IIki.f exlrae t or OVA. Sections were slained with H.t:E. Photographs .... ere whn .1 
400~. Th~ photographs are representative of 2·) ", .~perimenls. n " -1-5. 
a .--_---'P-.:8:::5::::::5k:::;,,".:":.:&=E=---_--, 
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Fif:ure 4.4.2. Hislo logita l and immunohistochemical ana lys is of PBS. and Ani.mkis_ 
uposro ~ kin . Ii) Skin sccliom werc stained .... illl H&E. The epidermis (E) wid dennis 
(0) are labelled. A"i.<I1~j~·-exposcd skin shows epide""a] hyperplasia. Photographs are 
representative of sew11l1 e"pt..-nmcnIS. II - .. -5 . bl Skin sections werc stained wilh anli-
IgE. Allisakil"oi:xposed skin showed increased IgE·bcaring cells inlhe dermis. Tnc arro" 
indicates an IgE'posiljvc cell. E· epidermis. 0 z dennis. Photogrnphs are representative 
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figur!- ·.IA.3. Lt·wl.~ of 11.-4, 11 ..... 3. IFN-y and IvlO mRNA in skin bio[lSics from 
mk~ erkut9n f(l u ~ l)" l"lposcd 10 PBS or AII;s(Jkis ulran. Levels wcre norm,,!i~~ to 
j3-actin. Each eiTe l<' represents skin from all individl.l31 mouse. P values arc indicated. ' . P 
< 0.05; ", P < 001. 
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Figure -1.-1 .... T (llallgE 3nll Allisuhl"-specifk IgGI, IgG2a and IgG2b mfllsured in 
the serum of micc epirul ilnl.'<lus ly exposed 10 J'llS or A llisakis H lne!. Antibodies 
lI'ere measured by ELISA. The graphs are representative of three experiments- n = 3-5. 
Data presented as mean tl_ SEM Statistical signilicance betll'een pns- and Anl;·akis-
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OVA-!tn ~ ilil.td mke. Antibodies w\,rc lMasumi by ELISA Values below 1M de!:KtiOD 
limi t 3!e indicated by N Results .rt rC'preso:ntall~'e or ''''0 ex!)C'rimcnlS, n - 3-4. Data 
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fiJ,:urc -'...1 .6. Cy' okine prooJocl;on by splrn04.'}.es ~ nd skin-d raining lymph node 
,·c lls fro m epicu ' :ln ~~u ~ ly scnsi' i1.cd mice. C~1I5 from individual spleens (1"1 • 4) and 
pooled lymph nodes (1"1 ~ 4) were reSlimulllled "ith anti-CD) Qr sensitizing antigen 
(OVAlAnisakis extract). SUj>C'malantS were tlI ken al 48 hours and eytokines were 
nle:lSl.lreJ b} ELISA. Data presented as mean +1- SE/l.1 SnllislicaJ significance was 
as~sstd against c)1okmc produclion of cells from PBS control sensilized mice. ' . P< 
0.05. 
11/ 
Iympb nodes from Allisa.tis-cxposed micc ,",'ilb Ani111kis CXlract ibowcd Increased 
production of IL-t3 and IL-IO In particular, with II !rend to ..... ards mmased IL·5 
prodUCIJOD. Howt'wr, OVA-restimulated lymph node ceUs from OVA-clI:poSl:d mice did 
not .how ddT~ntts in cy1M:ine pmdocuon all compared 10 cells from J' BS-cxposed 
mlCIC 
-I ...... In lrannOIl '! ch:atlcngr of fp .. :·ut :lnt'ously scnsit i7fi1 miff Tn" I!~ in M1l3plt) luis 
After the flCmoval of the third patch, mi« npo:sed C'J'Iru\anOusly to PBS. OVA or 
Amsllkis "ere cbilllenged mltalenousl) \11th 750).lG of Anisl.kis or OVA to &ICTImne 
biologically rdcvant sensilizauon (Fig. -1-1.7). Mice in the PBS group did not rlCact 10 
eilher Alli.Klkis or OVA challenge. No signs of anaphylaxis WCn' observc.! and lilt I'ICctal 
temperatures oftre mice rematned consUrlt. In contmSl. OVA or An/sakis sensitized mice 
shov.""d signs of an3pb~!nctic shock witll reduced activity. pilOC'rec1i and tcmpcmture 11m 
after chaltenge. R~taJ tempcralurC'S of OVA-scnsniled and challenged mice Il'maJncd 
decreased for longer than rectal tcmpcmlurlCs o f A nl$Oku-sensitil.l'd and cbaltenged mice 
-I.-I .S TbN"t ap plienlio ll! of A lIisakls U i rlict were required 10 eUd l nnnph~ lui'! II pon 
iu tn.·cnous challcul:c 
Intravenous ebalJcng~s wilb All/sakis eXlral;! .... "re performed after r~mo\"al of lk 5econd 
palch or after removal of the third p~lCh (Fig. 4 ~ 3). Upon challenGe follOWIng rcmo\'Dl 
of the second paH:h. mice ,!boweJ vogue sillns of discontcnt and irritability. bul did not 
have lemperature loss or m,monstral\' si\,;ns of shod (Fig. -1-1 Sa). However. upon 
chaJlenge follo .... inl: remo\·ol of the Iblrd patch. mlCC sbowed signs of shock and 
temperature loss. This demOnStlllle~ thai lhree patchcs were needed in order 10 scJl5ilizc 
mice for ::tnoph) lactic sbofk Thi' probabl) rdlem an Increase in antibody levels 
OCCUlTing bct .... cen lhe second nnd Ihir.! epicutMCOU! nprJicntions of AnislltiJ eXlract 
However. intrawnous aJ\ligen administration caUSC"S 3 decrc3S(' in free onl1bodies in thl> 
serum. so [USA IISS&)S could BOt be used 10 acrurnlely dt1cnnifll: anlibody level!!. 
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Figure ~...I. 1. Anallhylacl ic r~s l)o llses following II1Il'ann clUS chaJlcng\" of 
ellicutaneously sensilizfiJ mice. Mice (n = 3-4) were epicullml'ously exposed 10 PBS. 
A"isakis eXlrac!. or OVA al d~ys 0-5, 11-15 and 21-25. then challenged imravcnously on 
day 2S wilh Anisakis extract or OVA. llalf of the PBS-exposed mice were challenged 
with An;s(!kis extract and the Olh~ r half wilh OVA. No differences were seen between 
Illest' two groups. Rectal Icmpera!llres were recorded for I hour following challenge. 
Reactions were rated using a scoring system (0, no rea<:lions; I, irritability. scnllching 
(Illdior hyperserumivily 10 touch: 2, reduced activity andlor diarrhoea: 3. lying down. 
weakness and/or cyanosis: 4. lying on side. loss of grip. no activity upon prodding, loss 
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Figure 4A.S. Three cpicutallcous uposurcs ... crc ncccsSluy for a"arh),laxi, 
following inlra,·tnou ~ ch ~llellgc. a) An~phyladic responses following intravenous 
challenge of epkutaneously sensitized mice. Mice (n" 4-5) "'"ere epicutanenusly expo~d 
to PBS (three times) or Anisakis Clttracl (two or three limes), men challenged 
intravenously with An;m/ris extract Rcct~1 temperatures were recorded for I hour 
following challenge. Reactions were flitI'd using a scoring system (0, no reactions; l. 
irritability. scmtchlllg and/or hypersensitivity to louch: 2. reduced activity :mdlor 
diarrhoea: 3, lying down. weakness oodlor cyanosis; 4, lying on ~ide, loss of grip. no 
aCli~ily upoo prodding. loss of consciousness with or "ithou\ tonl'ulsions: 5. death.) •••. 
P<O.OOl b) Pouled $plcnucytes (n - 4) were restimulated with ,Ulti-CD3 and cytokincs 
werc measured In the 5upematan($ by ELISA. Data prescnted as mcao +/- SE.~ . 
'" 
IL-IO production were increased and IFN-y produclion was decreased as compared 
responses in splenocytl's from PBS rontrols and spl"nocyt"~ 13k"" aft .... lwo 1'~lche., 
indicating a trend tov .. ards s)'stemic Th2 skewing after rep",lted cpicutaneous Alllsakis 
exlmct e~posures (Fig. 4A.8b). 
4..1.6 Local patholop ' indu~cd by cpicutanrous A llirak is e.tposurc is primarily 
dep<'ndent on 11...-1 3 and th e IL-41{a 
Mice deficient in 11..·4, 11..-13. IL-4fil..-13 or Ihe IL-4Ra were exposed 10 Ihru 
epicut:meous applications of Am:wku antigen. IL-4 ./- mice showed simil:tr epidermal 
hyperplasia a"d detmal thickening to wildtype mice, and also exhibited a strong 
infiltration of immune cells (Fig. 4.4.9), I/ow('\'('r. very few infiltrating eosinophils "'ere 
viSIble in tissue sections from this strain. 
IL-13 ./- and IL-4I1L·13 -1- mice had drllllllltically reduced epitlmnal hypeypl:l:Sia and 
dermal thickening. In addition. infiltration of immune cells inlo Ihe dermis was strongly 
mluced in IL·13 ·f· and IL·4fIL·13 -1- mice. IL-4Ra-l. mice also had reduced epidermal 
hyperplasia. dermal thickening ood infiltration of immune cells as compared to ",i ldtypt" 
mice. However. a small degree of inllammation remained, contrary !O H.· 13 ./. mice, in 
which \inually no inflammation was present 31 aU Together the data indicate a primary 
role for [L-13 in local skin pathology due to epicutaneous application of Anisakis e:uracl. 
4.-1.7 Diffcffnccs in iS OIYPf antibody production in IL· 4 ·f-, 11",, 13 ·f· and IL.~R (l .(. 
mict 
Unlike wild\ype mice in which AniS(Jkls-~pecilk [gG 1 and lotal and A'iisakis- spe~ific 
IgE were raised. lL-4 -/- mice h:Jd undetectable levels of both specific and total 'SE lind 
ollly low Allisakis-specific !gGl levels (Fig. 4.410 and Fig_ 4 ,4.1 1). Att/sakis-specific 
IgGla le~'eJs were r.llsed. indicatmg skewing lowards a type I response. IL-13 -1- mice in 













figure- 4.4.\1. IIblolllj(ical fUlure-s or .. ·ildtypf and i:tne- dtficitlu mouse- .kin 
(·plculant'uusl)· npolfd 10 I'OS ur Anisllkis fXU·\j (I. Scrlions were stained with H&E. 
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C:PltUl81lW1Isly c:~poSl:'d 10 PBS or Amsuku C:XU1IC1 (n - 4), pnd Ani.mtis-spa:iflC [gOI. 










~ -~---.... . -"~ " .... ,.~ ........ .. " 
_'NT CJIL-I·i. Eiiiillt..-IJ./. CJI ..... 41}.i. ~1L-4Ra./. 
e a @ -a 





I.. ..' ,t' ,.' .. ' I.' --
....... .... ,. -0- 11..-4-.. -6- tL.]J-I. -o-1L-4JIJ..!. -o- IL-IRo.../. 
Figure -1.4. 11 . TOlal ~nd A";l akil -5pttl fic IgE in ..-ildtype and gcnr ddid~1 mitt. 
l'. t ,C<' were epicuum<:ously "x~ 10 PBS or A"'loid;r e:ICIIIICI {n .. 4). and IOIal and 
Ani!okis-specific IgE wen.' measured u; ELISA DaUl pn."SC11I~'I1 as mean +-,. SEM 
StauSlical sigmficance was cakuJatro belv.'l:1;'f\ witdtypes and other strains . • ' . P<OOI. 
··· .P<O.OOI. 
'" 
mice. ahhough specific IgE was undetectable in the ELISA assay used. Levels of 
Anisakis-specific IgGl and IgG2a were decreased in IL-l3 -t- mict'.Il..-4/i3 -1- and IL-
~R!l -t- nllce had low levels of IgG I and undetectable levels of IgE, but raised IgGZa 
levlo"l s. lrIdicating type I ismype sklo"wing. O\'lo"rall the results indicate an important role 
for IL-~ in controlling antibody isotypl" switching in this model 
~A .8 ()ifferenc rs in Thlrrh2 profile~ in IL-I·I·, IL_I.1 _1. and IL-IRa -f- mice 
Cytokinc production by splenoc}1t's restimulated with anti-CD3 was compared between 
strains (Fig. 4A 12). Splenocytes from "ildtype controls produced Ihe Th2 c)1okines IL-
-I. IL-5. IL·9 and IL-l3 as well as IL-IO and low le"els of IFN-y. Splcnocytes from IL-I _ 
1- mice did not produce IL-9, btU maintained the production of IL-5 and IL-B, albeit at 
lower levels than in wildtype mice. IL- l3 _1_ and IL4113 -/- mice did not show 
product;on of It-~ , I t-9 or IL- I 3, but mainlllint'd production of IL-5, at lower I Io"~els th,," 
in wildtyJX' mice. A II three knockout strains (I L-~ -1-, IL-l 3 ..f - and 1 L--I1I3 -/-) showed a 
trend towards decreased production of IL-tO and increased production of IFN-r 
comr~red to wiJdtype mice. indicating some degree of shift towards a Th I profile. The 
trend Hlwards dccreas~>d production o( IL-IO was also obser\'ed III spknocytes from these 
Sirains Ihal were restimulated with Allisakis extract. 
~.-I,9 I L-I and the I L·~Ra arc important in anOllh)'lads foll owing epiclllanrOu$ 
sfosit;l ation lo A ll isaliis 
After imrnvenous challenge of epicutaneously sensitized mice. IL-~ -1- mice had reduced 
tempemture loss and signs of shock. in contrast to It-I J -,- mice. which behaved the 
same as wildtypes (Fig. 4Al3a.b). IL-IIlL·IJ -,- mice and IL--IRu -/- mice were 
compktely resistant to anaphylaxis in this model. In correlation with anaphylactic 
response'S.onl} wildtype and Il-IJ -1- mice had raised levels o( MMCP-l after challenge 
(Fig. ~.4,13c), Wildtypc and IL-13 -/- mice were also the only strains in which ISE was 














FigU rT -'-"'.n Cylokinc produ~lion lly ~ [ll en l)('"yIH from ('pku lll n~ou~ly ~e ns ilu.td 
"ildtyvt :Iond gene dcficient mice. Cells from indi"iduaJ ~plecll'! (II - 4) wert 
restlmuloted y,l t h anti·CDl or Ani$okis extra<:;t Supt'mlllaJlts " "Cle taken 3\ 43 hours and 
t}lokines ,,'eTC measured by ELI SA. Data presented 3$ mean +/- SEM. Statistical 
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~' i g u", 4A. ll . Apa llhy l ~cl ic rcspolUn following I nl r:wcnou~ challenge of 
cpicutan touJly Jtn,i ll:ud wildlrpc anti gene t1e n(icn l Inkc. Mice (n - 7·9, combined 
results of IWO c:fperimenl,) ,,-ere Cricu!an('(lusly exposed 10 PBS or AU/sakis c~tracl at 
days 0-5. 11-1 S and 21-25, !hen challenged imrnveoou,ly on day 25 wilh Anisukis 
eJltmcl a) Rectal tcmptmlures were recorded ror 70 minutes following challenge. PBS· 
exposed mice did 001 show Irn'lpcmturc loss In response 10 Allisukis ch.allenge (data nOl 
sllo\\1I). Data presented as mean 'f"/_ SEM b) Reactions were rnletl using a 5coring system 
(0. no reactions: I. Irritability. scratching lind/or hyperscnsith'ity 10 touch; 2. reduced 
:lCliv!!),. pilar crecti and/or diarrhoea.. 3, I)'ing flat but upright, weakness and/or cyanosis: 
-I. lymG on side. loss of grip, 00 acth'ity upon prodding. loss of consciousness with or 
without con\ul$ions~ S, death.), c) Serum MMCP·1 11.'\'1;'15 after ~halleng<! "ere measured 
by ELISA. Statistical Slgnlfic.a1'lC1.' was ttSSeSSI.'d betw~n PBS· and A"I.f{Jkls·~nsitiled 
mit". Datil presented as mean +/. SFM " . 1'<0.01 . ••• . r<O.OOI 
and the signs of anaphylaxis. As an3phyla~is was only partially reduced in IL· 4 ./- mice. 
mher mc<:hanisms such as igG-m~di3t ... d anaphyla~i~ may alliQ playa role here. This 
would explnin why IL-4R(t -I-mk~. deiident in both IgE and IgG anlibodies, arc 
resistam 10 anaphylaxis in this mooel. 
4A.1 1l Ana phylllx ;~ is pa rlia Ill' 'lbrog3led in f",ti-I g£ or a nl;- F'c-y Ki. UI1I Irealed III ice 
Mice were Ireall~d wilh ami-lgE, anti-FC"/RIIIHl or comrol antibody prior to mtravenous 
challenge In order to determine the roles of IgE and !gG in anaphylaxis following 
cpicutaneous scnsitization with Allisukis extrac\. Anti-IgE treatment dfectively removed 
IgE from the serum and did not significantly affect IgGI levels (it has been sho"n IgGl 
is the anaphylactic IgO isotype in mice)"- ~ (Fig. 4.4.14a). Anti_FcyRIfIIH treatmem did 
not affect IgE levels. but reduced measured IgGI levels for reasons unknOVo"Tl. II W:lS 
amicipat~d that intravenous lItlhgen administration would decrease the levels of free: 
antilx>dy in the serum. but there is no obvious reason why this ... ff~cl should be greater III 
one group than in the others. As the purpose of anli-FcyRIII)! 1 treatment was to block 
IgG-mediated anaphylaxis by binding to the FcyRlUIIJ, the decrease in IgGI in anti· 
FC"(RJ[III I treated mice should not alTeetthe interpretation of me results. 
After inlrav~nous challeng<!, both 3Ilti- lgE and anti-FcyRWIII treated mice <!xbibited 
ilIIaphybc\ic reactions, with a sligbt but significant decrelsc in tempcr.uure loss 
comp:1red to conlrollrealed mice (Fig. 4.4.14b). ThIs sugg~sts that eIther IgE or [gG can 
mediale anaphyla~i5 following epicutaneous seru;iti1.ation. althollgh IgO appears to play 
the more significant role_ Unfonunate ly there was not enough depleting amibody left to 
repeat this experiment Il ith the addition of a group treated with botb anti-lgE and ami-
FeyRlIml in order to eonfinn this hypothesis. MII-·lep-l levels were raised in all three 
groups after challenge, sugge.~ling lhnt bolh IgE and IgG-mcdiated mast cell 
degranulation are possible in this model. Anti-ckit treatmcnt at days J8 and 20 led to l 
reduction in serum MMCP-\ levels after challenge (Fig. 4.4. J 4e). indicating p:1r1ial mast 
cell depiction. and was associated with decreased temperature loss after challenge and a 
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Figure ~ .·U-l. A" ~ ph) L:. ct ic resp" nses r" lIowing treat ment with ~ n l i· l gE, anti-
FcrRllfl U or control a nl ibod y. Mice (n • 7·8. combined results of IWO experiments) 
were epicutoneously exposed to A "isakis eXIt'llC! :ll days O· S, 11-1 5 and 21 -25. Depicting 
antibody was administered 011 day 24. and mice were challenged i.v. with Allisakis extract 
on day 25. Results are expressed as mean +/- SE.\.1. a) Total IgE and Allisakis-specific 
IgG 1 were measured by EU SA. llcfore and after values " 'ere compared for statistical 
sigmficance. b) Recta l temperatures .... 'ere recorded for I hour after challenge. Stat iMical 
s ignifica~ was assessed b~tween control-treated mice and mice treated with a 
neutralizing antibody. c) MMCP-l levels were measured in serum taken on day 24 and 
on day 25 afier challenge . Before and after values were compared for statistical 
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Figure .. IA. IS. The eITect or mas t celt depiction on anaphylactic responses in 
cll icUianeotlsly sensitized min. Mice (n ~ -I) were ~pjcuulJ1oously exposed to Allisuk;s 
~'XlmCl III days 0-5. II-IS and 21·15. Depicting antibody was oommi51ercd on days 22 
and 24, Bnd mice were challenged intravenously wilh AniSllhs eXlracl on day 25. Data 
presented as m~:an - I· SEM. a) MaS! cell depletion was assessed by measlIring MMCP-l 
levels in the scrum after illlr:l\"cnous challenge. Statistical significance was assessed 
bc:lwccn control and antj-c~it treated mIce. b) Rectal temperatures were recorded for 1 
hour aftcr challcng~. c) Reactions wen: rated using a scoring system (0. no reactions; I. 
irritability. scratching and/or hypersensitivity to Touch; 2, reduced aCTivity. pilar erecti 
and/or diarrhoea; J. lying flaT but upright. weakness and/or cyanosis; ~. lying on side. loss 
of grip. no aCTivity upon prodding. loss nf cnnscinll.'meS5 with or \>"thouT convulsIOns; 5, 
death.). '. P<O.05; +. death . 
met:hanisms must play Ht lea51 H partial role In anaphylaxis due to epicutaneous 
~.-n:llti7.atioJL 
4.-1.1 L The role of IL-4Ra expression on CD4' T ce lls and nJ:lcrophagtllfnrut rophi15 
in lonlskin pathology following epiculan oou~ appLintion or Anisokis extract 
The experimental data sho"T1 above demonstrntes that the Il-4Ro: plays an important 
roil"" in lot:al skin pathology, systemiC sensiti1.8tion and anaphylactic reoctions following 
epicutaneous applic:ltion of Animkis extract. The availability of ccl1-speeific 1l_-4Ra _1_ 
mice enabled B more thorough dissection of mt'Chanisms involved in epicutnllCOus 
sensiti7.8tion by allowing for determination of the ne<:essity for IL-4Ra on various cell 
types. 
As in previous e., periments. epiculaneous application of Anisalds extract ClIused lot:a1izo:i 
dermat itis in wildtyPt' mice consisting of cpidennal hyperplasia, dennaJ thickening and 
inflammatory cell infiltration (Fig. 4.4.16). This was reduccci in Il-4Ra .1- mice. A 
mInority of lL_4Ra -/- mice developed epidermal hyperplitSia almost comparuble 10 that 
secn in wildlyPt' mice (approximately 25%, data not sho"'II), but did not sho" increased 
infiltllllion ofinfl:ullInatOIY cells compared 10 PBS controls. 
Llk~ wildtyiH' mIce, after epicutaneous application of Anisalds eXlraet. CD·I' T-cell 
specific 11.-4Ra -f- mice dcveloped dermatilis characterized by epidcnnal hyperplasia. 
dcnnalthickening and infiltration of immune cells (Fig. 4,4 16). On average, epidenn~1 
hyperplasia in CD4· T-cell specific IL-4Ra -I- mice appeared Ille $3IT\C as in I'o;ldIYpe 
olice, but occasionally epidcnnal hyperplasia was strollgly exacerbat<'!l (drua 1I0t shol'oTl). 
In ihese cases. parakeratosis ,,·as enhanced. MlICrophageilleutrophil sped lie IL-4Ra -1-
mice also de\·doped dennal;lis similar to Ihat of "ildtype mice. AIli.lGkis-exposcd mice 
did nOI show di fference5 in pathology compared to OVA-exposed mke in any ofihc 
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Figu re -104 .16. II iSlll logiul fcaturl'll uf skin , il f'S epiCU l anl'flu ~ l)' .. 1 p,,,ed I" Aniwki.\' 
u iraci in "ildl ~ p e. 1I.r4H.a -1-. CI)-I ' T-n ll spedlk IL--IH.a -/- and ma~nlllh a l!e1 
neut ro phil 5pccific II .-'lta _1_ mkc. 5l'Ctions "cn' stained \\ilh H&E. Photogl'llphs 
were taken lit ..\(l()x. The phologrJphs are representative of 3 experiments. n = ..\-5. 
'" 
4.4.12 The role of IL-4Ra expression on CD4+ T cells and macrophages/neutrophili 
in systemic sensitization following epicutaneous application of Anisakis extract 
Antibody isotypes were measured in the serum following epicutaneous Anisakis extract 
application (Fig. 4.4.17). Wildtype mice showed a type 2 isotype profile, with high levels 
of total IgE and Anisakis-specific IgG 1, but only very lew levels of Anisakis~specific 
IgG2a and IgG2b. Macrophage/neutrophil specific IL-4Ra ~/~ mice also showed type 2 
skewing, with high levels of total IgE, moderate amounts of Anisakis-specific IgG 1 and 
low levels of Anisakis-specific IgG2a and IgG2b. In contrast, CD4+ T-cell specific cel 
IL-4Ra -/- mice showed a mixed type l/type 2 antibody profile, with comparatively high 
levels of total IgE, and Anisakis-specific IgG 1 and IgG2a, but levels of Anisakis-specific: 
IgG2b comparable to wildtypes. Complete IL-4Ra -/- showed type 1 antibody skewing, 
with high levels of Anisakis~specific IgG2a and IgG2b, but virtually no Anisakis-specific 
IgG 1 and total IgE. This indicates that expression ofIL~4Ra on CD4+ T cells plays a role 
in inhi~iting type 1 antibody isotype switching following epicutaneous sensitization, 
probably by mediating the differentiation of naIve T cells into Th2 cells producing IL-4 
and IL-13. 
4.4.13 The role of IL-4Ra expression on CD4+ T cells and macrophages/neutrophils 
in Thlffh2 skewing following epicutaneous application of Anisakis extract 
Restimulated splenocytes from CD4 + T cells produce a mixed Th 1 /Th2 response, with 
production of both IFN~y and production of Th2 effector cytokines (IL-5, IL-9 and IL-
13)(Fig. 4.4.18). IFN~y production tended to be raised in CD4+ T-cell specific IL-4Ra -/-
mice, while Th2 cytokines tended to be lower. Restimulated splenocytes from 
macrophage/neutrophil IL-4Ra -/- mice produced significantly lower levels of IL-5, IL-~ 
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Figure 4.4.17. Antibody production in wildtype, IL-4Ra -/- and cell specific IL-4Ra 
-/- mice after epicutaneous sensitization. Mice were epicutaneously exposed to 
Anisalds extract (n = 3-5), and Anisalds-specific IgOl, IgG2a and IgG2b were measured 
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Figure 4.4.18. Cytokine production by splenocytes from epicutaneously sensitized 
wildtype, IL-4Ra. -/- and cell specific IL-4Ra. -/- mice. Cells from individual spleens (n 
= 4) were restimulated with anti-CD3. Supernatants were taken at 48 hours and cytokines 
were measured by ELISA. Data presented as mean +/- SEM. Statistical significance was 
assessed between wildtype mice and other strains. *, P< 0.05; **, P<O.Ol; ***, P<O.OOl; 
N, undetectable. 
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4.4.14 The role of IL-4Ra expression on CD4+ T cells and macrophages/neutrophils 
in anaphylaxis following epicutaneous sensitization with Anisakis extract 
Intravenous challenge with Anisakis extract was given to mice sensitized epicutaneously 
with Anisakis extract. After the challenge, CD4+ T-cell specific IL-4Ra -/- mice . 
developed ahaphylaxis, but responses were significantly attenuated compared to those in 
wildtype mice (Fig. 4.4.19a,b). This was reflected by a decrease in temperature loss. 
MMCP-llevels were not significantly lowered (Fig. 4.4.19c). 
Following intravenous challenge of Anisakis-sensitized mice with Anisakis extract, 
macrophage/neutrophil specific IL-4Ra -/- mice developed anaphylaxis to the same 
degree as wildtype mice. Therefore IL-4Ra expression on macrophages and neutrophils, 
and accordingly the presence of alternative macrophages, does not play a major role in 
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Figure 4.4.19 Anaphylactic responses following intravenous challenge .f 
epicutaneously sensitized wildtype, IL-4Ra -/- and cell specific IL-4Ra -/- mic~. 
Mice (n = 8-10, combined results of two experiments) were epicutaneously exposed 10 
Anisakis extract at days 0-5, 11-15 and 21-25, then challenged intravenously on day 25 
with Anisakis extract. Data presented as mean +/- SEM. a) Rectal temperatures were 
recorded for 1 hour following challenge. b) Reactions were rated using a scoring system 
(0, no reactions; 1, irritability, scratching and/or hypersensitivity to touch; 2, reduced 
activity, pilar erecti and/or diarrhoea; 3, lying flat but upright, weakness and/or cyanosis; 
4, lying on side, loss of grip, no activity upon prodding, loss of consciousness with or 
without convulsions; 5, death). c) Serum MMCP-I levels after challenge were measured 
by ELISA. Statistical significance was assessed between wildtype mice and other straim. 
*, P<0.05; **, P<O.OI; ***, P<O.OOI. 
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4.5 DISCUSSION 
The data presented in this chapter demonstrate for the first time that epicutaneous 
exposure to Anisakis extract can cause systemic sensitization in mice, and shows 
distinctive roles for the cytokines 11-4 and IL-13 during sensitization via the 
epicutaneous route and subsequent systemic allergic reactions. 
Allergic skin diseases are associated with considerable morbidity, particularly when 
chronic 18. Two populations at special risk of allergic skin disease are children born to 
atopic families, and people working in jobs that involve wet work, latex/rubber gloves, 
friction, repeated microtraumas or exposure to solvents or caustic materials. The former 
group is at an increased risk of developing eczema while the latter is at an increased risk 
of developing eczema, contact dermatitis and contact urticaria 18, 76. The present study 
uses an experimental mouse model to dissect the immunological mechanisms of eczema 
induced by Anisakis extract, a relevant occupational sensitizing agent. Allergy to Anisakis 
proteins in the working environment has been demonstrated in several studies 5,7,8,77,78, 
Reactions to Anisakis include protein contact dermatitis, conjunctivitis, asthma and 
rhinitis. 
Wildtype BALB/c mice exposed to Anisakis extract developed epidermal hyperplasia, 
dermal thickening and infiltration of immune cells into the dermis. 19B-bearing cells were 
shown infiltrating the dermis of Anisakis-exposed mice, mimicking the response seen in 
patients with eczema 32, 58, The increased expression ofI1-4 and IL-13mRNA in Anisakis 
exposed mice is also in agreement with data from human eczema sufferers 11,38, Taken 
together these data demonstrate the relevance of the mouse model to this study. 
In order to establish the specific roles of IL-4, 11-13 and the IL-4Ra. in local skin 
inflammation, we utilized gene deficient mice. Mice deficient in IL-4 maintained skin 
inflammation, although the infiltrate contained fewer visible eosinophils, in agreement 
with previous studies 63, I~ contrast, in 11-13 -/- mice the skin pathology foll<?wing 
Anisakis exposure was strikingly reduced, with few signs of epidermal hyperplasia or 
cellular infiltration. Pathology was similarly reduced in mice deficient in both IL-4 and 
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IL-13 (IL-4113 -/-) or in mice deficient in the IL-4Ra., through which both IL-4 and IL-13 
signal. This suggests an important role for IL-13 signalling through the IL-4Ra. in 
mediating skin inflammation following epicutaneous exposure to Anisakis extract, and 
most likely other allergens as well. In all experiments where OV A sensitization was 
perfonned in parallel with Anisakis extract sensitization, there were no noticeable 
differences' between responses to these two substances. 
Having established the importance of the IL-4Ra. in Anisakis-induced skin inflammation, 
we used cell specific IL-4Ra. -/- mice to detennine the necessity for IL-4Ra. expression 
on CD4+ T cells, macrophages and neutrophils. It has been previously shown that a 
predominance of CD4 + T cells and macrophages exists in the cellular infiltrate of OV A-
induced dermatitis in mice, and that a.~+ TCR cells in particular are critical for skin 
inflammation and the generation of Th2 responses 53, 63, 79. In the current study, a similar 
predominance of macrophages and lymphocytes was observed in the cellular infiltrate. 
However, the results of experiments using CD4+ T cell specific IL-4Ra. -/- mice 
(LckcreIL_4Ra.-lloX) and macrophage/neutrophil specific IL-4Ra. -/- mice (LysMCre_ 
IL_4Ra.-lloX) show that IL-4Ra. expression on CD4+ T cells, macrophages or neutrophils 
does not play a major role in regulating skin inflammation. CD4+ T-cell specific 
IL-4Ra. -/- mice showed similar pathology to wildtype mice, despite having partially 
reduced Th2 responses. Macrophage/neutrophil specific IL-4Ra. -/- mice also had similar 
epidermal hyperplasia to wildtype mice, indicating that IL-4Ra expression on 
macrophages or neutrophils was not critical for acute skin inflammation. It is possible 
that alternative macrophages may playa more important role in chronic eczema, in which 
skin remodeling occurs 38. 
The data from this model suggest two possibilities: 1) IL-4Ra. expression on another cell 
type is critical in local skin pathology, via IL-13 signalling. This may be a local skin cell 
such as an epithelial cell, keratinocyte, Langerhans cell or dermal dendritic cell. In this 
. . 
case, topical application of an IL-4Ra. antagonist or anti-IL-13 monoclonal antibody 
might be sufficient to reduce skin inflammation and might remove the necessity for 
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systemic treatment. Experimental models of asthma show that IL-13 has direct effects 
upon non-immune cells such as epithelial cells, endothelial cells, goblet cells and smooth 
muscle cells 80-87. It is possible that IL-13 functions in a similar way to induce 
pathological changes in the skin. 
2) Resistance to skin inflammation in IL-4Ra -1- and IL-13 -1- mice is due to Th1 
skewing and/or Th2 cytokine' reduction in these strains. As far as this possibilitY is 
concerned, a recent study showed that IFN-y -1- mice had decreased dermal thickening 
compared to wildtype mice, suggesting that IFN-y enhances rather than abrogates skin 
hypertrophy in mice 63. IFN-y is predominant in chronic eczematous lesions in humans 88 
and is thought to exacerbate inflammation by causing keratinocyte apoptosis II, 89. 
However, in human trials, recombinant IFN-y treatment reduced skin inflammation in 
atopic eczema (but not nonatopic eczema) 90-93, In another murine model, CpG DNA 
treatment increased IFN-y production and reduced Th2 cytokine expression and the 
severity of eczema in 16/26 mice, but 10/26 mice had IFN-y hyperproduction and showed 
exacerbation of lesions 94, Overall these studies indicate that the right amount of IFN-y 
can be beneficial to atopic eczema, but that excessive IFN-y may be detrimental, 
In addition to local skin inflammation, mice epicutaneously exposed to Anisakis extract 
developed Anisakis-specific IgG 1 and IgE antibodies, indicating systemic sensitization 
through the skin. Intravenous challenges were performed in order to certify that this 
sensitization was biologically relevant, and indeed, sensitized mice developed 
anaphylactic responses upon challenge. As sensitization via the skin may play a 
significant role in the development of subsequent allergic diseases, an understanding of 
the underlying mechanisms is crucial for the development of therapies that can intervene 
at this stage 27,51,53, This is of relevance for children showing the first signs of eczema 
and for workers demonstrating skin responses to occupational allergens. 
Herrick et al investigated the role ofIL-4 and IL-13 in airway hyperreactivity following 
epicutaneous sensitization with OV A, and concluded that IL-13 was the critical mediator 
in regulating Th2 activation after epicutaneous sensitization 27. In the current study, 
anaphylaxis after intravenous challenge was used to assess systemic sensitization to 
254 
Anisakis extract in various gene deficient and transgenic mice. The results showed that 
epicutaneously sensitized IL-13 -/- mice did not have reduced anaphylactic responses 
after challenge. IL-13 -/- mice produced both total IgE and Anisalds-specific IgG 1, albeit 
at reduced levels, and had serum MMCP-1 levels equivalent to those of wildtype mice, 
indicating that mast cell degranulation occurred after challenge. In contrast, IL-4 -/- mice 
showed a reduction in anaphylactic reactions including temperature. loss. IL-4 -/- mice 
produced approximately the same levels of IgG 1 as IL-13 -/- mice, but total IgE was 
strikingly decreased, as were MMCP-1 levels in the serum. Decreased MMCP-1 levels 
could result from reduced numbers of mast cells or reduced degranulation of available 
mast cells. 
IL-4/13 -/- and IL-4Ra. -/- mice were completely protected against anaphylaxis. Both of 
these strains had very low levels of Anisalds-specific IgG 1, total IgE and MMCP-l 
present in the serum, while IgG2a levels were raised. Antibody depletion experiments 
with anti-IgE, anti-FcyRIIIIII and anti-ckit suggested that anaphylaxis in this model can 
be mediated by either IgE or IgG antibody, and is at least partially dependent on mast cell 
degranulation. As it has been demonstrated that IgGl is the only anaphylactic IgG 
antibody in ~ice 75, it is possible that the IL-4/13 -/- and IL-4:Ra. -/- strains were 
protected because of a deficit of IgE and IgG 1. Likewise, IL-4 -/- mice may have been 
partially protected due to strongly reduced IgE synthesis, associated with strongly 
reduced MMCP-1 levels. IL-4 was more important for anaphylaxis than IL-13 in this 
model. However, IL-13 may have partially compensated for IL-4, since IL-4 -/- mice had 
some degree of anaphylactic reactions, unlike IL-4/IL-13 -/- and IL-4Ra. -/- mice, which 
were completely protected. The data support an important role for IL-4Ra. in systemic 
sensitization via the epicutaneous route in mice. 
Subsequently, the role of IL-4Ra. on CD4+ Tcells and macrophageslneutrophils it: 
anaphylaxis in epicutaneously sensitized mice was investigated. Macrophage/neutrophil 
specific IL-4Ra. -/- mice reacted in the same way as wildtype mice to intravenom: 
challenge, undergoing anaphylaxis with temperature loss. Anaphylaxis was partiall} 
reduced in CD4+ T-cell specific IL-4Ra. -/- mice. The level of protection was not as 
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pronounced as the reduction in anaphylaxis in the intraperitoneal sensitization model 
described in chapter 3 of this thesis, highlighting mechanistic differences in different 
routes of sensitization, also seen by Herrick et al 65. It is unclear why CD4+ T cell 
specific IL-4Ra -/- mice experienced less severe anaphylaxis than wildtype mice. 
Total IgE and Anisakis-specific IgG 1 levels were not reduced compared to wildtype 
mice. However, levels of the type 1 antibody IgG2a were raised. It is possible that IgG2a ' 
present in the serum may have bound a portion of the injected antigen, resulting in a 
decrease in free antigen available to bind IgE and/or IgG 1. CD4+ T-cell specific IL-4Ra -
/- mice also demonstrated a trend towards decreased production of Th2 cytokines and 
increased production of IFN-r compared to wildtype mice. In chapter 3 we demonstrated 
that the presence of IFN-r was associated with a decrease in anaphylactic reactions. 
The fact remains that neither CD4+ T-cell specific IL-4Ra -/- mice or 
macrophage/neutrophil specific IL-4Ra -/- mice were completely resistant to anaphylaxis 
as IL-4Ra -/- mice were, nor had the strong reduction in Th2 cytokine production or 19B 
levels that IL-4Ra -/- mice did. This suggests that IL-4Ra on another cell type is 
important for induction of systen;lic sensitization, Th2 activation and IgE production via 
the skin, or that the overall phenotype resulting from the loss of lL-4Ra on all cells is 
responsible for the resistance to anaphylaxis and Th2 activation. Future studies should 
investigate these hypotheses, as the outcome has relevance for therapies aimed at 
treatment of eczema and prevention of the atopic march. 
In conclusion, the data demonstrate that epicutaneous exposure to Anisakis extract is a 
useful and relevant model of eczema in mice. The fact that Anisakis proteins appear 
capable of eliciting systemic sensitization via the skin highlights the importance of 
minimizing exposure to this and other allergens in fish processing workers. The Food and 
Agriculture Organization of the United Nations estimates that fishery and aquaculture 
production activities provided direct employment and revenue for 38 million people 
worldwide in 2002 95. In South Africa, the fishing industry employs approximately 
90 000 workers 96, An estimated 3-11% of workers involved in processing develop 
contact urticaria or protein contact dermatitis 16, Occupational dermal exposure to fish or 
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fish juices occurs mainly as a result of unprotected handling of fish during processes such 
as heading, skinning, degutting, mincing, filleting, trimming, cooking, frying, fishmeal 
milling, bagging and freezing 76, 97, Various preventative measures can be taken to reduce 
exposure, including the use of cotton-lined gloves and plastic sleeves, the immediate 
treatment of puncture wounds and lacerations and the use of emollients and moisturizers 
to protect skin. barrier function 98, In order to intervene at an early. stage to prevent 
exacerbation of symptoms and the atopic march, early subclinical biomarkers and target 
organ tests may be used for monitoring workers, such as eosinophil cationic protein, skin 
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CONCLUSIONS 
Ihis study demonstrates that Anisakis proteins are allergenic and can cause ingestion-
related allergic reactions, anaphylaxis and dermatitis in mice. IL-4, IL-13 and the 
common receptor subunit IL-4Ra. play important and distinct roles in these allergic 
diseases. 
Mice deficient in IL-13 or the IL-4Ra. showed particularly enhanced inflammatory 
responses against intraperitoneally administered Anisakis larvae, compared to wildtype 
and IL-4 deficient mice. Wildtype mice demonstrated the least inflammation but the 
strongest memory responses, with elevated specific IgG 1 and total and specific IgE. Live 
larvae predisposed wildtype mice to allergic reactions following subsequent ingestion of 
Anisakis proteins. Oral sensitization with Anisakis extract induced Anisakis-specific 
antibodies but was less effective at sensitizing for subsequent allergic reactions than live 
infection. Allergic reactions were reduced and abrogated in IL-4 -/- and IL-4Ra. -/- mice, 
respectively, suggesting important roles for IL-4, IL-13 and the IL-4Ra. in food allergy. 
Anisakis proteins behaved similarly to oValbumin in a mouse model of anaphylaxis. 
Mechanisms of anaphylaxis were explored using CD4+ I cell specific IL-4Ra. -/- and 
macrophage/neutrophil specific IL-4Ra. -/- mice. CD4+ I cell specific IL-4Ra. -/- mice 
were protected against anaphylaxis by an IFN-y dependent mechanism. Protection was 
associated with decreased degranulation of mast cells and may therefore be related to an 
in vivo inhibitory effect of IFN-y on mast cell degranulation. 
Epicutaneous application of Anisakis proteins in mice induced a localized dermatitis and 
led to biologically relevant systemic sensitization. Local skin pathology was dependent 
on IL-13, while IL-4 played an important role in systemic sensitization. Mice deficient in 
the IL-4Ra. were protected against both skin pathology and anaphylactic reactions 
following intravenous challenge of sensitized' mice. Deletion of IL-4Ra. on CD4 + I cells 
did not reduce skin pathology, but increased resistance to anaphylactic reactions. In 
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contrast, deletion of IL-4Ra on macrophages/neutrophils did not reduce anaphylaxis, but 
slightly decreased local skin pathology. 
Based on the models used in this thesis, observations can be made about differences in 
the immune responses elicited by exposure to live Anisakis, Anisakis extract and 
ovalbumin, and by differenf routes of exposure to these antigens. Live Anisakis it\duced 
much stronger systemic Th2 cytokine responses than Anisakis extract or OV A 
administered either orally, intraperitoneally or by epicutaneous application. 
Subsequently, exposure to live Anisakis was the most effective at sensitizing mice to have 
allergic reactions after the oral ingestion of Anisakis proteins. This strong sensitizing 
effect of live Anisakis could be due to factors such as its prolonged presence in the 
peritoneal cavity, the release of proteolytic enzymes and/or tissue damage caused by the 
parasite. However, once sensitized by live infection, mice responded to ingestion of 
Anisakis extract alone. Using intraperitoneal or epicutaneous sensitization, Anisakis 
extract behaved similarly to the model allergen OVA, although Anisakis extract tended to 
induce higher levels of total 19E than OV A, suggesting an intrinsic capability of Anisakis 
proteins to induce polyclonal IgE. Another point of interest is that epicutaneous 
sensitization with Anisakis extract consistently induced higher levels of specific IgE than 
intraperitoneal sensitization or even infection with live Anisakis larvae. This highlights 
the fact that the skin may be an important route of sensitization, particularly in fish 
processing workers. 
In conclusion, the data presented in this thesis have clarified certain aspects of Anisakis-
induced allergy, and contributed to the knowledge on the distinct roles ofIL-4, IL-13 and 
the IL-4Ra in various allergic diseases. 
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APPENDIX A - Reagents 
Anaesthetic 
l.2ml ketamine (Anaket-V) 
O.Sml xylazine (Rompun) 
Sml PBS. 
DEPC treated water 
lml diethyl-pyrocarbonate 
1 litre of water 
Caution: Work in the fume cupboard as the fumes from DEPC are toxic. Wear gloves as 
the skin is full ofRNAses, and use RNAse-free tips. 
Take the DEPC bottle from the fridge and let it warm to room temperature. Carefully 
remove the cap and stopper. 
Add the DEPC to the ddH20 (or any other solution being DEPC-treated) at a final 
concentration of 0.1 %. Shake well to disperse DEPC. Incubate at 37°C overnight with 





ELISA Block Buffer 
2% milk powder (20g) 
0.02% NaN3 (0.2g) 
lxPBS (lOOml of lOx PBS) 
Make up to 1 litre and store at 4°C. 
ELISA Dilution Buffer 
1% BSA (lOg) 
0.02% NaN3 (0.2g) 
1 x PBS (100ml of lOx PBS) 
Make up to 1 litre and store at 4°C. 
ELISA Substrate buffer 
0.2gNaN3 
O.Sg MgCL2.6H20 
Dissolve in 700ml ddH20. 
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Add 97ml di-ethanolamine. 
Adjust the pH to 9.8 with 10M HCl. 
Make up to 1 litre and store at 4°C. 





50ml Tween 20 
100mi 10% NaN3 
Make up to 5L with ddH20. 
Formaldehyde denaturing 1 % agarose gel 
For a 100mi gel: 
Ig agarose 
73.2ml DEPC water 
10.0ml MEA electrophoresis buffer 
16.8mI12.3M Formaldehyde (30-40% w/v) 
Add agarose to water and melt in the microwave. 
Let the melted agarose cool slightly so that it is comfortable to touch the flask (about 
60°C). . 
Add the 10x MEA buffer and mix well. 
CAUTION: perform the following steps in a fumehood as the formaldehyde fumes are 
noxious. 
Add the formaldehyde and mix well. 
Pour the gel (in the fumehood) and allow to set. 
Gel running marker (6x) 
50% (v/v) glycerol (diluted in DEPC-treated H20) 
0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol FF 
10mM EDT A (PH 8.0) 
Iscove's Modified Dulbecco's Medium (IMDM) 
Dissolve 1 tube (17.66g) IMDM in 750ml ddH20. 
Add 81.7ml of37g!L NaHC03• 
Add 2ml of 500x penicillin/streptomycin (PIS). 
Using IN NaOH, adjust pH to between 7.2 and 7.4. 
Make up to 1 litre. Filter sterilize and store at 4°C. 
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Just before use: add 50ml heat-inactivated FCS and 5ml 200mM L-glu per 500ml. Filter-
sterilize. 
Lethal anaesthetic 
500J,l1 Rompun (20mg xylazine/ml stock) Bayer 
2ml Anaket V (1 OOmg ketamine/ml stock) 
9mlPBS 
MEA electrophoresis butter 
0.2M MOPS (PH 7.0) 
20mM sodium acetate 
10mM EDTA (PH 8.0) 
For lOx solution: 
Dissolve 41.8g of MOPS in 700ml of sterile DEPC-treated H20. Adjust the pH to 7.0 
with 2N NaOH. Add 20ml of DE PC-treated 1M sodium acetate and 20ml of DE PC-
treated 0.5M EDTA (PH 8.0). Adjust the volume of the solution to 1 litre with DEPC· 
treated H20. Add DEPC to 1 % and incubate overnight at 31'C with shaking. Autoclave 
to heat deactivate the DEPC and to sterilize. Store at 4°C wrapped in foil to protect from 
light. 





Dissolve the above chemicals in 900ml distilled water. 
Adjust to pH 7.4. 
Make up to 1 litre. 
Filter sterilize. 
PNP Substrate 
Add 0.5g of 4-nitrophenyl phosphate disodium salt hexahydrate (PNP) to 50ml of ELISA 
substrate buffer. Mix. 





Dissolve in 1 litre of distilled water. 
Filter sterilize. Store at 4°C. 
RNA loading buffer 
Add 7.4J.1l ofloading buffer to 2.6J.1l of RNA. 
lOx MEA buffer 
10mglmi ethidium bromide 
Tris-Triton buffer 
100mM Tris 
0.1 % Triton-X 
Adjust to pH 8.0. 




APPENDIX B - Neutralization of Cell Samples for TGF-f3 ELISA 
• Prepare IN HCl and acidify to pH 3 . 
. -. Pipette 48111 of sample (e.g. cell supernatant) into em Eppendorftube. 
• Add 2111 of the prepared IN HCl to sample (1:25 dilution). 
• Incubate the acidified sample at 22°C (Rn for 15 minutes or at 4°C for 60 minutes. 
• From these acidified, incubated samples, pipette 48111 into an Eppendorftube and add 
2111 of IN NaOH (1 :25 dilution). 
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APPENDIX C - Glossary 
acanthosis - thickening of the epidermal layer; an increase in the thickness of the stratwn 
spinoswn (prickle celliayer)ofthe epidermis 
anaphyJaxis - a severe, systemic immediate-type hypersensitivity reaction involving 
multiple organ systems 
angioedema - oedema affecting the deeper layers of the skin, or subcutaneous or 
submucosal tissues 
anoxia - lack of oxygen 
cetaceans - an order of sea mammals composed of whales, dolphins and porpoises 
cornification - the maturation process of epidermal cells (also known as. keratinization) 
cutis - the whole skin 
cytokine - a non-antibody protein released by a cell in response to an antigen which acts 
as an intercellular mediator 
cyanosis - blue tinge to the skin due to lack of oxygen 
Der p 1 - a major house dust mite allergen 
dermatitis - inflammation of the skin 
dermis - the layer of skin between the epidermis and subcutis, composed of connective 
tissue, blood vessels, lymph vessels, nerve endings and glands 
epidermis - the outer layer of skin, a cornifying stratified squamous epithelium 
erythema - reddening of the skin (caused by congestion of the capillaries) 
excoriation - erosions and ulcers caused by self-trawna 
exocytosis - the appearance of migrating inflammatory cells in the epidermis 
fibrosis - excessive deposition of fibrous connective tissue 
helminth - parasitic worm 
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hyperaemia - increased blood flow to a part due to dilatation of blood vessels, resulting 
in reddening and/or engorgement 
hyperkeratosis -increased thickness of the stratum corneum 
hyperplasia - an abnormal increase of cells in a tissue or organ 
Jlypertrophy - an abnormal increase in cell size 
hypovolaemic shock - shock due to loss of blood volume 
hypoxia - insufficient oxygen 
hypoxaemia - insufficient oxygen in the blood 
idiopathic - of unknown cause 
interleukin - an immunoregulatory molecule which has effects within the lymphopoietic 
system 
keratinocyte - epidermal cell undergoing maturation 
keratosis - a condition of excessive development of horny tissue 
lichenification - a thickening of the superficial layers of the skin characterized by 
exaggerated crevices 
macule - a circumscribed change in colour of the skin, less than 1 cm diameter 
nematode - unsegmented worm with a rounded body and pointed end, belonging to class 
Nematoda 
oedema - excessive intercellular accumulation offluid in tissues or body cavities 
papule - solid elevation of the skin less than lcm diameter 
parakeratosis - abnormal cornification; cells of the stratum corneum (keratinocytes) 
retain nuclei 
plaque - flat topped swelling more than lcm in diameter 
pruritic - itchy 
pruritis - intense and persistent itchiness 
scale - accumulation of fragments of stratum corneum 
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spongiosis - intercellular oedema of the epidermis 
stratum corneum - outermost layer of the epidermis, composed of dead skin cells 
(cornified squamous epithelium) 
stratum germinativum (also called stratum basale) - germinative layer at the base of 
the epidermis, c.o~posed of living keratinocytes that will gradually gro'Y ~loser to the 
surface and cornify (keratinize) to form the stratum corneum. Is composed of simple, 
columnar epithelial cells on a basement membrane. 
stratum granulosum -layer of the epidermis composed of 1-3 rows of flattened, 
granular cells, the last living layer of cells 
stratum lucidum - a layer of the epidermis composed of a single row of freshly made 
cornified squamous epithelial cells 
stratum spinosum -layer of the epidermis beneath the stratum granolosum, composed 
of multiple layers of cuboidal cells called prickle cells. Also known as the prickle cell 
layer. 
urticaria - wheals induced by histamine release, hives 
vasodilation - dilation of the blood vessels 
wheal - a sharply demarcated raised lesion caused by dermal oedema 
zoonosis - a disease of animals that may be communicated to man 
277 

